data_2kl1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kl1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -102.33 123.07 45.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.78 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.598 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 6.2 p -45.67 164.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.097 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.431 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 25.1 mmt -104.87 -70.27 0.78 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.609 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.9 t -156.2 175.26 14.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.712 0.291 . . . . 1.0 110.95 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.8 105.91 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.8 mt -93.71 143.96 27.41 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.857 -0.156 . . . . 1.0 110.889 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -72.9 156.42 52.55 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.159 1.906 . . . . 1.0 112.274 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.13 32.36 21.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.864 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 6.3 mtt -122.32 152.39 60.76 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 110.506 -0.183 . . . . 1.0 110.506 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.01 -16.88 57.39 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.534 2.156 . . . . 1.0 112.932 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 -24.03 27.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.96 0.409 . . . . 1.0 111.222 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 131.06 45.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.818 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.04 -21.21 35.3 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.59 -43.94 4.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.788 0.328 . . . . 1.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.29 140.45 49.31 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -131.53 159.21 38.83 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.301 0.572 . . . . 1.0 110.696 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.59 133.31 50.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.273 -0.876 . . . . 1.0 109.805 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.598 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 110.07 -23.1 21.96 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.418 ' OD1' ' NE ' ' A' ' 61' ' ' ARG . 36.3 m-20 -79.36 144.47 34.15 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.025 -0.103 . . . . 1.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 -110.34 161.4 15.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.921 0.391 . . . . 1.0 110.787 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -98.05 115.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.434 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.87 -14.89 28.94 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.12 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 177.93 168.06 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.249 0.547 . . . . 1.0 111.161 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.0 125.94 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.79 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 47.79 22.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.0 111.176 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -6.87 57.29 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.992 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -87.39 126.4 62.43 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.417 -0.325 . . . . 1.0 111.161 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.54 126.66 8.41 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.589 1.526 . . . . 1.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mm -100.62 120.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.731 0.777 . . . . 1.0 111.933 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -116.13 -19.32 10.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.455 -1.248 . . . . 1.0 111.142 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -133.32 155.9 48.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.179 0.514 . . . . 1.0 111.093 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -71.68 -32.33 67.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.454 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -65.01 -32.45 74.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.584 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -58.86 -30.31 67.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.619 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -72.16 -29.09 31.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.332 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.11 -40.02 84.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 O-C-N 123.29 0.369 . . . . 1.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.1 p -69.48 -40.86 76.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.337 0.589 . . . . 1.0 109.551 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -56.37 -56.79 16.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.56 -36.29 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 1.0 110.455 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -57.79 -41.57 82.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.293 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.71 -42.88 98.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.493 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -89.32 154.29 20.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.171 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.48 -176.17 2.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.985 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.68 138.91 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.214 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.38 0.87 81.95 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 29.7 t70 -74.67 179.62 4.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.087 0.47 . . . . 1.0 110.568 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.536 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 80.7 ttt180 -139.56 123.4 17.58 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.87 134.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.777 0.799 . . . . 1.0 111.821 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.48 122.61 32.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.502 -1.226 . . . . 1.0 108.601 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.6 t -116.17 130.3 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.0 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.7 m -96.95 136.11 37.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.308 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.62 151.32 37.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.62 137.15 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.103 0.478 . . . . 1.0 110.356 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 17.7 ttm180 -136.66 120.48 17.42 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.789 -0.642 . . . . 1.0 109.467 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 49.97 39.42 18.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.782 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 73.33 12.64 4.77 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.53 0.196 . . . . 1.0 111.53 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -110.74 100.25 9.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.738 0.304 . . . . 1.0 110.395 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.17 127.62 33.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.47 0.652 . . . . 1.0 111.711 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.07 141.2 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.774 -0.648 . . . . 1.0 111.139 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.03 146.17 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.616 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.98 130.91 53.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.077 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.416 ' OE2' ' CZ ' ' A' ' 54' ' ' ARG . 77.3 tt0 -92.23 105.39 17.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 mp -111.3 146.33 37.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.045 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.88 130.21 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.59 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -66.11 132.91 49.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.802 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.11 133.81 54.26 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.988 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.99 120.81 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.943 -0.392 . . . . 1.0 109.943 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.52 -69.13 0.5 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.028 -0.269 . . . . 1.0 111.657 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.1 p -128.4 165.34 20.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.044 0.45 . . . . 1.0 111.03 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.29 122.15 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.87 153.24 52.12 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.757 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 152.63 64.7 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.611 2.207 . . . . 1.0 112.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 52.61 45.15 29.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.519 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.8 mmt -121.17 154.18 58.39 Favored Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.013 0.196 . . . . 1.0 110.706 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.05 -19.34 65.92 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.339 2.026 . . . . 1.0 112.869 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 22' ' ' LEU . . . -89.63 -24.01 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.844 0.354 . . . . 1.0 111.484 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.23 141.37 52.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.627 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -22.73 14.03 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.4 -34.01 4.44 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.452 ' CD2' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -118.55 139.79 50.9 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.934 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.18 152.65 49.38 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.511 0.672 . . . . 1.0 110.964 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.06 139.92 53.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.33 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.49 -28.88 13.19 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.206 -1.157 . . . . 1.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.464 ' CG ' HH21 ' A' ' 61' ' ' ARG . 80.5 m-20 -70.75 147.02 49.45 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.294 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -114.58 159.71 20.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.891 0.377 . . . . 1.0 110.351 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.7 mm -97.55 118.75 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.396 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.27 -15.9 25.32 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.786 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.95 163.5 0.81 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.139 0.495 . . . . 1.0 111.076 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 98.1 mt -138.29 129.09 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.87 0.843 . . . . 1.0 110.713 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.83 15.33 0.23 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.11 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.75 -5.84 43.77 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.376 -0.375 . . . . 1.0 112.234 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -94.35 134.41 25.64 Favored Pre-proline 0 CA--C 1.556 1.175 0 CA-C-N 117.174 0.487 . . . . 1.0 110.76 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.14 134.82 13.25 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.848 1.699 . . . . 1.0 111.937 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mm -102.81 116.18 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.633 0.73 . . . . 1.0 111.36 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -110.86 -26.84 9.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.502 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 p -136.99 165.34 26.22 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.168 0.509 . . . . 1.0 110.901 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -66.5 -33.62 76.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.372 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.37 -39.14 89.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 1.0 110.405 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -51.44 -39.13 56.76 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.473 -0.491 . . . . 1.0 109.868 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 42' ' ' ILE . 50.0 mm -62.72 -34.71 67.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 121.233 -0.187 . . . . 1.0 111.031 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.62 -44.48 99.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.735 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.548 ' HG ' ' H ' ' A' ' 45' ' ' TYR . 65.7 p -58.36 -43.55 88.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.544 0.688 . . . . 1.0 110.542 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.548 ' H ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -58.3 -57.6 12.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.191 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 45' ' ' TYR . 97.6 t -52.59 -40.3 33.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.95 0.405 . . . . 1.0 110.298 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -37.49 80.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.386 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.45 -48.04 82.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.798 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -89.31 175.02 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.171 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 51' ' ' ALA . 17.8 pt20 -155.41 125.32 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.705 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -2.69 124.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 125.73 1.894 . . . . 1.0 110.414 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.57 -6.53 49.24 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.609 -1.397 . . . . 1.0 109.609 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 20.6 t70 -83.89 177.22 8.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.851 0.358 . . . . 1.0 110.872 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 58.7 mtp180 -146.59 123.48 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.566 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.0 m -130.99 131.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 122.225 1.012 . . . . 1.0 111.674 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.568 ' H ' ' HE ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -75.05 116.96 16.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.763 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.65 134.92 43.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.837 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 m -101.81 133.38 46.65 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CD1' ' CD2' ' A' ' 22' ' ' LEU . 31.5 p90 -146.5 150.14 34.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.77 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.422 0.629 . . . . 1.0 110.759 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.464 HH21 ' CG ' ' A' ' 26' ' ' ASP . 40.6 ttm-85 -138.04 121.27 16.92 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.598 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 53.29 39.82 30.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.932 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 69.81 10.13 7.41 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.484 0.49 . . . . 1.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -110.34 106.53 15.93 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.479 HE21 ' C ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.01 127.7 33.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.257 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -142.0 144.58 33.73 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.04 140.75 29.54 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.504 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.72 125.81 51.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.828 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -79.97 102.84 9.46 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.839 -1.073 . . . . 1.0 109.948 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.29 142.63 41.64 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.484 0.659 . . . . 1.0 110.667 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.09 134.32 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.375 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -71.6 129.48 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.979 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt . . . . . 0 CA--C 1.552 1.03 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.096 179.771 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 38.2 t . . . . . 0 C--O 1.217 -0.629 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' VAL . 32.7 m-85 -126.97 132.17 50.89 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.647 0.261 . . . . 1.0 110.671 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 8' ' ' TYR . 41.4 t -44.47 170.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.5 tpp -95.11 -65.28 0.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.392 -0.193 . . . . 1.0 111.231 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -155.15 173.84 16.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.266 -0.573 . . . . 1.0 111.095 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 t -118.03 100.74 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASN . 9.7 mp -99.86 117.93 62.63 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.84 -0.6 . . . . 1.0 110.323 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.77 49.36 0.04 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.112 2.541 . . . . 1.0 112.838 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 58.4 t30 -171.18 8.89 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.009 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.6 mmt -107.9 155.66 39.54 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 120.566 0.222 . . . . 1.0 110.507 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.83 -23.65 73.02 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.273 1.982 . . . . 1.0 113.406 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.4 -13.06 41.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.163 0.506 . . . . 1.0 110.819 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.57 113.87 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.712 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.46 -11.87 63.22 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -113.28 -36.65 4.95 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.017 0.437 . . . . 1.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -123.31 149.9 44.26 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.707 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -139.63 155.06 47.65 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.298 -0.865 . . . . 1.0 110.873 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 131.97 52.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.651 -1.159 . . . . 1.0 108.945 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.06 -25.48 12.72 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.032 -1.227 . . . . 1.0 110.032 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.47 ' OD1' ' NH2' ' A' ' 61' ' ' ARG . 97.1 m-20 -79.29 153.16 30.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.577 0.227 . . . . 1.0 110.437 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 26.7 ptt180 -123.25 165.24 17.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -99.38 122.65 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.374 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.91 -22.62 15.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.791 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.37 159.04 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.391 0.615 . . . . 1.0 111.624 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.1 mt -136.64 122.41 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.037 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 t0 51.5 23.38 1.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.146 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.09 -6.78 58.38 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -90.01 122.27 67.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 122.625 -0.338 . . . . 1.0 111.162 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.33 133.32 17.51 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.693 1.595 . . . . 1.0 111.485 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mm -100.18 111.15 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.689 0.757 . . . . 1.0 112.257 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -110.85 -16.73 13.49 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.322 -1.308 . . . . 1.0 111.302 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.8 p -141.8 155.01 45.59 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.048 0.451 . . . . 1.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -68.9 -26.01 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.441 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -66.88 -32.72 74.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.493 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -59.99 -29.9 68.76 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.772 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.09 -27.37 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.749 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.26 -44.49 77.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.484 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.2 p -68.81 -42.2 77.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.489 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -58.78 -52.82 64.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.678 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.12 -40.76 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.99 -39.25 94.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.354 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.54 -55.16 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.345 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -80.98 146.52 30.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.138 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -97.52 177.57 5.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.494 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 136.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.758 . . . . 1.0 110.076 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.07 -3.64 70.26 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 33.7 t70 -73.59 170.45 15.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.082 0.468 . . . . 1.0 111.007 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 40.2 ptt85 -138.2 131.68 30.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.169 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.35 131.64 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.854 0.835 . . . . 1.0 111.877 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -75.51 109.26 8.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.615 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.92 138.06 25.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.448 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.1 m -107.11 140.83 39.32 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -148.79 152.78 37.14 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.17 135.54 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 121.695 0.76 . . . . 1.0 111.62 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.47 ' NH2' ' OD1' ' A' ' 26' ' ' ASP . 44.5 ttm-85 -140.83 122.09 14.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 114.543 -1.208 . . . . 1.0 109.621 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 46.25 49.09 12.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 64.05 9.37 4.6 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.554 0.534 . . . . 1.0 111.758 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -113.92 105.89 13.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.63 0.252 . . . . 1.0 110.636 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -80.01 146.23 32.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 111.176 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -153.48 145.51 23.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.968 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -89.93 129.88 36.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.445 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.1 128.24 55.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.992 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -80.37 102.74 9.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 1.0 109.928 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.05 145.55 38.3 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.234 0.54 . . . . 1.0 110.791 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.81 132.55 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.39 128.68 36.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.493 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt . . . . . 0 CA--C 1.551 0.997 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.746 -179.461 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 120.783 0.325 . . . . 1.0 110.276 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -133.87 139.76 46.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.834 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -74.47 125.63 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.031 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.4 mtt -84.8 -64.37 1.17 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.425 0.155 . . . . 1.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -123.08 149.73 44.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.279 0.561 . . . . 1.0 111.159 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.56 133.47 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 mp -93.47 150.56 39.11 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.797 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.04 -27.76 16.81 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.565 2.176 . . . . 1.0 112.788 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.57 39.91 2.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.0 162.44 21.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 123.189 0.306 . . . . 1.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.29 -33.68 94.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.262 1.975 . . . . 1.0 112.972 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.05 -11.61 54.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.743 0.306 . . . . 1.0 111.636 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.74 135.22 53.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.9 -16.37 51.37 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.84 -33.86 4.65 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.327 -0.249 . . . . 1.0 110.327 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 tp -122.63 152.66 40.25 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.294 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 60.9 mm-40 -139.42 154.33 47.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.599 0.714 . . . . 1.0 111.087 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.15 139.02 53.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.32 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -29.69 8.93 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.209 -1.156 . . . . 1.0 110.209 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 1.7 p-10 -69.69 149.52 47.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.807 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.4 158.79 21.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.903 0.382 . . . . 1.0 110.445 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.7 mm -100.04 119.98 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.011 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.65 -21.94 19.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.86 163.06 2.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.109 0.48 . . . . 1.0 111.528 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 33' ' ' GLY . 89.1 mt -136.79 126.53 38.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 122.294 1.045 . . . . 1.0 110.872 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t0 51.05 11.2 0.09 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.591 -0.693 . . . . 1.0 111.405 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . 111.06 -6.48 28.99 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.986 -0.341 . . . . 1.0 112.312 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 0.4 OUTLIER -94.9 110.6 50.64 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 117.239 0.519 . . . . 1.0 111.789 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.78 136.15 73.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.266 1.311 . . . . 1.0 111.522 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.79 115.64 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.597 0.713 . . . . 1.0 111.429 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -112.45 -20.22 11.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.253 -1.339 . . . . 1.0 110.963 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.423 ' HG1' ' H ' ' A' ' 41' ' ' GLN . 60.8 p -135.18 151.29 50.52 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.041 0.448 . . . . 1.0 110.76 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.0 p -69.55 -29.66 67.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.54 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.02 -29.47 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.648 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' H ' ' HG1' ' A' ' 38' ' ' THR . 7.4 tt0 -63.4 -28.62 70.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.078 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.35 -28.35 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.706 -0.224 . . . . 1.0 111.257 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.96 -40.98 76.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.034 0.445 . . . . 1.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.9 m -69.71 -41.1 75.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 1.0 109.595 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.49 -56.28 23.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.727 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.02 -33.55 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.302 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -64.35 -40.13 95.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.506 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -57.76 -50.25 73.86 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.666 -0.413 . . . . 1.0 110.321 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -81.6 149.09 28.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.36 -179.43 3.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.311 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 135.69 55.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.964 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.5 -0.21 65.42 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 35.5 t70 -78.06 171.05 15.6 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.877 0.37 . . . . 1.0 110.935 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 82.2 mtp180 -139.3 125.21 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.98 132.73 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.943 0.878 . . . . 1.0 111.646 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -81.02 113.46 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.093 -1.412 . . . . 1.0 108.748 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.95 132.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.644 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.8 m -101.17 137.71 39.16 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -150.28 152.18 34.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.51 138.54 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.41 0.624 . . . . 1.0 111.04 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -143.73 123.8 13.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.719 -1.128 . . . . 1.0 109.964 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 50.64 43.01 27.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.817 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 67.08 9.59 7.04 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.822 0.449 . . . . 1.0 111.841 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -115.46 106.54 14.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.919 0.39 . . . . 1.0 110.654 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' ' NE2' ' A' ' 65' ' ' GLN . 5.0 pp0? -74.13 138.52 43.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.383 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -149.16 144.28 26.5 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.362 -0.836 . . . . 1.0 111.269 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.68 136.52 32.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.037 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.18 122.55 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.36 102.04 12.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.933 -1.03 . . . . 1.0 110.026 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.79 150.18 30.68 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.195 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.29 131.77 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.292 -0.867 . . . . 1.0 110.36 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.66 129.51 40.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.813 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt . . . . . 0 CA--C 1.551 0.992 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.104 179.724 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.236 0.541 . . . . 1.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -58.96 134.36 56.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.239 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.598 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 7.5 p -46.35 160.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.829 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.1 ttt -103.21 -62.29 1.3 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.857 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 m -151.94 154.36 35.93 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.156 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 t -122.45 101.94 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 13' ' ' LEU . 3.9 mm? -74.83 135.02 74.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.414 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.3 -20.95 42.09 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 122.32 2.013 . . . . 1.0 112.782 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -107.18 33.62 3.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.81 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.17 165.35 19.4 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.03 0.206 . . . . 1.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.491 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.2 Cg_exo -68.38 -16.6 43.7 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.403 2.069 . . . . 1.0 112.933 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.91 36.85 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.101 -0.375 . . . . 1.0 111.856 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.79 137.62 57.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.985 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.75 39.1 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.254 -0.738 . . . . 1.0 111.254 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' NH2' ' O ' ' A' ' 17' ' ' PRO . 36.0 mtm180 -113.69 -34.23 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.482 0.313 . . . . 1.0 110.806 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 mt -123.54 154.01 39.81 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.05 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -138.94 154.02 48.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.104 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.83 139.8 55.95 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.301 -0.863 . . . . 1.0 109.398 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.598 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 104.6 -26.31 23.0 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 26' ' ' ASP . 2.4 m-20 -67.49 145.35 55.05 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.937 -0.305 . . . . 1.0 110.253 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -109.09 153.39 23.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.726 0.298 . . . . 1.0 110.386 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.7 mm -96.16 118.01 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.095 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.75 -16.24 28.77 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.808 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 171.12 163.67 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.243 0.544 . . . . 1.0 110.965 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.93 126.75 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.774 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 50.77 20.68 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.036 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.0 56.31 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.852 -0.499 . . . . 1.0 111.852 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -92.85 126.33 51.96 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.961 0.381 . . . . 1.0 111.454 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.91 135.21 17.19 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.826 1.684 . . . . 1.0 111.468 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.66 115.75 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.865 0.84 . . . . 1.0 112.216 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -107.12 -23.27 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.09 -1.414 . . . . 1.0 111.161 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -134.86 154.28 51.71 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.165 0.507 . . . . 1.0 111.142 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -69.95 -33.73 72.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.337 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -62.51 -28.46 69.86 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -63.47 -30.27 71.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.628 -0.429 . . . . 1.0 109.919 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.54 -29.95 36.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 116.743 -0.208 . . . . 1.0 111.278 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.36 -42.21 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.461 . . . . 1.0 110.213 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -65.13 -40.39 94.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.161 0.505 . . . . 1.0 109.868 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.94 -57.68 11.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.895 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.0 m -55.16 -39.94 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.826 0.346 . . . . 1.0 110.202 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -40.95 94.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.72 -47.0 70.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.378 . . . . 1.0 110.46 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -81.5 -173.45 4.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.87 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' ALA . 40.3 tt0 -130.91 171.45 13.17 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.985 0.422 . . . . 1.0 110.834 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' A' ' 50' ' ' GLN . . . -64.83 136.28 56.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.771 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.3 -0.83 81.67 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.391 -1.084 . . . . 1.0 110.391 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 36.9 t70 -71.54 179.51 2.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.804 0.335 . . . . 1.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.529 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 87.4 mtm180 -138.47 123.55 19.08 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.5 130.98 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 122.06 0.933 . . . . 1.0 112.112 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -85.96 118.89 25.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.961 -1.472 . . . . 1.0 109.084 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -108.55 134.42 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.544 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.5 m -104.62 132.63 50.64 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.26 153.37 37.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.3 138.52 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.215 0.531 . . . . 1.0 110.341 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -141.31 121.78 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.304 -0.862 . . . . 1.0 109.444 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 54.37 39.6 31.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.34 -0.846 . . . . 1.0 110.873 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 68.92 9.09 7.21 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 123.161 0.288 . . . . 1.0 111.66 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -108.87 116.72 32.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.96 0.409 . . . . 1.0 110.131 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.9 128.58 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.887 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -144.18 139.12 28.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.27 0.557 . . . . 1.0 111.105 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.84 138.56 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.32 117.0 31.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.868 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.47 103.54 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.142 -0.935 . . . . 1.0 109.2 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.23 146.22 39.69 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.73 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.06 134.68 63.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.655 -1.157 . . . . 1.0 110.077 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -66.55 125.49 25.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.447 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.7 tttt . . . . . 0 CA--C 1.55 0.978 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.435 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.0 t . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.824 0.345 . . . . 1.0 110.397 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -130.2 140.37 50.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.71 128.02 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.4 ttt -78.03 -64.74 1.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.194 -0.316 . . . . 1.0 111.723 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -133.6 160.77 36.49 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.031 0.443 . . . . 1.0 111.535 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.6 136.52 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.99 148.91 38.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 O-C-N 123.42 0.45 . . . . 1.0 111.854 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' SD ' ' A' ' 16' ' ' MET . 74.4 Cg_endo -73.23 157.43 50.17 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.288 1.992 . . . . 1.0 111.351 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 64.15 28.0 14.07 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.296 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -106.59 157.94 33.91 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-O 120.748 0.309 . . . . 1.0 110.357 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 -19.55 64.16 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.157 1.905 . . . . 1.0 112.979 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.25 -17.72 17.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.65 0.738 . . . . 1.0 111.091 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.32 129.57 42.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.819 -1.082 . . . . 1.0 109.337 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.33 -7.94 62.2 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -134.27 -24.36 1.62 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.826 0.346 . . . . 1.0 110.537 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.41 134.07 55.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.011 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 97.5 mt-10 -134.45 148.0 50.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.549 0.69 . . . . 1.0 110.405 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.2 136.89 48.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.931 -1.032 . . . . 1.0 109.483 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.62 -26.63 13.95 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 2.8 p-10 -64.78 145.0 56.86 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.72 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -109.69 142.22 41.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.933 0.397 . . . . 1.0 109.979 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.23 122.26 43.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.569 -0.742 . . . . 1.0 109.191 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.54 -22.45 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.125 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.02 154.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.2 mt -129.55 125.46 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.878 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 17.12 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.529 -0.76 . . . . 1.0 111.013 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.73 -5.29 47.17 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.72 -0.552 . . . . 1.0 111.72 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -95.19 111.19 54.06 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.026 0.413 . . . . 1.0 111.486 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.18 136.45 74.81 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 122.326 2.017 . . . . 1.0 111.484 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.69 106.37 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.578 0.704 . . . . 1.0 111.805 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -102.68 -25.02 13.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.605 -1.18 . . . . 1.0 111.419 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -140.53 160.18 40.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.078 0.466 . . . . 1.0 111.051 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -67.39 -23.04 65.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.103 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -66.01 -32.96 74.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.209 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -61.55 -31.35 71.37 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.511 -0.476 . . . . 1.0 109.82 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.43 -27.96 19.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 CA-C-O 120.983 0.421 . . . . 1.0 110.485 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.52 -42.74 83.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.734 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 59.2 p -64.21 -39.73 94.58 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -58.23 -56.21 24.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.505 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.82 -44.0 76.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.946 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -69.62 -35.79 75.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.68 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.42 -62.53 1.59 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.224 -0.287 . . . . 1.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.32 -169.21 2.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.635 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -131.91 176.37 8.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.676 0.75 . . . . 1.0 112.039 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.62 134.84 57.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.889 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.5 -0.78 74.89 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.441 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 19.3 t0 -68.62 169.95 10.17 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.888 0.375 . . . . 1.0 111.16 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 76.4 mtp180 -140.73 117.75 11.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 m -129.23 135.14 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.855 0.836 . . . . 1.0 111.88 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.434 ' NH1' ' OE2' ' A' ' 69' ' ' GLU . 83.9 mmt-85 -76.75 105.84 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.31 -1.314 . . . . 1.0 108.786 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.0 t -95.06 135.21 29.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.561 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.9 m -104.97 137.52 42.6 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.9 150.96 32.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.12 137.67 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.741 0.781 . . . . 1.0 111.706 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -143.34 117.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.465 -1.243 . . . . 1.0 110.175 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 52.84 44.77 29.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.251 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 66.67 8.31 5.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.706 -0.225 . . . . 1.0 111.335 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.686 ' HZ2' ' HE2' ' A' ' 66' ' ' HIS . 9.0 mtmp? -111.92 113.34 25.61 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 51.1 mt-30 -75.79 146.23 40.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.401 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.686 ' HE2' ' HZ2' ' A' ' 64' ' ' LYS . 98.2 m-70 -156.53 140.94 16.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.979 0.419 . . . . 1.0 110.817 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.99 128.69 36.91 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.85 123.88 49.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.401 0.619 . . . . 1.0 110.471 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.434 ' OE2' ' NH1' ' A' ' 56' ' ' ARG . 42.6 tp10 -78.74 100.54 7.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.041 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -114.83 149.24 37.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.462 0.649 . . . . 1.0 110.846 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -136.13 137.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 114.755 -1.112 . . . . 1.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 mt -61.16 120.44 10.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.995 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 CA--C 1.552 1.027 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.872 -179.628 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 120.783 0.325 . . . . 1.0 110.383 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.65 129.51 36.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.961 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.34 127.75 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.179 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.0 tpt -75.84 -53.04 9.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.186 -0.321 . . . . 1.0 111.278 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.1 p -148.05 165.26 31.33 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.015 0.436 . . . . 1.0 111.365 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.59 135.28 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.19 153.08 39.81 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.434 0.459 . . . . 1.0 111.176 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.64 158.75 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.558 2.172 . . . . 1.0 111.88 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.6 t30 56.27 32.45 20.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.405 -0.816 . . . . 1.0 111.116 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.9 mmm -106.88 161.13 23.87 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.174 0.296 . . . . 1.0 110.882 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.32 -30.43 91.03 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.343 2.029 . . . . 1.0 112.821 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.85 -14.43 20.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.922 0.391 . . . . 1.0 111.465 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 122.66 14.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.65 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.71 -8.22 65.85 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -119.73 -25.66 5.86 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.238 0.542 . . . . 1.0 110.538 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.2 mt -140.03 170.62 15.52 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.743 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 mt-10 -156.06 165.01 37.7 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.377 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.85 137.71 57.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.498 -1.228 . . . . 1.0 109.025 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.81 14.72 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 7.6 p-10 -72.64 154.04 40.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.791 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -121.81 151.42 40.63 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -96.69 129.24 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.78 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.5 -27.29 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.85 151.03 2.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 1.0 111.409 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.84 123.6 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.166 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.2 t0 56.59 17.16 2.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.962 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.27 42.3 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.927 -0.469 . . . . 1.0 111.927 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -96.2 110.45 52.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 119.379 -0.344 . . . . 1.0 111.399 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.88 137.53 81.45 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.336 2.024 . . . . 1.0 111.394 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mm -97.75 106.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.575 0.702 . . . . 1.0 111.744 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -104.22 -21.52 13.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.8 p -144.3 161.01 40.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.993 0.425 . . . . 1.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.0 p -66.86 -23.85 66.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.353 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.21 -34.1 77.57 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.071 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -59.95 -33.34 71.78 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.775 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 42' ' ' ILE . 47.9 mm -71.92 -28.16 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.942 0.401 . . . . 1.0 110.547 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.02 -42.98 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.909 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 t -62.75 -41.43 99.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.789 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -58.18 8.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.883 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.42 -43.0 81.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -62.85 -44.36 96.34 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.959 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -60.15 -58.09 10.02 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 1.0 110.25 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -81.49 170.94 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.382 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -136.41 -172.24 3.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.126 0.489 . . . . 1.0 111.42 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 129.73 40.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.143 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.39 -8.73 64.57 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 20.2 t70 -70.81 174.61 5.84 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.975 0.417 . . . . 1.0 111.155 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.494 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 83.7 mtt85 -145.14 127.89 16.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.93 132.9 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.905 0.86 . . . . 1.0 111.862 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -78.12 103.01 7.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.272 -1.331 . . . . 1.0 108.496 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.1 t -95.42 135.49 29.33 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.051 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.5 m -105.08 138.87 40.62 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -148.92 155.15 40.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -110.19 134.59 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.629 0.728 . . . . 1.0 111.13 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -141.91 123.84 15.31 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.657 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 48.02 46.16 19.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.655 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 67.67 6.66 5.15 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.846 0.355 . . . . 1.0 110.606 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -112.29 116.12 29.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -90.55 143.21 26.97 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.91 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -152.34 148.49 27.56 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.839 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.99 127.08 36.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.632 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.93 124.54 49.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.446 0.641 . . . . 1.0 110.044 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.08 102.14 14.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.558 -1.201 . . . . 1.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 36.3 mt -113.31 151.19 31.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.669 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.07 130.64 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.019 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.2 mm? -56.67 120.16 7.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.134 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttp . . . . . 0 CA--C 1.551 1.014 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.547 -179.638 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.699 0.285 . . . . 1.0 110.381 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -129.11 137.41 51.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.8 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.21 127.69 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.12 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.6 mtt -75.35 -65.46 0.89 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.733 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -128.94 160.87 31.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.166 0.507 . . . . 1.0 111.16 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -128.12 138.92 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.89 145.17 31.48 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 123.137 0.273 . . . . 1.0 111.121 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.08 -24.28 20.59 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.441 2.094 . . . . 1.0 112.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -99.05 17.93 18.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.639 -0.255 . . . . 1.0 111.159 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.8 mtt -113.17 158.53 37.83 Favored Pre-proline 0 N--CA 1.469 0.485 0 O-C-N 123.055 0.222 . . . . 1.0 110.9 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.66 -32.11 53.2 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.415 2.076 . . . . 1.0 113.295 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.78 57.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.685 0.279 . . . . 1.0 111.385 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.07 109.65 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.122 -0.631 . . . . 1.0 110.719 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.68 -14.83 64.59 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.232 -0.747 . . . . 1.0 111.232 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -108.11 -41.63 4.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.124 0.488 . . . . 1.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.47 156.84 40.04 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.484 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -144.29 158.1 43.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.157 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.81 56.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.421 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.2 18.15 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.247 -1.141 . . . . 1.0 110.247 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 150.68 42.63 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 122.782 -0.246 . . . . 1.0 110.63 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -114.61 154.58 28.11 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.161 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mm -97.35 120.14 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.024 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.47 19.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.6 158.72 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 1.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.75 125.03 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.105 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 51.22 21.72 1.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.124 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.33 57.81 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.617 -0.593 . . . . 1.0 111.617 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -89.93 124.85 62.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.75 -0.265 . . . . 1.0 111.254 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.4 132.8 15.28 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.981 1.787 . . . . 1.0 111.465 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -99.13 110.89 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.496 0.665 . . . . 1.0 112.433 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -115.53 -18.18 11.0 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.661 -1.154 . . . . 1.0 111.108 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -139.37 156.01 47.28 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.241 0.544 . . . . 1.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.1 m -66.28 -22.57 66.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.233 -0.894 . . . . 1.0 108.878 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.33 -35.34 77.63 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.523 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' H ' HG23 ' A' ' 38' ' ' THR . 69.6 tp60 -57.1 -31.71 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.859 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -74.79 -26.84 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.781 -0.191 . . . . 1.0 110.971 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.54 -41.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 1.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.2 t -65.62 -40.58 92.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.281 0.562 . . . . 1.0 109.944 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -58.18 -57.16 14.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.646 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' LYS . 29.0 m -58.55 -39.77 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.325 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -66.04 -37.61 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.707 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.77 -53.86 47.89 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.339 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 46' ' ' VAL . 72.1 mmtt -87.31 156.96 19.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.55 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.4 -178.18 3.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.295 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.27 135.91 55.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.177 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.82 -1.53 74.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 30.7 t70 -74.24 172.04 12.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.033 0.444 . . . . 1.0 110.879 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.0 mtp85 -141.76 130.04 22.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.078 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.63 133.51 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.892 0.854 . . . . 1.0 111.942 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.14 107.44 7.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.383 -1.28 . . . . 1.0 108.767 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.03 137.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.329 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -104.92 139.22 39.96 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -150.31 151.87 33.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.23 132.07 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.525 0.679 . . . . 1.0 111.472 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -138.58 124.24 19.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.4 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 49.58 43.82 24.15 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 115.291 -0.868 . . . . 1.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 70.43 -1.35 2.54 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.322 0.119 . . . . 1.0 111.322 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -107.42 106.06 16.28 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.529 0.204 . . . . 1.0 110.824 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -76.82 145.3 38.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.212 0.529 . . . . 1.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -153.88 146.09 23.8 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.327 -0.852 . . . . 1.0 111.052 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -89.12 132.11 34.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.543 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.94 124.62 52.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.91 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 39.1 mp0 -80.04 101.95 9.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.738 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tt -109.34 143.0 39.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.749 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.7 131.0 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.442 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.68 131.6 46.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.502 . . . . 1.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 CA--C 1.545 0.786 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.942 179.663 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -120.99 125.73 48.1 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.323 -0.398 . . . . 1.0 111.091 -179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.55 124.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.6 mmt -70.67 -66.47 0.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.659 -0.246 . . . . 1.0 111.544 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.3 t -137.99 173.57 11.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.069 0.461 . . . . 1.0 111.064 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.15 133.58 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 mt -112.64 114.2 49.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.115 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.54 163.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.98 1.786 . . . . 1.0 112.06 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 m120 68.18 19.02 9.24 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.971 0.794 . . . . 1.0 111.027 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.8 mmt -111.1 160.28 29.58 Favored Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.239 0.337 . . . . 1.0 111.116 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.73 -39.56 90.4 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.796 1.664 . . . . 1.0 112.954 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.94 -12.5 53.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.01 0.433 . . . . 1.0 111.596 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.23 131.27 45.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.551 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.53 -14.53 64.81 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.111 -0.795 . . . . 1.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.445 ' HE ' ' HA ' ' A' ' 68' ' ' ALA . 6.8 ptm85 -129.06 -23.45 3.03 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.912 0.387 . . . . 1.0 110.728 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 23.1 tp -122.97 148.19 45.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.441 -0.8 . . . . 1.0 110.311 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -143.79 157.9 44.06 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.687 0.756 . . . . 1.0 111.197 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.8 136.19 56.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.62 -1.173 . . . . 1.0 109.075 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.56 10.2 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 110.066 -1.214 . . . . 1.0 110.066 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -71.02 146.04 49.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.283 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -114.93 161.54 18.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.277 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -99.74 119.28 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.061 0.458 . . . . 1.0 110.303 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.6 -19.36 21.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.674 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.42 164.44 2.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.582 0.706 . . . . 1.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.6 mt -139.78 122.81 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.909 -1.041 . . . . 1.0 109.813 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 49.88 24.2 1.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.892 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.34 -6.12 61.18 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.801 -0.52 . . . . 1.0 111.801 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -93.0 107.88 28.17 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 116.887 0.344 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 136.42 71.03 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.905 1.737 . . . . 1.0 111.546 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.3 mm -102.84 113.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.68 0.752 . . . . 1.0 111.886 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' OD1' ' NE2' ' A' ' 41' ' ' GLN . 51.4 p30 -114.14 -20.65 10.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.586 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 56.4 p -134.6 160.34 38.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.015 0.436 . . . . 1.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.8 p -77.55 -27.61 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.052 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -67.8 -30.34 69.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' NE2' ' OD1' ' A' ' 37' ' ' ASN . 16.0 mt-30 -64.11 -27.45 69.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mm -78.06 -26.55 14.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -70.46 -41.79 78.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 123.536 0.522 . . . . 1.0 110.209 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.1 m -70.07 -39.29 75.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.307 0.575 . . . . 1.0 109.782 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.408 ' OH ' ' CG1' ' A' ' 55' ' ' VAL . 86.4 t80 -58.89 -55.74 31.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.888 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 m -55.45 -36.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 120.733 0.301 . . . . 1.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -65.58 -36.57 84.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.941 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -58.44 -43.41 88.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.013 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -93.29 149.8 20.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.309 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.529 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -101.24 178.3 4.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.143 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.58 57.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.125 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.47 -1.87 82.35 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.782 -0.927 . . . . 1.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 24.4 t70 -71.95 175.93 5.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.826 0.345 . . . . 1.0 110.716 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.515 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -139.39 129.99 25.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' OH ' ' A' ' 45' ' ' TYR . 5.9 m -136.11 130.89 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.974 0.892 . . . . 1.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -80.85 106.51 12.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.286 -1.325 . . . . 1.0 108.968 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -97.07 143.46 12.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.599 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.1 m -109.75 138.88 45.48 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.536 0.522 . . . . 1.0 109.685 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -150.24 150.91 32.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.88 134.06 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.672 0.749 . . . . 1.0 111.192 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -138.05 121.9 17.66 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 114.37 -1.287 . . . . 1.0 109.885 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 49.11 43.25 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.851 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 71.67 3.11 4.54 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.886 -0.143 . . . . 1.0 111.343 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -108.61 105.36 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.72 0.295 . . . . 1.0 110.946 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -78.26 138.68 38.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 1.0 111.011 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -148.43 145.24 27.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.641 -0.708 . . . . 1.0 110.992 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -89.89 132.88 35.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.246 -0.888 . . . . 1.0 110.343 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.445 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . . . -110.13 121.3 44.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.843 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.0 102.3 7.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.394 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -115.51 149.68 37.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.876 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.8 m -128.25 135.58 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.443 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt . . . . . 0 CA--C 1.546 0.797 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.473 -179.309 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -60.72 114.01 2.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.528 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -79.54 131.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.906 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.9 ttt -81.27 -72.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 111.692 0.256 . . . . 1.0 111.692 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -129.71 162.0 29.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.17 0.51 . . . . 1.0 111.209 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.64 131.5 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.307 -0.861 . . . . 1.0 108.915 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' A' ' 13' ' ' LEU . 4.2 mm? -89.09 115.2 62.99 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.771 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.04 -19.94 12.69 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.976 1.784 . . . . 1.0 112.246 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -99.19 22.28 10.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.653 -0.248 . . . . 1.0 110.982 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 mmt -121.04 159.05 50.93 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.683 -0.235 . . . . 1.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.85 -22.05 66.63 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.485 2.123 . . . . 1.0 112.772 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.11 -14.23 59.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.833 0.349 . . . . 1.0 111.671 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 132.74 48.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.915 0.388 . . . . 1.0 110.407 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.98 27.97 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -104.92 -41.49 5.6 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.15 156.63 31.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.34 155.95 48.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.101 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.21 134.29 56.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.311 -0.858 . . . . 1.0 109.469 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.37 -26.4 18.59 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.07 145.46 51.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.381 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -111.0 153.24 25.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.871 0.367 . . . . 1.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.43 119.62 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.861 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.75 -16.95 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.99 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 174.41 164.32 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.31 0.576 . . . . 1.0 110.934 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.7 mt -135.93 125.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.625 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.419 ' OD2' ' CE1' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 49.97 17.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.15 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.95 -5.84 46.95 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.053 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -92.94 108.77 34.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.978 0.389 . . . . 1.0 111.318 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.04 133.28 52.32 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.219 1.946 . . . . 1.0 111.551 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mm -102.16 116.7 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.649 0.738 . . . . 1.0 111.855 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 38' ' ' THR . 48.9 p30 -107.92 -23.52 12.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.579 -1.191 . . . . 1.0 111.409 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.467 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 69.2 p -137.21 155.26 49.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.034 0.445 . . . . 1.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.2 p -68.73 -32.81 72.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.484 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -61.94 -30.87 71.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.264 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -61.99 -30.01 70.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.318 -0.553 . . . . 1.0 109.946 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 42' ' ' ILE . 50.4 mm -71.6 -29.63 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.547 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.65 -43.68 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.268 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -65.17 -42.51 93.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.419 ' CE1' ' OD2' ' A' ' 32' ' ' ASP . 64.8 t80 -57.61 -57.1 14.21 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.325 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.96 -40.93 47.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -65.97 -20.81 66.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -61.85 -56.19 21.98 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.71 -163.41 1.02 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.961 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.46 -171.62 3.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.343 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 134.72 53.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.141 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.52 63.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.42 161.79 25.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.831 0.348 . . . . 1.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -127.5 122.35 33.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.62 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.997 0.904 . . . . 1.0 111.535 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -83.34 116.34 22.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.401 -1.272 . . . . 1.0 109.033 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.0 t -107.41 131.14 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.95 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.4 m -101.48 133.4 46.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.83 152.19 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -109.67 139.47 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.389 0.614 . . . . 1.0 110.651 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -142.84 121.85 12.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.192 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 52.39 40.82 30.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 69.1 13.37 8.69 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.332 0.395 . . . . 1.0 111.363 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.642 ' HZ3' ' HE2' ' A' ' 66' ' ' HIS . 8.2 mtmp? -114.16 109.0 17.73 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -77.27 131.52 38.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.0 111.278 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.642 ' HE2' ' HZ3' ' A' ' 64' ' ' LYS . 98.4 m-70 -146.07 144.47 30.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.949 -0.568 . . . . 1.0 111.037 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 40.6 mp0 -90.89 137.46 32.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.649 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 120.21 41.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.321 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.86 101.44 9.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.93 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tt -110.95 140.99 44.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.959 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.85 131.97 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.456 0.645 . . . . 1.0 110.651 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -65.71 121.99 16.25 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.641 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 CA--C 1.549 0.914 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.873 -179.897 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -161.44 36.92 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 53.69 78.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.958 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.47 -63.82 1.15 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.512 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.88 86.67 0.09 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.934 0.397 . . . . 1.0 110.832 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.45 -105.6 2.54 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 111.391 -0.684 . . . . 1.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.16 142.66 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -102.33 123.07 45.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.78 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 6.2 p -45.67 164.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.097 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.431 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 25.1 mmt -104.87 -70.27 0.78 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.609 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.9 t -156.2 175.26 14.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.712 0.291 . . . . 1.0 110.95 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.8 105.91 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.8 mt -93.71 143.96 27.41 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.857 -0.156 . . . . 1.0 110.889 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -72.9 156.42 52.55 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.159 1.906 . . . . 1.0 112.274 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.13 32.36 21.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.864 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 6.3 mtt -122.32 152.39 60.76 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 110.506 -0.183 . . . . 1.0 110.506 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.01 -16.88 57.39 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.534 2.156 . . . . 1.0 112.932 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 -24.03 27.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.96 0.409 . . . . 1.0 111.222 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 131.06 45.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.818 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.04 -21.21 35.3 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.59 -43.94 4.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.788 0.328 . . . . 1.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.29 140.45 49.31 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -131.53 159.21 38.83 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.301 0.572 . . . . 1.0 110.696 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.59 133.31 50.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.273 -0.876 . . . . 1.0 109.805 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.598 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 110.07 -23.1 21.96 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.418 ' OD1' ' NE ' ' A' ' 61' ' ' ARG . 36.3 m-20 -79.36 144.47 34.15 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.025 -0.103 . . . . 1.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 -110.34 161.4 15.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.921 0.391 . . . . 1.0 110.787 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -98.05 115.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.434 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.87 -14.89 28.94 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.12 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 177.93 168.06 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.249 0.547 . . . . 1.0 111.161 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.0 125.94 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.79 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 47.79 22.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.0 111.176 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -6.87 57.29 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.992 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -87.39 126.4 62.43 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.417 -0.325 . . . . 1.0 111.161 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.54 126.66 8.41 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.589 1.526 . . . . 1.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mm -100.62 120.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.731 0.777 . . . . 1.0 111.933 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -116.13 -19.32 10.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.455 -1.248 . . . . 1.0 111.142 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -133.32 155.9 48.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.179 0.514 . . . . 1.0 111.093 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -71.68 -32.33 67.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.454 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -65.01 -32.45 74.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.584 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -58.86 -30.31 67.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.619 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -72.16 -29.09 31.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.332 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.11 -40.02 84.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 O-C-N 123.29 0.369 . . . . 1.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.1 p -69.48 -40.86 76.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.337 0.589 . . . . 1.0 109.551 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -56.37 -56.79 16.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.56 -36.29 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 1.0 110.455 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -57.79 -41.57 82.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.293 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.71 -42.88 98.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.493 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -89.32 154.29 20.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.171 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.48 -176.17 2.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.985 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.68 138.91 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.214 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.38 0.87 81.95 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.536 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 29.7 t70 -74.67 179.62 4.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.087 0.47 . . . . 1.0 110.568 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.536 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 80.7 ttt180 -139.56 123.4 17.58 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.87 134.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.777 0.799 . . . . 1.0 111.821 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.48 122.61 32.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.502 -1.226 . . . . 1.0 108.601 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.6 t -116.17 130.3 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.0 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.7 m -96.95 136.11 37.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.308 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -146.62 151.32 37.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -112.62 137.15 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.103 0.478 . . . . 1.0 110.356 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 17.7 ttm180 -136.66 120.48 17.42 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.789 -0.642 . . . . 1.0 109.467 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 49.97 39.42 18.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.782 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 73.33 12.64 4.77 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.53 0.196 . . . . 1.0 111.53 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -110.74 100.25 9.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.738 0.304 . . . . 1.0 110.395 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.17 127.62 33.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.47 0.652 . . . . 1.0 111.711 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.07 141.2 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.774 -0.648 . . . . 1.0 111.139 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.03 146.17 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.616 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.98 130.91 53.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.077 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.416 ' OE2' ' CZ ' ' A' ' 54' ' ' ARG . 77.3 tt0 -92.23 105.39 17.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.5 mp -111.3 146.33 37.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.045 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.88 130.21 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.59 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -66.11 132.91 49.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -139.51 140.38 25.22 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.78 162.14 40.11 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 122.69 2.26 . . . . 1.0 111.775 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -120.8 145.81 42.16 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.51 -28.11 45.86 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.708 1.606 . . . . 1.0 111.961 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -68.42 -33.43 74.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.152 0.501 . . . . 1.0 109.967 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -147.46 74.81 11.5 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.086 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.85 -29.78 64.86 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.608 2.205 . . . . 1.0 111.824 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -82.99 17.26 1.99 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.572 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -133.28 138.86 46.61 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' GLY . 0.1 OUTLIER -118.57 133.51 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.079 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' ILE . . . 49.55 106.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.282 -0.485 . . . . 1.0 112.341 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.5 mt -97.47 0.68 48.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.78 47.9 3.3 Favored Glycine 0 N--CA 1.466 0.667 0 CA-C-N 114.754 -1.112 . . . . 1.0 111.03 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 p -108.71 149.17 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.755 -0.461 . . . . 1.0 109.755 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 118.126 -0.94 . . . . 1.0 110.466 -179.833 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.21 -178.95 6.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.505 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.51 154.19 16.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.258 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 76.08 155.43 0.16 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.152 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.53 -177.56 4.48 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.324 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.33 -110.91 2.89 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t -128.58 156.76 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.11 133.81 54.26 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.988 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.99 120.81 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.943 -0.392 . . . . 1.0 109.943 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.52 -69.13 0.5 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.028 -0.269 . . . . 1.0 111.657 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.1 p -128.4 165.34 20.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.044 0.45 . . . . 1.0 111.03 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.29 122.15 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.87 153.24 52.12 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.757 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 152.63 64.7 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.611 2.207 . . . . 1.0 112.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 52.61 45.15 29.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.519 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.8 mmt -121.17 154.18 58.39 Favored Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.013 0.196 . . . . 1.0 110.706 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.05 -19.34 65.92 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.339 2.026 . . . . 1.0 112.869 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.439 ' O ' ' N ' ' A' ' 22' ' ' LEU . . . -89.63 -24.01 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.844 0.354 . . . . 1.0 111.484 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.23 141.37 52.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.627 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -22.73 14.03 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.4 -34.01 4.44 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.452 ' CD2' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -118.55 139.79 50.9 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.934 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -130.18 152.65 49.38 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.511 0.672 . . . . 1.0 110.964 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.06 139.92 53.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.33 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.49 -28.88 13.19 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.206 -1.157 . . . . 1.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.464 ' CG ' HH21 ' A' ' 61' ' ' ARG . 80.5 m-20 -70.75 147.02 49.45 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.294 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -114.58 159.71 20.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.891 0.377 . . . . 1.0 110.351 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.7 mm -97.55 118.75 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.396 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.27 -15.9 25.32 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.786 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.95 163.5 0.81 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.139 0.495 . . . . 1.0 111.076 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 98.1 mt -138.29 129.09 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.87 0.843 . . . . 1.0 110.713 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.83 15.33 0.23 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.11 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.75 -5.84 43.77 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.376 -0.375 . . . . 1.0 112.234 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -94.35 134.41 25.64 Favored Pre-proline 0 CA--C 1.556 1.175 0 CA-C-N 117.174 0.487 . . . . 1.0 110.76 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.14 134.82 13.25 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.848 1.699 . . . . 1.0 111.937 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mm -102.81 116.18 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.633 0.73 . . . . 1.0 111.36 -178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -110.86 -26.84 9.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.502 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 p -136.99 165.34 26.22 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.168 0.509 . . . . 1.0 110.901 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -66.5 -33.62 76.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.372 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.37 -39.14 89.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 1.0 110.405 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -51.44 -39.13 56.76 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.473 -0.491 . . . . 1.0 109.868 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 42' ' ' ILE . 50.0 mm -62.72 -34.71 67.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 121.233 -0.187 . . . . 1.0 111.031 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.62 -44.48 99.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.735 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.548 ' HG ' ' H ' ' A' ' 45' ' ' TYR . 65.7 p -58.36 -43.55 88.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.544 0.688 . . . . 1.0 110.542 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.548 ' H ' ' HG ' ' A' ' 44' ' ' SER . 0.0 OUTLIER -58.3 -57.6 12.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.191 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 45' ' ' TYR . 97.6 t -52.59 -40.3 33.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.95 0.405 . . . . 1.0 110.298 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -37.49 80.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.386 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.45 -48.04 82.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.798 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -89.31 175.02 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.171 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 51' ' ' ALA . 17.8 pt20 -155.41 125.32 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.705 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -2.69 124.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 125.73 1.894 . . . . 1.0 110.414 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.57 -6.53 49.24 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.609 -1.397 . . . . 1.0 109.609 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 20.6 t70 -83.89 177.22 8.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.851 0.358 . . . . 1.0 110.872 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 58.7 mtp180 -146.59 123.48 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.566 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.0 m -130.99 131.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 122.225 1.012 . . . . 1.0 111.674 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.568 ' H ' ' HE ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -75.05 116.96 16.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.763 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.65 134.92 43.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.837 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 m -101.81 133.38 46.65 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CD1' ' CD2' ' A' ' 22' ' ' LEU . 31.5 p90 -146.5 150.14 34.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -108.77 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.422 0.629 . . . . 1.0 110.759 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.464 HH21 ' CG ' ' A' ' 26' ' ' ASP . 40.6 ttm-85 -138.04 121.27 16.92 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.598 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 53.29 39.82 30.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.932 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 69.81 10.13 7.41 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.484 0.49 . . . . 1.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -110.34 106.53 15.93 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.479 HE21 ' C ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.01 127.7 33.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.257 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -142.0 144.58 33.73 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.04 140.75 29.54 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.504 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.72 125.81 51.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.828 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -79.97 102.84 9.46 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.839 -1.073 . . . . 1.0 109.948 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -110.29 142.63 41.64 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.484 0.659 . . . . 1.0 110.667 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.09 134.32 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.375 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' A' ' 72' ' ' LEU . 3.7 mm? -71.6 129.48 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.979 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -137.16 139.86 29.43 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.096 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.08 166.58 29.26 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.906 2.404 . . . . 1.0 112.522 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -97.62 153.37 38.33 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.374 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.52 ' C ' ' H ' ' A' ' 78' ' ' HIS . 37.0 Cg_endo -64.44 -71.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.617 2.211 . . . . 1.0 112.459 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.584 ' CD2' ' HD1' ' A' ' 78' ' ' HIS . 0.6 OUTLIER -68.39 10.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.909 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.584 ' HD1' ' CD2' ' A' ' 77' ' ' HIS . 39.4 m80 -157.92 73.95 4.03 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.84 -13.52 21.78 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.286 1.99 . . . . 1.0 112.089 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -91.6 11.96 22.57 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 122.236 -0.29 . . . . 1.0 110.304 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -131.48 148.86 52.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.466 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -107.59 -175.06 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.124 -0.944 . . . . 1.0 110.116 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.98 155.41 6.62 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 110.893 -0.883 . . . . 1.0 110.893 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.15 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.437 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.71 14.82 0.02 OUTLIER Glycine 0 CA--C 1.536 1.372 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.27 156.95 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.845 -0.428 . . . . 1.0 109.845 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.055 -0.974 . . . . 1.0 111.065 -179.368 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 54.19 101.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.804 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.03 86.49 0.54 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.704 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.87 163.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.39 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 56.89 -159.95 0.23 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.762 -0.654 . . . . 1.0 111.153 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.88 57.58 0.61 Allowed Glycine 0 C--N 1.346 1.084 0 N-CA-C 111.465 -0.654 . . . . 1.0 111.465 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 38.2 t -96.5 129.15 46.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' VAL . 32.7 m-85 -126.97 132.17 50.89 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.647 0.261 . . . . 1.0 110.671 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 8' ' ' TYR . 41.4 t -44.47 170.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 35.5 tpp -95.11 -65.28 0.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.392 -0.193 . . . . 1.0 111.231 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -155.15 173.84 16.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.266 -0.573 . . . . 1.0 111.095 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 t -118.03 100.74 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASN . 9.7 mp -99.86 117.93 62.63 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.84 -0.6 . . . . 1.0 110.323 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.77 49.36 0.04 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.112 2.541 . . . . 1.0 112.838 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 58.4 t30 -171.18 8.89 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.009 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 16.6 mmt -107.9 155.66 39.54 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 120.566 0.222 . . . . 1.0 110.507 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.83 -23.65 73.02 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.273 1.982 . . . . 1.0 113.406 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.4 -13.06 41.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.163 0.506 . . . . 1.0 110.819 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.57 113.87 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.712 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.46 -11.87 63.22 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -113.28 -36.65 4.95 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.017 0.437 . . . . 1.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -123.31 149.9 44.26 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.707 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -139.63 155.06 47.65 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.298 -0.865 . . . . 1.0 110.873 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 131.97 52.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.651 -1.159 . . . . 1.0 108.945 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.06 -25.48 12.72 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.032 -1.227 . . . . 1.0 110.032 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.47 ' OD1' ' NH2' ' A' ' 61' ' ' ARG . 97.1 m-20 -79.29 153.16 30.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.577 0.227 . . . . 1.0 110.437 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 26.7 ptt180 -123.25 165.24 17.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -99.38 122.65 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.374 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.91 -22.62 15.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.791 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.37 159.04 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.391 0.615 . . . . 1.0 111.624 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.1 mt -136.64 122.41 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.037 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 t0 51.5 23.38 1.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.146 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.09 -6.78 58.38 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -90.01 122.27 67.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 122.625 -0.338 . . . . 1.0 111.162 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.33 133.32 17.51 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.693 1.595 . . . . 1.0 111.485 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mm -100.18 111.15 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.689 0.757 . . . . 1.0 112.257 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -110.85 -16.73 13.49 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.322 -1.308 . . . . 1.0 111.302 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.8 p -141.8 155.01 45.59 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.048 0.451 . . . . 1.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -68.9 -26.01 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.441 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -66.88 -32.72 74.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.493 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -59.99 -29.9 68.76 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.772 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.09 -27.37 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.749 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.26 -44.49 77.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.484 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.2 p -68.81 -42.2 77.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.489 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -58.78 -52.82 64.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.678 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.12 -40.76 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.99 -39.25 94.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.354 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.54 -55.16 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.345 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -80.98 146.52 30.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.138 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -97.52 177.57 5.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.494 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 136.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.758 . . . . 1.0 110.076 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.07 -3.64 70.26 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 33.7 t70 -73.59 170.45 15.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.082 0.468 . . . . 1.0 111.007 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 40.2 ptt85 -138.2 131.68 30.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.169 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.35 131.64 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.854 0.835 . . . . 1.0 111.877 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -75.51 109.26 8.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.615 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.92 138.06 25.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.448 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.1 m -107.11 140.83 39.32 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -148.79 152.78 37.14 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.17 135.54 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 121.695 0.76 . . . . 1.0 111.62 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.47 ' NH2' ' OD1' ' A' ' 26' ' ' ASP . 44.5 ttm-85 -140.83 122.09 14.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 114.543 -1.208 . . . . 1.0 109.621 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 46.25 49.09 12.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 64.05 9.37 4.6 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.554 0.534 . . . . 1.0 111.758 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -113.92 105.89 13.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.63 0.252 . . . . 1.0 110.636 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -80.01 146.23 32.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 111.176 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -153.48 145.51 23.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.968 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -89.93 129.88 36.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.445 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.1 128.24 55.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.992 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -80.37 102.74 9.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 1.0 109.928 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.05 145.55 38.3 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.234 0.54 . . . . 1.0 110.791 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.81 132.55 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.39 128.68 36.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.493 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -136.33 121.85 13.39 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.746 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.96 -174.52 2.21 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 122.373 2.049 . . . . 1.0 112.02 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -106.42 147.87 35.71 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.764 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.14 -34.59 45.53 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.0 1.8 . . . . 1.0 112.196 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.662 ' HD1' ' CG ' ' A' ' 78' ' ' HIS . 6.9 p80 -77.25 -16.31 59.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 1.0 110.295 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.662 ' CG ' ' HD1' ' A' ' 77' ' ' HIS . 28.0 m80 -144.4 73.74 15.68 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.359 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.26 -12.83 37.35 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.052 1.834 . . . . 1.0 111.953 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -93.94 18.93 9.68 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -143.01 131.18 21.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.457 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -76.15 157.83 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.648 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.93 103.76 0.63 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.218 -0.753 . . . . 1.0 111.218 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.67 -12.3 58.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.896 0.379 . . . . 1.0 110.842 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -104.45 168.34 16.33 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 111.174 -0.77 . . . . 1.0 111.174 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.7 t -137.91 151.08 25.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.787 0 N-CA-C 110.245 -0.279 . . . . 1.0 110.245 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.222 -0.382 0 CA-C-O 118.142 -0.932 . . . . 1.0 109.522 -179.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 56.16 52.41 10.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.352 -0.386 . . . . 1.0 111.026 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 53.6 76.15 0.23 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.982 0.42 . . . . 1.0 111.14 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.4 -64.86 0.81 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.447 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm 60.3 88.38 0.08 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.638 -0.256 . . . . 1.0 111.421 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.49 -117.13 2.56 Favored Glycine 0 N--CA 1.476 1.352 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.37 169.63 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 122.749 0.419 . . . . 1.0 110.276 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -133.87 139.76 46.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.834 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -74.47 125.63 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.031 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.4 mtt -84.8 -64.37 1.17 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.425 0.155 . . . . 1.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -123.08 149.73 44.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.279 0.561 . . . . 1.0 111.159 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.56 133.47 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 mp -93.47 150.56 39.11 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.797 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.04 -27.76 16.81 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.565 2.176 . . . . 1.0 112.788 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.57 39.91 2.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.0 162.44 21.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 123.189 0.306 . . . . 1.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.29 -33.68 94.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.262 1.975 . . . . 1.0 112.972 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.05 -11.61 54.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.743 0.306 . . . . 1.0 111.636 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.74 135.22 53.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.665 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.9 -16.37 51.37 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.84 -33.86 4.65 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.327 -0.249 . . . . 1.0 110.327 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 tp -122.63 152.66 40.25 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.294 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 60.9 mm-40 -139.42 154.33 47.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.599 0.714 . . . . 1.0 111.087 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.15 139.02 53.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.32 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -29.69 8.93 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.209 -1.156 . . . . 1.0 110.209 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 1.7 p-10 -69.69 149.52 47.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.807 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.4 158.79 21.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.903 0.382 . . . . 1.0 110.445 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.7 mm -100.04 119.98 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.011 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.65 -21.94 19.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.86 163.06 2.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.109 0.48 . . . . 1.0 111.528 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 33' ' ' GLY . 89.1 mt -136.79 126.53 38.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 122.294 1.045 . . . . 1.0 110.872 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t0 51.05 11.2 0.09 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.591 -0.693 . . . . 1.0 111.405 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . 111.06 -6.48 28.99 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.986 -0.341 . . . . 1.0 112.312 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 0.4 OUTLIER -94.9 110.6 50.64 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 117.239 0.519 . . . . 1.0 111.789 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.78 136.15 73.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.266 1.311 . . . . 1.0 111.522 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.79 115.64 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.597 0.713 . . . . 1.0 111.429 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -112.45 -20.22 11.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.253 -1.339 . . . . 1.0 110.963 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.423 ' HG1' ' H ' ' A' ' 41' ' ' GLN . 60.8 p -135.18 151.29 50.52 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.041 0.448 . . . . 1.0 110.76 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.0 p -69.55 -29.66 67.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.54 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.02 -29.47 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.648 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' H ' ' HG1' ' A' ' 38' ' ' THR . 7.4 tt0 -63.4 -28.62 70.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.078 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.35 -28.35 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.706 -0.224 . . . . 1.0 111.257 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.96 -40.98 76.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.034 0.445 . . . . 1.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.9 m -69.71 -41.1 75.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 1.0 109.595 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.49 -56.28 23.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.727 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.02 -33.55 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.302 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -64.35 -40.13 95.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.506 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -57.76 -50.25 73.86 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.666 -0.413 . . . . 1.0 110.321 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -81.6 149.09 28.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.36 -179.43 3.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.311 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 135.69 55.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.964 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.5 -0.21 65.42 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 35.5 t70 -78.06 171.05 15.6 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.877 0.37 . . . . 1.0 110.935 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 82.2 mtp180 -139.3 125.21 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.98 132.73 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.943 0.878 . . . . 1.0 111.646 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -81.02 113.46 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.093 -1.412 . . . . 1.0 108.748 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.95 132.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.644 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.8 m -101.17 137.71 39.16 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -150.28 152.18 34.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.51 138.54 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.41 0.624 . . . . 1.0 111.04 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -143.73 123.8 13.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.719 -1.128 . . . . 1.0 109.964 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 50.64 43.01 27.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.817 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 67.08 9.59 7.04 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.822 0.449 . . . . 1.0 111.841 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -115.46 106.54 14.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.919 0.39 . . . . 1.0 110.654 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' ' NE2' ' A' ' 65' ' ' GLN . 5.0 pp0? -74.13 138.52 43.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.383 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -149.16 144.28 26.5 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.362 -0.836 . . . . 1.0 111.269 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.68 136.52 32.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.037 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.18 122.55 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.36 102.04 12.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.933 -1.03 . . . . 1.0 110.026 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.8 mp -111.79 150.18 30.68 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.195 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 9.9 p -122.29 131.77 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.292 -0.867 . . . . 1.0 110.36 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.66 129.51 40.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.813 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -141.5 119.75 7.84 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.104 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.21 -169.49 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.155 1.904 . . . . 1.0 112.183 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -110.65 149.15 39.9 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.091 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.73 -27.56 68.34 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.175 1.917 . . . . 1.0 111.693 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.6 ' HD1' ' N ' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -85.35 -14.11 47.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.392 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -148.45 69.54 10.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.71 -11.5 24.1 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.421 2.08 . . . . 1.0 112.182 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -101.52 17.95 21.46 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.58 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -134.75 128.23 32.49 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.77 160.29 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.619 -0.718 . . . . 1.0 109.641 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.91 64.15 0.1 OUTLIER Glycine 0 N--CA 1.468 0.79 0 CA-C-N 115.042 -0.981 . . . . 1.0 111.259 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.9 tp -96.29 -83.59 0.37 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.517 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.37 -96.6 0.01 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 123.865 0.728 . . . . 1.0 112.354 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.01 155.44 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 122.57 0.348 . . . . 1.0 110.182 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.045 -0.979 . . . . 1.0 111.013 -179.411 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.599 ' C ' ' H ' ' A' ' 4' ' ' ALA . 15.3 m120 55.12 14.75 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.292 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 64.55 -15.25 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.487 0.492 . . . . 1.0 111.137 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.599 ' H ' ' C ' ' A' ' 2' ' ' ASN . . . -58.74 144.26 44.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.92 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -123.16 -52.11 1.86 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.344 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.66 -131.92 7.11 Favored Glycine 0 N--CA 1.471 1.033 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 t -135.36 111.88 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.236 0.541 . . . . 1.0 111.126 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -58.96 134.36 56.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.239 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 7.5 p -46.35 160.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.829 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 26.1 ttt -103.21 -62.29 1.3 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.857 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 m -151.94 154.36 35.93 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.156 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 t -122.45 101.94 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 13' ' ' LEU . 3.9 mm? -74.83 135.02 74.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.414 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.3 -20.95 42.09 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 122.32 2.013 . . . . 1.0 112.782 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -107.18 33.62 3.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.81 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.17 165.35 19.4 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.03 0.206 . . . . 1.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.491 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.2 Cg_exo -68.38 -16.6 43.7 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.403 2.069 . . . . 1.0 112.933 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.91 36.85 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.101 -0.375 . . . . 1.0 111.856 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.79 137.62 57.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.985 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.75 39.1 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.254 -0.738 . . . . 1.0 111.254 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' NH2' ' O ' ' A' ' 17' ' ' PRO . 36.0 mtm180 -113.69 -34.23 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.482 0.313 . . . . 1.0 110.806 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 mt -123.54 154.01 39.81 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.05 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -138.94 154.02 48.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.104 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.83 139.8 55.95 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.301 -0.863 . . . . 1.0 109.398 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.598 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 104.6 -26.31 23.0 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 26' ' ' ASP . 2.4 m-20 -67.49 145.35 55.05 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.937 -0.305 . . . . 1.0 110.253 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -109.09 153.39 23.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.726 0.298 . . . . 1.0 110.386 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.7 mm -96.16 118.01 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.095 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.75 -16.24 28.77 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.808 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 171.12 163.67 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.243 0.544 . . . . 1.0 110.965 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.93 126.75 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.774 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 50.77 20.68 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.036 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.0 56.31 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.852 -0.499 . . . . 1.0 111.852 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -92.85 126.33 51.96 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.961 0.381 . . . . 1.0 111.454 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.91 135.21 17.19 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.826 1.684 . . . . 1.0 111.468 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.66 115.75 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.865 0.84 . . . . 1.0 112.216 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -107.12 -23.27 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.09 -1.414 . . . . 1.0 111.161 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -134.86 154.28 51.71 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.165 0.507 . . . . 1.0 111.142 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -69.95 -33.73 72.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.337 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -62.51 -28.46 69.86 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -63.47 -30.27 71.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.628 -0.429 . . . . 1.0 109.919 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.54 -29.95 36.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 116.743 -0.208 . . . . 1.0 111.278 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.36 -42.21 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.461 . . . . 1.0 110.213 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -65.13 -40.39 94.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.161 0.505 . . . . 1.0 109.868 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.94 -57.68 11.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.895 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.0 m -55.16 -39.94 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.826 0.346 . . . . 1.0 110.202 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -40.95 94.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.72 -47.0 70.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.378 . . . . 1.0 110.46 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -81.5 -173.45 4.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.87 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' ALA . 40.3 tt0 -130.91 171.45 13.17 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.985 0.422 . . . . 1.0 110.834 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' A' ' 50' ' ' GLN . . . -64.83 136.28 56.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.771 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.3 -0.83 81.67 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.391 -1.084 . . . . 1.0 110.391 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.529 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 36.9 t70 -71.54 179.51 2.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.804 0.335 . . . . 1.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.529 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 87.4 mtm180 -138.47 123.55 19.08 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.5 130.98 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 122.06 0.933 . . . . 1.0 112.112 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -85.96 118.89 25.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.961 -1.472 . . . . 1.0 109.084 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -108.55 134.42 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.544 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.5 m -104.62 132.63 50.64 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.26 153.37 37.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.3 138.52 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.215 0.531 . . . . 1.0 110.341 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -141.31 121.78 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.304 -0.862 . . . . 1.0 109.444 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 54.37 39.6 31.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.34 -0.846 . . . . 1.0 110.873 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 68.92 9.09 7.21 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 123.161 0.288 . . . . 1.0 111.66 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -108.87 116.72 32.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.96 0.409 . . . . 1.0 110.131 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.9 128.58 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.887 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -144.18 139.12 28.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.27 0.557 . . . . 1.0 111.105 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.84 138.56 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.32 117.0 31.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.868 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -77.47 103.54 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.142 -0.935 . . . . 1.0 109.2 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.23 146.22 39.69 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.73 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.06 134.68 63.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.655 -1.157 . . . . 1.0 110.077 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -66.55 125.49 25.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.447 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.42 117.66 13.43 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.435 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.12 -170.78 0.92 Allowed 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.303 2.002 . . . . 1.0 112.353 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -125.25 145.72 51.66 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.131 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.72 -34.15 19.49 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 121.948 1.766 . . . . 1.0 111.94 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -81.45 -29.81 33.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.44 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -137.57 62.35 35.46 Favored Pre-proline 0 N--CA 1.467 0.422 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.272 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.29 -26.79 71.69 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.944 1.763 . . . . 1.0 111.954 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -56.53 -13.38 2.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.52 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -114.29 170.86 7.98 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.808 -0.442 . . . . 1.0 109.808 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.474 ' O ' ' N ' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -118.06 -177.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.192 -179.214 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -47.9 86.54 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.894 -0.594 . . . . 1.0 112.079 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.583 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -97.9 -3.22 39.0 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.761 0.424 . . . . 1.0 111.168 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.14 -32.97 85.95 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 111.941 -0.464 . . . . 1.0 111.941 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 t -108.18 144.8 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.845 0.355 . . . . 1.0 110.255 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.418 -179.707 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.536 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -81.13 70.22 7.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.475 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 73.52 -155.83 0.07 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.129 0.893 . . . . 1.0 111.256 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.8 -140.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.705 0.288 . . . . 1.0 111.535 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -62.68 -48.98 76.96 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.622 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.39 -120.43 2.64 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 111.43 -0.668 . . . . 1.0 111.43 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.0 t -134.15 168.55 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 120.824 0.345 . . . . 1.0 110.397 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -130.2 140.37 50.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.913 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.71 128.02 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.453 ' H ' ' CG2' ' A' ' 87' ' ' THR . 23.4 ttt -78.03 -64.74 1.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.194 -0.316 . . . . 1.0 111.723 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -133.6 160.77 36.49 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.031 0.443 . . . . 1.0 111.535 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.6 136.52 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.99 148.91 38.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 O-C-N 123.42 0.45 . . . . 1.0 111.854 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' SD ' ' A' ' 16' ' ' MET . 74.4 Cg_endo -73.23 157.43 50.17 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.288 1.992 . . . . 1.0 111.351 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 64.15 28.0 14.07 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.296 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -106.59 157.94 33.91 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-O 120.748 0.309 . . . . 1.0 110.357 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 -19.55 64.16 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.157 1.905 . . . . 1.0 112.979 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.25 -17.72 17.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.65 0.738 . . . . 1.0 111.091 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.32 129.57 42.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.819 -1.082 . . . . 1.0 109.337 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.33 -7.94 62.2 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -134.27 -24.36 1.62 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.826 0.346 . . . . 1.0 110.537 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.41 134.07 55.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.011 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 97.5 mt-10 -134.45 148.0 50.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.549 0.69 . . . . 1.0 110.405 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.2 136.89 48.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.931 -1.032 . . . . 1.0 109.483 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.62 -26.63 13.95 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 2.8 p-10 -64.78 145.0 56.86 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.72 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -109.69 142.22 41.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.933 0.397 . . . . 1.0 109.979 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.23 122.26 43.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.569 -0.742 . . . . 1.0 109.191 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -94.54 -22.45 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.125 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.02 154.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.2 mt -129.55 125.46 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.878 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 17.12 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.529 -0.76 . . . . 1.0 111.013 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.73 -5.29 47.17 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.72 -0.552 . . . . 1.0 111.72 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -95.19 111.19 54.06 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.026 0.413 . . . . 1.0 111.486 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.18 136.45 74.81 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 122.326 2.017 . . . . 1.0 111.484 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.69 106.37 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.578 0.704 . . . . 1.0 111.805 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -102.68 -25.02 13.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.605 -1.18 . . . . 1.0 111.419 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -140.53 160.18 40.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.078 0.466 . . . . 1.0 111.051 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -67.39 -23.04 65.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.103 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -66.01 -32.96 74.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.209 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -61.55 -31.35 71.37 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.511 -0.476 . . . . 1.0 109.82 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.43 -27.96 19.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 CA-C-O 120.983 0.421 . . . . 1.0 110.485 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.52 -42.74 83.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.734 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 59.2 p -64.21 -39.73 94.58 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -58.23 -56.21 24.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.505 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.82 -44.0 76.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.946 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -69.62 -35.79 75.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.68 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.42 -62.53 1.59 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.224 -0.287 . . . . 1.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.32 -169.21 2.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.635 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -131.91 176.37 8.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.676 0.75 . . . . 1.0 112.039 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.62 134.84 57.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.889 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.5 -0.78 74.89 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.441 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 19.3 t0 -68.62 169.95 10.17 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.888 0.375 . . . . 1.0 111.16 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 76.4 mtp180 -140.73 117.75 11.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.7 m -129.23 135.14 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.855 0.836 . . . . 1.0 111.88 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.434 ' NH1' ' OE2' ' A' ' 69' ' ' GLU . 83.9 mmt-85 -76.75 105.84 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.31 -1.314 . . . . 1.0 108.786 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.0 t -95.06 135.21 29.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.561 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.9 m -104.97 137.52 42.6 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.9 150.96 32.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -103.12 137.67 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.741 0.781 . . . . 1.0 111.706 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -143.34 117.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.465 -1.243 . . . . 1.0 110.175 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 52.84 44.77 29.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.251 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 66.67 8.31 5.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.706 -0.225 . . . . 1.0 111.335 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.686 ' HZ2' ' HE2' ' A' ' 66' ' ' HIS . 9.0 mtmp? -111.92 113.34 25.61 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 51.1 mt-30 -75.79 146.23 40.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.401 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.686 ' HE2' ' HZ2' ' A' ' 64' ' ' LYS . 98.2 m-70 -156.53 140.94 16.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.979 0.419 . . . . 1.0 110.817 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.99 128.69 36.91 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.85 123.88 49.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.401 0.619 . . . . 1.0 110.471 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.434 ' OE2' ' NH1' ' A' ' 56' ' ' ARG . 42.6 tp10 -78.74 100.54 7.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.041 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -114.83 149.24 37.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.462 0.649 . . . . 1.0 110.846 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -136.13 137.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 114.755 -1.112 . . . . 1.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 mt -61.16 120.44 10.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.995 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 83' ' ' GLY . 84.4 tttt -118.62 119.94 32.22 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.872 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.22 174.0 13.56 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.744 2.296 . . . . 1.0 112.713 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -85.5 159.13 56.37 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.759 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -44.46 -86.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.393 2.062 . . . . 1.0 113.612 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.429 ' O ' ' CG ' ' A' ' 77' ' ' HIS . 60.9 t60 -101.38 8.06 42.41 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.771 0.32 . . . . 1.0 110.692 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.431 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 58.6 m-70 -121.93 50.7 2.55 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.849 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 81' ' ' GLN . 25.5 Cg_endo -60.89 -6.65 6.36 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.869 2.379 . . . . 1.0 111.353 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -50.16 -13.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.53 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.44 ' N ' ' C ' ' A' ' 79' ' ' PRO . 12.4 tp60 -131.06 -167.34 1.83 Allowed 'General case' 0 C--N 1.347 0.491 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 84' ' ' LEU . 1.2 mm -129.72 170.4 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.821 -0.627 . . . . 1.0 109.695 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 73' ' ' LYS . . . -47.37 82.01 0.01 OUTLIER Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.418 -0.81 . . . . 1.0 112.153 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -99.59 -3.68 32.72 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.373 0.269 . . . . 1.0 110.348 -179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.83 -25.17 3.43 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.959 -0.639 . . . . 1.0 112.041 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 t -107.98 145.74 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.668 0.271 . . . . 1.0 110.474 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.453 ' CG2' ' H ' ' A' ' 10' ' ' MET . 13.2 t . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.124 -0.941 . . . . 1.0 111.253 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.534 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.696 HD21 ' H ' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -81.03 167.66 19.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.216 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -73.39 -76.79 0.12 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.871 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.63 140.57 47.18 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.664 -0.244 . . . . 1.0 110.582 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.29 172.69 10.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.67 0.272 . . . . 1.0 110.85 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.49 -119.12 3.36 Favored Glycine 0 N--CA 1.474 1.18 0 N-CA-C 111.474 -0.651 . . . . 1.0 111.474 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -130.82 170.39 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.783 0.325 . . . . 1.0 110.383 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.65 129.51 36.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.961 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.34 127.75 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.179 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.5 ' H ' ' CG2' ' A' ' 87' ' ' THR . 11.0 tpt -75.84 -53.04 9.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.186 -0.321 . . . . 1.0 111.278 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.1 p -148.05 165.26 31.33 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.015 0.436 . . . . 1.0 111.365 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.59 135.28 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.19 153.08 39.81 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.434 0.459 . . . . 1.0 111.176 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.64 158.75 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.558 2.172 . . . . 1.0 111.88 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.6 t30 56.27 32.45 20.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.405 -0.816 . . . . 1.0 111.116 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.9 mmm -106.88 161.13 23.87 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.174 0.296 . . . . 1.0 110.882 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.32 -30.43 91.03 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.343 2.029 . . . . 1.0 112.821 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.85 -14.43 20.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.922 0.391 . . . . 1.0 111.465 -178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 122.66 14.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.65 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.71 -8.22 65.85 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -119.73 -25.66 5.86 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.238 0.542 . . . . 1.0 110.538 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.2 mt -140.03 170.62 15.52 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.743 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 mt-10 -156.06 165.01 37.7 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.377 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.85 137.71 57.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.498 -1.228 . . . . 1.0 109.025 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.81 14.72 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 7.6 p-10 -72.64 154.04 40.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.791 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -121.81 151.42 40.63 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -96.69 129.24 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.78 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.5 -27.29 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.85 151.03 2.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 1.0 111.409 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.84 123.6 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.166 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.2 t0 56.59 17.16 2.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.962 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.27 42.3 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.927 -0.469 . . . . 1.0 111.927 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -96.2 110.45 52.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 119.379 -0.344 . . . . 1.0 111.399 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.88 137.53 81.45 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.336 2.024 . . . . 1.0 111.394 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mm -97.75 106.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.575 0.702 . . . . 1.0 111.744 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -104.22 -21.52 13.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.8 p -144.3 161.01 40.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.993 0.425 . . . . 1.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.0 p -66.86 -23.85 66.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.353 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.21 -34.1 77.57 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.071 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -59.95 -33.34 71.78 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.775 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.406 HD12 HG21 ' A' ' 42' ' ' ILE . 47.9 mm -71.92 -28.16 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.942 0.401 . . . . 1.0 110.547 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.02 -42.98 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.909 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 t -62.75 -41.43 99.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.789 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -58.18 8.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.883 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.42 -43.0 81.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -62.85 -44.36 96.34 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.959 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -60.15 -58.09 10.02 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 1.0 110.25 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -81.49 170.94 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.382 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -136.41 -172.24 3.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.126 0.489 . . . . 1.0 111.42 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 129.73 40.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.143 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.39 -8.73 64.57 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.494 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 20.2 t70 -70.81 174.61 5.84 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.975 0.417 . . . . 1.0 111.155 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.494 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 83.7 mtt85 -145.14 127.89 16.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.93 132.9 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.905 0.86 . . . . 1.0 111.862 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -78.12 103.01 7.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.272 -1.331 . . . . 1.0 108.496 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.1 t -95.42 135.49 29.33 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.051 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.5 m -105.08 138.87 40.62 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -148.92 155.15 40.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -110.19 134.59 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.629 0.728 . . . . 1.0 111.13 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -141.91 123.84 15.31 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.657 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 48.02 46.16 19.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.655 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 67.67 6.66 5.15 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.846 0.355 . . . . 1.0 110.606 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -112.29 116.12 29.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -90.55 143.21 26.97 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.91 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -152.34 148.49 27.56 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.839 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.99 127.08 36.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.632 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.93 124.54 49.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.446 0.641 . . . . 1.0 110.044 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.08 102.14 14.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.558 -1.201 . . . . 1.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 36.3 mt -113.31 151.19 31.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.669 -178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.07 130.64 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.019 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.451 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.2 mm? -56.67 120.16 7.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.134 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -121.74 117.15 30.07 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.547 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.1 179.27 6.28 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.913 2.409 . . . . 1.0 112.244 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.8 152.23 46.45 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.603 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.27 -60.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.349 2.032 . . . . 1.0 112.612 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -100.31 21.21 13.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.514 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -164.2 45.12 0.12 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.373 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 78' ' ' HIS . 15.1 Cg_endo -53.82 -10.63 1.83 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.679 2.252 . . . . 1.0 112.107 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -56.0 -8.64 0.47 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.587 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 79' ' ' PRO . 1.1 mp0 -130.52 156.38 44.9 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.4 mt -142.53 142.57 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.623 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.55 2.89 52.22 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.601 -0.6 . . . . 1.0 111.601 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -66.19 -40.17 90.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.144 -0.222 . . . . 1.0 111.492 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -33.66 -47.48 0.46 Allowed Glycine 0 N--CA 1.47 0.9 0 O-C-N 123.621 0.575 . . . . 1.0 112.32 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.92 157.17 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.932 0.396 . . . . 1.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.5 ' CG2' ' H ' ' A' ' 10' ' ' MET . 6.7 t . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.87 -1.062 . . . . 1.0 111.097 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 tmm? . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -164.59 -76.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.931 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 60.25 56.38 3.27 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.445 0.465 . . . . 1.0 110.363 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.81 -63.16 1.12 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.545 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -119.19 -43.93 2.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 111.357 0.132 . . . . 1.0 111.357 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -116.6 -112.71 2.72 Favored Glycine 0 N--CA 1.476 1.321 0 N-CA-C 111.463 -0.655 . . . . 1.0 111.463 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.31 158.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.699 0.285 . . . . 1.0 110.381 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -129.11 137.41 51.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.8 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.21 127.69 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.12 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.6 mtt -75.35 -65.46 0.89 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.733 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -128.94 160.87 31.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.166 0.507 . . . . 1.0 111.16 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -128.12 138.92 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.89 145.17 31.48 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 123.137 0.273 . . . . 1.0 111.121 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.08 -24.28 20.59 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.441 2.094 . . . . 1.0 112.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -99.05 17.93 18.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.639 -0.255 . . . . 1.0 111.159 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 85' ' ' GLY . 27.8 mtt -113.17 158.53 37.83 Favored Pre-proline 0 N--CA 1.469 0.485 0 O-C-N 123.055 0.222 . . . . 1.0 110.9 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.66 -32.11 53.2 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.415 2.076 . . . . 1.0 113.295 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.78 57.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.685 0.279 . . . . 1.0 111.385 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.07 109.65 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.122 -0.631 . . . . 1.0 110.719 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.68 -14.83 64.59 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.232 -0.747 . . . . 1.0 111.232 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -108.11 -41.63 4.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.124 0.488 . . . . 1.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.47 156.84 40.04 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.484 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -144.29 158.1 43.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.157 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.81 56.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.421 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.2 18.15 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.247 -1.141 . . . . 1.0 110.247 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 150.68 42.63 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 122.782 -0.246 . . . . 1.0 110.63 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -114.61 154.58 28.11 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.161 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mm -97.35 120.14 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.024 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.47 19.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.6 158.72 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 1.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.75 125.03 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.105 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 51.22 21.72 1.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.124 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.33 57.81 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.617 -0.593 . . . . 1.0 111.617 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -89.93 124.85 62.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.75 -0.265 . . . . 1.0 111.254 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.4 132.8 15.28 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.981 1.787 . . . . 1.0 111.465 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -99.13 110.89 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.496 0.665 . . . . 1.0 112.433 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -115.53 -18.18 11.0 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.661 -1.154 . . . . 1.0 111.108 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -139.37 156.01 47.28 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.241 0.544 . . . . 1.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.1 m -66.28 -22.57 66.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.233 -0.894 . . . . 1.0 108.878 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.33 -35.34 77.63 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.523 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' H ' HG23 ' A' ' 38' ' ' THR . 69.6 tp60 -57.1 -31.71 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.859 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -74.79 -26.84 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.781 -0.191 . . . . 1.0 110.971 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.54 -41.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 1.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.2 t -65.62 -40.58 92.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.281 0.562 . . . . 1.0 109.944 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -58.18 -57.16 14.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.646 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' LYS . 29.0 m -58.55 -39.77 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.325 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -66.04 -37.61 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.707 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.77 -53.86 47.89 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.339 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 46' ' ' VAL . 72.1 mmtt -87.31 156.96 19.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.55 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.4 -178.18 3.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.295 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.27 135.91 55.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.177 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.82 -1.53 74.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 30.7 t70 -74.24 172.04 12.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.033 0.444 . . . . 1.0 110.879 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.0 mtp85 -141.76 130.04 22.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.078 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.63 133.51 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.892 0.854 . . . . 1.0 111.942 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.14 107.44 7.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.383 -1.28 . . . . 1.0 108.767 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.03 137.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.329 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -104.92 139.22 39.96 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -150.31 151.87 33.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.23 132.07 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.525 0.679 . . . . 1.0 111.472 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -138.58 124.24 19.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.4 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 49.58 43.82 24.15 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 115.291 -0.868 . . . . 1.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 70.43 -1.35 2.54 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.322 0.119 . . . . 1.0 111.322 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -107.42 106.06 16.28 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.529 0.204 . . . . 1.0 110.824 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -76.82 145.3 38.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.212 0.529 . . . . 1.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -153.88 146.09 23.8 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.327 -0.852 . . . . 1.0 111.052 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -89.12 132.11 34.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.543 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.94 124.62 52.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.91 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 39.1 mp0 -80.04 101.95 9.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.738 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tt -109.34 143.0 39.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.749 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.7 131.0 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.442 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.68 131.6 46.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.502 . . . . 1.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -145.09 135.21 11.8 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.942 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.55 171.82 16.98 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.811 2.341 . . . . 1.0 112.356 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -109.43 137.28 20.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -48.65 -40.05 38.0 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.051 1.834 . . . . 1.0 112.269 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -73.4 -39.01 65.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.848 0.356 . . . . 1.0 110.479 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -118.96 70.07 9.87 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.997 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.56 -29.58 78.44 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.135 1.89 . . . . 1.0 111.859 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -86.66 25.88 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.21 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -144.4 149.77 36.63 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.762 -0.458 . . . . 1.0 109.762 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.1 138.96 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.055 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.81 -179.01 28.01 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 6.4 mp -68.7 -89.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.257 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.483 ' O ' ' SD ' ' A' ' 16' ' ' MET . . . 177.18 -10.74 0.03 OUTLIER Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.3 m -108.09 171.54 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 122.595 -0.356 . . . . 1.0 110.079 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.689 -179.285 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.751 -0.833 . . . . 1.0 108.751 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -151.89 86.18 1.31 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.851 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 4' ' ' ALA . 97.0 mt-10 -101.95 165.08 11.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.193 -0.458 . . . . 1.0 109.831 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' GLU . . . -24.0 126.17 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.855 0.722 . . . . 1.0 112.141 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.456 ' NZ ' ' OH ' ' A' ' 8' ' ' TYR . 54.6 mtmt -85.54 -164.96 1.09 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.909 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.586 ' N ' ' NH2' ' A' ' 27' ' ' ARG . . . -110.39 -122.28 4.37 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.102 -0.799 . . . . 1.0 111.102 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.8 t -120.63 164.06 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.456 ' OH ' ' NZ ' ' A' ' 5' ' ' LYS . 67.9 m-85 -120.99 125.73 48.1 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.323 -0.398 . . . . 1.0 111.091 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.55 124.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.6 mmt -70.67 -66.47 0.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.659 -0.246 . . . . 1.0 111.544 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.3 t -137.99 173.57 11.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.069 0.461 . . . . 1.0 111.064 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.15 133.58 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 mt -112.64 114.2 49.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.115 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.54 163.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.98 1.786 . . . . 1.0 112.06 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 m120 68.18 19.02 9.24 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.971 0.794 . . . . 1.0 111.027 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.8 mmt -111.1 160.28 29.58 Favored Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.239 0.337 . . . . 1.0 111.116 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.73 -39.56 90.4 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.796 1.664 . . . . 1.0 112.954 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.94 -12.5 53.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.01 0.433 . . . . 1.0 111.596 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.23 131.27 45.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.551 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.53 -14.53 64.81 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.111 -0.795 . . . . 1.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.445 ' HE ' ' HA ' ' A' ' 68' ' ' ALA . 6.8 ptm85 -129.06 -23.45 3.03 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.912 0.387 . . . . 1.0 110.728 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 23.1 tp -122.97 148.19 45.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.441 -0.8 . . . . 1.0 110.311 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -143.79 157.9 44.06 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.687 0.756 . . . . 1.0 111.197 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.8 136.19 56.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.62 -1.173 . . . . 1.0 109.075 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.56 10.2 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 110.066 -1.214 . . . . 1.0 110.066 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -71.02 146.04 49.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.283 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.586 ' NH2' ' N ' ' A' ' 6' ' ' GLY . 14.8 ptm180 -114.93 161.54 18.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.277 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -99.74 119.28 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.061 0.458 . . . . 1.0 110.303 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.6 -19.36 21.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.674 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.42 164.44 2.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.582 0.706 . . . . 1.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.6 mt -139.78 122.81 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.909 -1.041 . . . . 1.0 109.813 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 49.88 24.2 1.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.892 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.34 -6.12 61.18 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.801 -0.52 . . . . 1.0 111.801 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -93.0 107.88 28.17 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 116.887 0.344 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 136.42 71.03 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.905 1.737 . . . . 1.0 111.546 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.3 mm -102.84 113.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.68 0.752 . . . . 1.0 111.886 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' OD1' ' NE2' ' A' ' 41' ' ' GLN . 51.4 p30 -114.14 -20.65 10.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.586 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 56.4 p -134.6 160.34 38.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.015 0.436 . . . . 1.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.8 p -77.55 -27.61 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.052 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -67.8 -30.34 69.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.464 ' NE2' ' OD1' ' A' ' 37' ' ' ASN . 16.0 mt-30 -64.11 -27.45 69.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mm -78.06 -26.55 14.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -70.46 -41.79 78.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 123.536 0.522 . . . . 1.0 110.209 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.1 m -70.07 -39.29 75.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.307 0.575 . . . . 1.0 109.782 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.408 ' OH ' ' CG1' ' A' ' 55' ' ' VAL . 86.4 t80 -58.89 -55.74 31.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.888 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 m -55.45 -36.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 120.733 0.301 . . . . 1.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.625 ' NH2' HE22 ' A' ' 81' ' ' GLN . 30.1 mmt180 -65.58 -36.57 84.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.941 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -58.44 -43.41 88.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.013 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -93.29 149.8 20.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.309 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.529 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -101.24 178.3 4.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.143 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.58 57.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.125 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.47 -1.87 82.35 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.782 -0.927 . . . . 1.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.515 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 24.4 t70 -71.95 175.93 5.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.826 0.345 . . . . 1.0 110.716 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.515 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -139.39 129.99 25.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' OH ' ' A' ' 45' ' ' TYR . 5.9 m -136.11 130.89 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.974 0.892 . . . . 1.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -80.85 106.51 12.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.286 -1.325 . . . . 1.0 108.968 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -97.07 143.46 12.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.599 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.1 m -109.75 138.88 45.48 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.536 0.522 . . . . 1.0 109.685 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -150.24 150.91 32.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.88 134.06 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.672 0.749 . . . . 1.0 111.192 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -138.05 121.9 17.66 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 114.37 -1.287 . . . . 1.0 109.885 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 49.11 43.25 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.851 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 71.67 3.11 4.54 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.886 -0.143 . . . . 1.0 111.343 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -108.61 105.36 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.72 0.295 . . . . 1.0 110.946 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -78.26 138.68 38.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 1.0 111.011 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -148.43 145.24 27.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.641 -0.708 . . . . 1.0 110.992 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -89.89 132.88 35.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.246 -0.888 . . . . 1.0 110.343 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.445 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . . . -110.13 121.3 44.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.843 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.0 102.3 7.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.394 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -115.51 149.68 37.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.876 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.8 m -128.25 135.58 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.453 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.443 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -143.59 92.91 6.41 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.473 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.3 177.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.719 2.279 . . . . 1.0 112.424 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -109.65 148.3 37.86 Favored Pre-proline 0 N--CA 1.474 0.763 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.06 -30.84 76.23 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.103 1.869 . . . . 1.0 111.845 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.601 ' HD1' ' N ' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -74.05 -33.5 63.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.965 0.412 . . . . 1.0 109.988 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -132.66 72.22 77.84 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.888 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.14 -20.69 68.95 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.231 1.954 . . . . 1.0 111.878 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -93.63 17.08 12.36 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.956 -0.387 . . . . 1.0 109.956 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.625 HE22 ' NH2' ' A' ' 47' ' ' ARG . 9.3 tp-100 -136.02 124.57 23.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.003 0.43 . . . . 1.0 110.094 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -84.97 -175.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.003 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.31 172.99 31.48 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 84' ' ' LEU . 3.6 mm? -78.24 -88.67 0.05 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.53 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -179.23 -11.12 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 N-CA-C 110.967 -0.853 . . . . 1.0 110.967 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.0 m -109.63 170.87 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.469 0.308 . . . . 1.0 110.262 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.218 -0.597 0 CA-C-O 118.029 -0.986 . . . . 1.0 111.051 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' ASN . 83.1 mmm . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' MET . 65.9 m-80 57.54 118.72 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.777 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 50.39 64.36 1.83 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.108 0.48 . . . . 1.0 110.694 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.74 166.66 11.56 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -134.7 -112.1 0.21 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' A' ' 8' ' ' TYR . . . 108.73 111.32 3.45 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.575 -0.61 . . . . 1.0 111.575 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.2 96.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 6' ' ' GLY . 4.1 m-85 -60.72 114.01 2.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.528 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -79.54 131.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.906 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.9 ttt -81.27 -72.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 111.692 0.256 . . . . 1.0 111.692 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -129.71 162.0 29.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.17 0.51 . . . . 1.0 111.209 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.64 131.5 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.307 -0.861 . . . . 1.0 108.915 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' A' ' 13' ' ' LEU . 4.2 mm? -89.09 115.2 62.99 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.771 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.04 -19.94 12.69 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.976 1.784 . . . . 1.0 112.246 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -99.19 22.28 10.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.653 -0.248 . . . . 1.0 110.982 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 mmt -121.04 159.05 50.93 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.683 -0.235 . . . . 1.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.85 -22.05 66.63 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.485 2.123 . . . . 1.0 112.772 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.11 -14.23 59.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.833 0.349 . . . . 1.0 111.671 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 132.74 48.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.915 0.388 . . . . 1.0 110.407 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.98 27.97 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -104.92 -41.49 5.6 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.15 156.63 31.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.34 155.95 48.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.101 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.21 134.29 56.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.311 -0.858 . . . . 1.0 109.469 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.37 -26.4 18.59 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.07 145.46 51.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.381 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -111.0 153.24 25.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.871 0.367 . . . . 1.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.43 119.62 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.861 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.75 -16.95 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.99 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 174.41 164.32 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.31 0.576 . . . . 1.0 110.934 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 92.7 mt -135.93 125.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.625 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.419 ' OD2' ' CE1' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 49.97 17.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.15 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.95 -5.84 46.95 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.053 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -92.94 108.77 34.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.978 0.389 . . . . 1.0 111.318 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.04 133.28 52.32 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.219 1.946 . . . . 1.0 111.551 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mm -102.16 116.7 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.649 0.738 . . . . 1.0 111.855 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 38' ' ' THR . 48.9 p30 -107.92 -23.52 12.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.579 -1.191 . . . . 1.0 111.409 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.467 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 69.2 p -137.21 155.26 49.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.034 0.445 . . . . 1.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.2 p -68.73 -32.81 72.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.484 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -61.94 -30.87 71.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.264 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -61.99 -30.01 70.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.318 -0.553 . . . . 1.0 109.946 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.406 HG23 HD11 ' A' ' 42' ' ' ILE . 50.4 mm -71.6 -29.63 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.547 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.65 -43.68 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.268 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -65.17 -42.51 93.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.419 ' CE1' ' OD2' ' A' ' 32' ' ' ASP . 64.8 t80 -57.61 -57.1 14.21 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.325 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.96 -40.93 47.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -65.97 -20.81 66.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -61.85 -56.19 21.98 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.71 -163.41 1.02 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.961 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.46 -171.62 3.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.343 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 134.72 53.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.141 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.52 63.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.42 161.79 25.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.831 0.348 . . . . 1.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -127.5 122.35 33.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.62 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.997 0.904 . . . . 1.0 111.535 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -83.34 116.34 22.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.401 -1.272 . . . . 1.0 109.033 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.0 t -107.41 131.14 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.95 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.4 m -101.48 133.4 46.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -147.83 152.19 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -109.67 139.47 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.389 0.614 . . . . 1.0 110.651 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -142.84 121.85 12.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.192 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 52.39 40.82 30.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 69.1 13.37 8.69 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.332 0.395 . . . . 1.0 111.363 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.642 ' HZ3' ' HE2' ' A' ' 66' ' ' HIS . 8.2 mtmp? -114.16 109.0 17.73 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -77.27 131.52 38.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.0 111.278 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.642 ' HE2' ' HZ3' ' A' ' 64' ' ' LYS . 98.4 m-70 -146.07 144.47 30.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.949 -0.568 . . . . 1.0 111.037 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 40.6 mp0 -90.89 137.46 32.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.649 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 120.21 41.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.321 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.86 101.44 9.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.93 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tt -110.95 140.99 44.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.959 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.85 131.97 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.456 0.645 . . . . 1.0 110.651 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -65.71 121.99 16.25 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.641 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -132.23 124.53 19.39 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.19 -177.0 3.36 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.824 2.349 . . . . 1.0 112.565 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -118.75 144.6 35.88 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.275 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.27 -36.43 16.33 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.997 1.798 . . . . 1.0 111.934 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -70.42 -39.16 74.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.066 0.46 . . . . 1.0 110.119 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -139.9 74.05 32.48 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 115.708 -0.678 . . . . 1.0 110.715 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.07 -23.34 60.34 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.658 2.239 . . . . 1.0 111.703 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -59.34 -17.36 28.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.748 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 66.5 tp60 -111.97 147.61 35.54 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 121.171 0.51 . . . . 1.0 109.877 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.488 ' CD1' ' N ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -94.05 179.62 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.418 -0.81 . . . . 1.0 110.602 -179.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.71 130.0 36.44 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.402 -0.679 . . . . 1.0 111.402 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.63 -17.94 20.06 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.719 0.295 . . . . 1.0 110.692 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.61 -94.45 0.34 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.74 -0.544 . . . . 1.0 111.74 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.42 172.2 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.489 0.316 . . . . 1.0 110.68 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.108 -0.949 . . . . 1.0 110.967 -178.91 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -102.33 123.07 45.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.78 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 6.2 p -45.67 164.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.097 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.538 ' N ' HG22 ' A' ' 9' ' ' VAL . 25.1 mmt -104.87 -70.27 0.78 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.609 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.9 t -156.2 175.26 14.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.712 0.291 . . . . 1.0 110.95 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.8 105.91 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.8 mt -93.71 143.96 27.41 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.857 -0.156 . . . . 1.0 110.889 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -72.9 156.42 52.55 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.159 1.906 . . . . 1.0 112.274 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.13 32.36 21.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.864 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 6.3 mtt -122.32 152.39 60.76 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 110.506 -0.183 . . . . 1.0 110.506 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.01 -16.88 57.39 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.534 2.156 . . . . 1.0 112.932 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 -24.03 27.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.96 0.409 . . . . 1.0 111.222 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 131.06 45.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.818 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.04 -21.21 35.3 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.59 -43.94 4.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.788 0.328 . . . . 1.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.646 HD13 ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -116.29 140.45 49.31 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.646 ' H ' HD13 ' A' ' 22' ' ' LEU . 61.5 mm-40 -131.53 159.21 38.83 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.301 0.572 . . . . 1.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.59 133.31 50.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.273 -0.876 . . . . 1.0 109.805 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.626 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 110.07 -23.1 21.96 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.418 ' OD1' ' NE ' ' A' ' 61' ' ' ARG . 36.3 m-20 -79.36 144.47 34.15 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.025 -0.103 . . . . 1.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 -110.34 161.4 15.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.921 0.391 . . . . 1.0 110.787 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -98.05 115.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.434 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.87 -14.89 28.94 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.12 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 177.93 168.06 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.249 0.547 . . . . 1.0 111.161 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.0 125.94 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.79 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 47.79 22.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.0 111.176 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -6.87 57.29 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.992 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -87.39 126.4 62.43 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.417 -0.325 . . . . 1.0 111.161 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.54 126.66 8.41 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.589 1.526 . . . . 1.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.463 HG21 HD11 ' A' ' 42' ' ' ILE . 29.9 mm -100.62 120.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.731 0.777 . . . . 1.0 111.933 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -116.13 -19.32 10.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.455 -1.248 . . . . 1.0 111.142 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -133.32 155.9 48.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.179 0.514 . . . . 1.0 111.093 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -71.68 -32.33 67.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.454 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -65.01 -32.45 74.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.584 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -58.86 -30.31 67.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.619 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.463 HD11 HG21 ' A' ' 36' ' ' ILE . 50.4 mm -72.16 -29.09 31.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.332 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.11 -40.02 84.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 O-C-N 123.29 0.369 . . . . 1.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.1 p -69.48 -40.86 76.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.337 0.589 . . . . 1.0 109.551 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -56.37 -56.79 16.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.56 -36.29 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 1.0 110.455 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -57.79 -41.57 82.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.293 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.71 -42.88 98.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.493 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -89.32 154.29 20.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.171 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.48 -176.17 2.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.985 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.68 138.91 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.214 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.38 0.87 81.95 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 29.7 t70 -74.67 179.62 4.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.087 0.47 . . . . 1.0 110.568 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 80.7 ttt180 -139.56 123.4 17.58 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.87 134.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.777 0.799 . . . . 1.0 111.821 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.48 122.61 32.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.502 -1.226 . . . . 1.0 108.601 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.6 t -116.17 130.3 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.0 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.7 m -96.95 136.11 37.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.308 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.489 ' C ' HD12 ' A' ' 60' ' ' ILE . 22.9 p90 -146.62 151.32 37.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -112.62 137.15 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.103 0.478 . . . . 1.0 110.356 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 17.7 ttm180 -136.66 120.48 17.42 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.789 -0.642 . . . . 1.0 109.467 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 49.97 39.42 18.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.782 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 73.33 12.64 4.77 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.53 0.196 . . . . 1.0 111.53 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -110.74 100.25 9.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.738 0.304 . . . . 1.0 110.395 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.17 127.62 33.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.47 0.652 . . . . 1.0 111.711 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.07 141.2 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.774 -0.648 . . . . 1.0 111.139 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.03 146.17 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.616 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.98 130.91 53.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.077 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 70' ' ' LEU . 77.3 tt0 -92.23 105.39 17.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.476 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.5 mp -111.3 146.33 37.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.045 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.88 130.21 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.59 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -66.11 132.91 49.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.802 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.11 133.81 54.26 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.988 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.99 120.81 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.943 -0.392 . . . . 1.0 109.943 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.52 -69.13 0.5 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.028 -0.269 . . . . 1.0 111.657 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.1 p -128.4 165.34 20.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.044 0.45 . . . . 1.0 111.03 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.29 122.15 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.87 153.24 52.12 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.757 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 152.63 64.7 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.611 2.207 . . . . 1.0 112.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 52.61 45.15 29.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.519 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.8 mmt -121.17 154.18 58.39 Favored Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.013 0.196 . . . . 1.0 110.706 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HD3' ' HZ1' ' A' ' 73' ' ' LYS . 28.2 Cg_endo -62.05 -19.34 65.92 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.339 2.026 . . . . 1.0 112.869 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -89.63 -24.01 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.844 0.354 . . . . 1.0 111.484 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.23 141.37 52.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.627 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -22.73 14.03 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.4 -34.01 4.44 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.533 HD13 ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -118.55 139.79 50.9 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.934 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' H ' HD13 ' A' ' 22' ' ' LEU . 97.0 mt-10 -130.18 152.65 49.38 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.511 0.672 . . . . 1.0 110.964 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.06 139.92 53.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.33 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.49 -28.88 13.19 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.206 -1.157 . . . . 1.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 61' ' ' ARG . 80.5 m-20 -70.75 147.02 49.45 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.294 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -114.58 159.71 20.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.891 0.377 . . . . 1.0 110.351 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.7 mm -97.55 118.75 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.396 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.27 -15.9 25.32 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.786 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.95 163.5 0.81 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.139 0.495 . . . . 1.0 111.076 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 98.1 mt -138.29 129.09 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.87 0.843 . . . . 1.0 110.713 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.83 15.33 0.23 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.11 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.75 -5.84 43.77 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.376 -0.375 . . . . 1.0 112.234 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -94.35 134.41 25.64 Favored Pre-proline 0 CA--C 1.556 1.175 0 CA-C-N 117.174 0.487 . . . . 1.0 110.76 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.14 134.82 13.25 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.848 1.699 . . . . 1.0 111.937 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 42' ' ' ILE . 23.9 mm -102.81 116.18 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.633 0.73 . . . . 1.0 111.36 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -110.86 -26.84 9.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.502 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 p -136.99 165.34 26.22 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.168 0.509 . . . . 1.0 110.901 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -66.5 -33.62 76.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.372 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.37 -39.14 89.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 1.0 110.405 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -51.44 -39.13 56.76 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.473 -0.491 . . . . 1.0 109.868 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 36' ' ' ILE . 50.0 mm -62.72 -34.71 67.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 121.233 -0.187 . . . . 1.0 111.031 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.62 -44.48 99.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.735 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 p -58.36 -43.55 88.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.544 0.688 . . . . 1.0 110.542 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.3 -57.6 12.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.191 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 45' ' ' TYR . 97.6 t -52.59 -40.3 33.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.95 0.405 . . . . 1.0 110.298 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -37.49 80.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.386 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.45 -48.04 82.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.798 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -89.31 175.02 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.171 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 51' ' ' ALA . 17.8 pt20 -155.41 125.32 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.705 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -2.69 124.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 125.73 1.894 . . . . 1.0 110.414 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.57 -6.53 49.24 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.609 -1.397 . . . . 1.0 109.609 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 20.6 t70 -83.89 177.22 8.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.851 0.358 . . . . 1.0 110.872 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 58.7 mtp180 -146.59 123.48 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.566 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.0 m -130.99 131.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 122.225 1.012 . . . . 1.0 111.674 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.635 ' H ' ' HE ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -75.05 116.96 16.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.763 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.65 134.92 43.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.837 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 m -101.81 133.38 46.65 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.462 ' CD1' HD21 ' A' ' 22' ' ' LEU . 31.5 p90 -146.5 150.14 34.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -108.77 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.422 0.629 . . . . 1.0 110.759 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' A' ' 26' ' ' ASP . 40.6 ttm-85 -138.04 121.27 16.92 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.598 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 53.29 39.82 30.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.932 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 69.81 10.13 7.41 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.484 0.49 . . . . 1.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -110.34 106.53 15.93 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -76.01 127.7 33.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.257 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -142.0 144.58 33.73 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.04 140.75 29.54 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.504 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.72 125.81 51.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.828 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.433 ' C ' HD22 ' A' ' 70' ' ' LEU . 38.7 tp10 -79.97 102.84 9.46 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.839 -1.073 . . . . 1.0 109.948 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.433 HD22 ' C ' ' A' ' 69' ' ' GLU . 4.4 mm? -110.29 142.63 41.64 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.484 0.659 . . . . 1.0 110.667 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.09 134.32 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.375 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -71.6 129.48 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.979 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HZ1' ' HD3' ' A' ' 17' ' ' PRO . 14.0 ptpt . . . . . 0 CA--C 1.552 1.03 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.096 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 38.2 t . . . . . 0 C--O 1.217 -0.629 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' VAL . 32.7 m-85 -126.97 132.17 50.89 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.647 0.261 . . . . 1.0 110.671 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.645 HG21 HD12 ' A' ' 22' ' ' LEU . 41.4 t -44.47 170.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.53 ' N ' HG12 ' A' ' 9' ' ' VAL . 35.5 tpp -95.11 -65.28 0.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.392 -0.193 . . . . 1.0 111.231 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -155.15 173.84 16.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.266 -0.573 . . . . 1.0 111.095 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 t -118.03 100.74 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASN . 9.7 mp -99.86 117.93 62.63 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.84 -0.6 . . . . 1.0 110.323 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.77 49.36 0.04 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.112 2.541 . . . . 1.0 112.838 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 58.4 t30 -171.18 8.89 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.009 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.401 ' H ' ' H ' ' A' ' 15' ' ' ASN . 16.6 mmt -107.9 155.66 39.54 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 120.566 0.222 . . . . 1.0 110.507 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.83 -23.65 73.02 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.273 1.982 . . . . 1.0 113.406 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -88.4 -13.06 41.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.163 0.506 . . . . 1.0 110.819 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.57 113.87 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.712 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.46 -11.87 63.22 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -113.28 -36.65 4.95 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.017 0.437 . . . . 1.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.645 HD12 HG21 ' A' ' 9' ' ' VAL . 1.1 mm? -123.31 149.9 44.26 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.707 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -139.63 155.06 47.65 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.298 -0.865 . . . . 1.0 110.873 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 131.97 52.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.651 -1.159 . . . . 1.0 108.945 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.06 -25.48 12.72 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.032 -1.227 . . . . 1.0 110.032 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.47 ' OD1' ' NH2' ' A' ' 61' ' ' ARG . 97.1 m-20 -79.29 153.16 30.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.577 0.227 . . . . 1.0 110.437 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 26.7 ptt180 -123.25 165.24 17.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -99.38 122.65 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.374 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -98.91 -22.62 15.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.37 159.04 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.391 0.615 . . . . 1.0 111.624 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.1 mt -136.64 122.41 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.037 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 t0 51.5 23.38 1.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.146 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.09 -6.78 58.38 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -90.01 122.27 67.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 122.625 -0.338 . . . . 1.0 111.162 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.33 133.32 17.51 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.693 1.595 . . . . 1.0 111.485 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mm -100.18 111.15 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.689 0.757 . . . . 1.0 112.257 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -110.85 -16.73 13.49 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.322 -1.308 . . . . 1.0 111.302 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.8 p -141.8 155.01 45.59 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.048 0.451 . . . . 1.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -68.9 -26.01 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.441 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -66.88 -32.72 74.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.493 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -59.99 -29.9 68.76 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.772 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.09 -27.37 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.749 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.26 -44.49 77.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.484 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.2 p -68.81 -42.2 77.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.489 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -58.78 -52.82 64.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.678 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.12 -40.76 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.99 -39.25 94.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.354 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.54 -55.16 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.345 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -80.98 146.52 30.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.138 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -97.52 177.57 5.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.494 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 136.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.758 . . . . 1.0 110.076 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.07 -3.64 70.26 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 33.7 t70 -73.59 170.45 15.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.082 0.468 . . . . 1.0 111.007 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 40.2 ptt85 -138.2 131.68 30.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.169 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.35 131.64 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.854 0.835 . . . . 1.0 111.877 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -75.51 109.26 8.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.615 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.92 138.06 25.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.448 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.1 m -107.11 140.83 39.32 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.476 ' CD1' HD21 ' A' ' 22' ' ' LEU . 35.0 p90 -148.79 152.78 37.14 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.5 mp -107.17 135.54 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 121.695 0.76 . . . . 1.0 111.62 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.47 ' NH2' ' OD1' ' A' ' 26' ' ' ASP . 44.5 ttm-85 -140.83 122.09 14.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 114.543 -1.208 . . . . 1.0 109.621 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 46.25 49.09 12.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 64.05 9.37 4.6 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.554 0.534 . . . . 1.0 111.758 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -113.92 105.89 13.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.63 0.252 . . . . 1.0 110.636 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.01 146.23 32.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 111.176 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -153.48 145.51 23.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.968 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -89.93 129.88 36.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.445 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.1 128.24 55.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.992 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' C ' HD22 ' A' ' 70' ' ' LEU . 42.4 tp10 -80.37 102.74 9.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 1.0 109.928 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 18' ' ' ALA . 4.4 mm? -111.05 145.55 38.3 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.234 0.54 . . . . 1.0 110.791 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.81 132.55 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.39 128.68 36.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.493 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt . . . . . 0 CA--C 1.551 0.997 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.746 -179.461 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 120.783 0.325 . . . . 1.0 110.276 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -133.87 139.76 46.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.834 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -74.47 125.63 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.031 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.4 mtt -84.8 -64.37 1.17 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.425 0.155 . . . . 1.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -123.08 149.73 44.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.279 0.561 . . . . 1.0 111.159 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.56 133.47 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 10.9 mp -93.47 150.56 39.11 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.797 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.04 -27.76 16.81 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.565 2.176 . . . . 1.0 112.788 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.57 39.91 2.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.0 162.44 21.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 123.189 0.306 . . . . 1.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.29 -33.68 94.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.262 1.975 . . . . 1.0 112.972 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.05 -11.61 54.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.743 0.306 . . . . 1.0 111.636 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 13' ' ' LEU . . . -66.74 135.22 53.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.665 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.9 -16.37 51.37 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.84 -33.86 4.65 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.327 -0.249 . . . . 1.0 110.327 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' OD2' ' A' ' 26' ' ' ASP . 14.1 tp -122.63 152.66 40.25 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.294 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 60.9 mm-40 -139.42 154.33 47.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.599 0.714 . . . . 1.0 111.087 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.15 139.02 53.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.32 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -29.69 8.93 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.209 -1.156 . . . . 1.0 110.209 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.491 ' OD2' HD11 ' A' ' 22' ' ' LEU . 1.7 p-10 -69.69 149.52 47.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.807 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.4 158.79 21.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.903 0.382 . . . . 1.0 110.445 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.7 mm -100.04 119.98 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.011 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.65 -21.94 19.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.86 163.06 2.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.109 0.48 . . . . 1.0 111.528 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 33' ' ' GLY . 89.1 mt -136.79 126.53 38.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 122.294 1.045 . . . . 1.0 110.872 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t0 51.05 11.2 0.09 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.591 -0.693 . . . . 1.0 111.405 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . 111.06 -6.48 28.99 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.986 -0.341 . . . . 1.0 112.312 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.487 ' NE2' ' CD1' ' A' ' 45' ' ' TYR . 4.4 pt20 -94.9 110.6 50.64 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 117.239 0.519 . . . . 1.0 111.789 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.78 136.15 73.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.266 1.311 . . . . 1.0 111.522 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.79 115.64 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.597 0.713 . . . . 1.0 111.429 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -112.45 -20.22 11.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.253 -1.339 . . . . 1.0 110.963 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.8 p -135.18 151.29 50.52 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.041 0.448 . . . . 1.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.0 p -69.55 -29.66 67.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.54 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.02 -29.47 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.648 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -63.4 -28.62 70.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.078 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.35 -28.35 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.706 -0.224 . . . . 1.0 111.257 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.96 -40.98 76.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.034 0.445 . . . . 1.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.9 m -69.71 -41.1 75.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 1.0 109.595 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.487 ' CD1' ' NE2' ' A' ' 34' ' ' GLN . 72.9 t80 -57.49 -56.28 23.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.727 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.02 -33.55 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.302 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -64.35 -40.13 95.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.506 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -57.76 -50.25 73.86 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.666 -0.413 . . . . 1.0 110.321 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -81.6 149.09 28.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -102.36 -179.43 3.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.311 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 135.69 55.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.964 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.5 -0.21 65.42 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.411 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 35.5 t70 -78.06 171.05 15.6 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.877 0.37 . . . . 1.0 110.935 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 82.2 mtp180 -139.3 125.21 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.98 132.73 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.943 0.878 . . . . 1.0 111.646 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -81.02 113.46 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.093 -1.412 . . . . 1.0 108.748 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.95 132.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.644 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.8 m -101.17 137.71 39.16 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.436 ' C ' HD12 ' A' ' 60' ' ' ILE . 32.7 p90 -150.28 152.18 34.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -106.51 138.54 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.41 0.624 . . . . 1.0 111.04 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -143.73 123.8 13.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.719 -1.128 . . . . 1.0 109.964 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 50.64 43.01 27.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.817 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 67.08 9.59 7.04 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.822 0.449 . . . . 1.0 111.841 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -115.46 106.54 14.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.919 0.39 . . . . 1.0 110.654 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' ' NE2' ' A' ' 65' ' ' GLN . 5.0 pp0? -74.13 138.52 43.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.383 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -149.16 144.28 26.5 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.362 -0.836 . . . . 1.0 111.269 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.68 136.52 32.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.037 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.18 122.55 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' HD12 ' A' ' 70' ' ' LEU . 51.3 mt-10 -84.36 102.04 12.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.933 -1.03 . . . . 1.0 110.026 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.8 mp -111.79 150.18 30.68 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.195 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 53' ' ' ASP . 9.9 p -122.29 131.77 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.292 -0.867 . . . . 1.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.66 129.51 40.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.813 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt . . . . . 0 CA--C 1.551 0.992 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.104 179.724 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.236 0.541 . . . . 1.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -58.96 134.36 56.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.239 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 7.5 p -46.35 160.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.829 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' HG22 ' A' ' 9' ' ' VAL . 26.1 ttt -103.21 -62.29 1.3 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.857 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 m -151.94 154.36 35.93 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.156 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 t -122.45 101.94 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 13' ' ' LEU . 3.9 mm? -74.83 135.02 74.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.414 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.3 -20.95 42.09 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 122.32 2.013 . . . . 1.0 112.782 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -107.18 33.62 3.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.81 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.17 165.35 19.4 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.03 0.206 . . . . 1.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.491 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.2 Cg_exo -68.38 -16.6 43.7 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.403 2.069 . . . . 1.0 112.933 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.91 36.85 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.101 -0.375 . . . . 1.0 111.856 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.79 137.62 57.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.985 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.75 39.1 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.254 -0.738 . . . . 1.0 111.254 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' NH2' ' O ' ' A' ' 17' ' ' PRO . 36.0 mtm180 -113.69 -34.23 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.482 0.313 . . . . 1.0 110.806 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 mt -123.54 154.01 39.81 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.05 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -138.94 154.02 48.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.104 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.83 139.8 55.95 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.301 -0.863 . . . . 1.0 109.398 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.629 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 104.6 -26.31 23.0 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 26' ' ' ASP . 2.4 m-20 -67.49 145.35 55.05 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.937 -0.305 . . . . 1.0 110.253 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -109.09 153.39 23.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.726 0.298 . . . . 1.0 110.386 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.7 mm -96.16 118.01 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.095 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . -90.75 -16.24 28.77 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.808 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . 171.12 163.67 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.243 0.544 . . . . 1.0 110.965 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.93 126.75 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.774 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 50.77 20.68 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.036 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.0 56.31 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.852 -0.499 . . . . 1.0 111.852 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -92.85 126.33 51.96 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.961 0.381 . . . . 1.0 111.454 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.91 135.21 17.19 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.826 1.684 . . . . 1.0 111.468 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.66 115.75 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.865 0.84 . . . . 1.0 112.216 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -107.12 -23.27 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.09 -1.414 . . . . 1.0 111.161 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -134.86 154.28 51.71 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.165 0.507 . . . . 1.0 111.142 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -69.95 -33.73 72.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.337 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -62.51 -28.46 69.86 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -63.47 -30.27 71.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.628 -0.429 . . . . 1.0 109.919 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.54 -29.95 36.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 116.743 -0.208 . . . . 1.0 111.278 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.36 -42.21 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.461 . . . . 1.0 110.213 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -65.13 -40.39 94.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.161 0.505 . . . . 1.0 109.868 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.94 -57.68 11.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.895 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.0 m -55.16 -39.94 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.826 0.346 . . . . 1.0 110.202 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -40.95 94.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.72 -47.0 70.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.378 . . . . 1.0 110.46 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -81.5 -173.45 4.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.87 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' ALA . 40.3 tt0 -130.91 171.45 13.17 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.985 0.422 . . . . 1.0 110.834 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' A' ' 50' ' ' GLN . . . -64.83 136.28 56.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.771 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.3 -0.83 81.67 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.391 -1.084 . . . . 1.0 110.391 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 36.9 t70 -71.54 179.51 2.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.804 0.335 . . . . 1.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.498 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 87.4 mtm180 -138.47 123.55 19.08 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.5 130.98 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 122.06 0.933 . . . . 1.0 112.112 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -85.96 118.89 25.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.961 -1.472 . . . . 1.0 109.084 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -108.55 134.42 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.544 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.5 m -104.62 132.63 50.64 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.26 153.37 37.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.3 138.52 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.215 0.531 . . . . 1.0 110.341 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -141.31 121.78 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.304 -0.862 . . . . 1.0 109.444 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 54.37 39.6 31.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.34 -0.846 . . . . 1.0 110.873 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 68.92 9.09 7.21 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 123.161 0.288 . . . . 1.0 111.66 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -108.87 116.72 32.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.96 0.409 . . . . 1.0 110.131 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.9 128.58 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.887 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -144.18 139.12 28.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.27 0.557 . . . . 1.0 111.105 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.84 138.56 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.32 117.0 31.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.868 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' CD ' HH11 ' A' ' 21' ' ' ARG . 3.3 pt-20 -77.47 103.54 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.142 -0.935 . . . . 1.0 109.2 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.23 146.22 39.69 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.73 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.06 134.68 63.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.655 -1.157 . . . . 1.0 110.077 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -66.55 125.49 25.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.447 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.7 tttt . . . . . 0 CA--C 1.55 0.978 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.435 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 8' ' ' TYR . 36.0 t . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.824 0.345 . . . . 1.0 110.397 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.571 ' N ' HG12 ' A' ' 7' ' ' VAL . 97.4 m-85 -130.2 140.37 50.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.71 128.02 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.4 ttt -78.03 -64.74 1.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.194 -0.316 . . . . 1.0 111.723 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -133.6 160.77 36.49 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.031 0.443 . . . . 1.0 111.535 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.6 136.52 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.99 148.91 38.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 O-C-N 123.42 0.45 . . . . 1.0 111.854 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' SD ' ' A' ' 16' ' ' MET . 74.4 Cg_endo -73.23 157.43 50.17 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.288 1.992 . . . . 1.0 111.351 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 64.15 28.0 14.07 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.296 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -106.59 157.94 33.91 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-O 120.748 0.309 . . . . 1.0 110.357 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 -19.55 64.16 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.157 1.905 . . . . 1.0 112.979 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 22' ' ' LEU . . . -100.25 -17.72 17.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.65 0.738 . . . . 1.0 111.091 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.32 129.57 42.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.819 -1.082 . . . . 1.0 109.337 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.33 -7.94 62.2 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -134.27 -24.36 1.62 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.826 0.346 . . . . 1.0 110.537 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -117.41 134.07 55.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.011 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 97.5 mt-10 -134.45 148.0 50.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.549 0.69 . . . . 1.0 110.405 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.2 136.89 48.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.931 -1.032 . . . . 1.0 109.483 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.62 -26.63 13.95 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 2.8 p-10 -64.78 145.0 56.86 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.72 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -109.69 142.22 41.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.933 0.397 . . . . 1.0 109.979 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.23 122.26 43.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.569 -0.742 . . . . 1.0 109.191 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.552 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -94.54 -22.45 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.125 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.02 154.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.2 mt -129.55 125.46 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.878 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 17.12 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.529 -0.76 . . . . 1.0 111.013 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.73 -5.29 47.17 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.72 -0.552 . . . . 1.0 111.72 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -95.19 111.19 54.06 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.026 0.413 . . . . 1.0 111.486 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.18 136.45 74.81 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 122.326 2.017 . . . . 1.0 111.484 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.69 106.37 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.578 0.704 . . . . 1.0 111.805 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -102.68 -25.02 13.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.605 -1.18 . . . . 1.0 111.419 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -140.53 160.18 40.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.078 0.466 . . . . 1.0 111.051 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -67.39 -23.04 65.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.103 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -66.01 -32.96 74.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.209 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -61.55 -31.35 71.37 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.511 -0.476 . . . . 1.0 109.82 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.43 -27.96 19.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 CA-C-O 120.983 0.421 . . . . 1.0 110.485 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.52 -42.74 83.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.734 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 59.2 p -64.21 -39.73 94.58 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' CE1' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -58.23 -56.21 24.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.505 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.82 -44.0 76.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.946 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -69.62 -35.79 75.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.68 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.42 -62.53 1.59 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.224 -0.287 . . . . 1.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.32 -169.21 2.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.635 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -131.91 176.37 8.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.676 0.75 . . . . 1.0 112.039 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.62 134.84 57.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.889 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.5 -0.78 74.89 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.441 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 19.3 t0 -68.62 169.95 10.17 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.888 0.375 . . . . 1.0 111.16 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 76.4 mtp180 -140.73 117.75 11.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.449 HG21 ' CE1' ' A' ' 45' ' ' TYR . 6.7 m -129.23 135.14 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.855 0.836 . . . . 1.0 111.88 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.434 ' NH1' ' OE2' ' A' ' 69' ' ' GLU . 83.9 mmt-85 -76.75 105.84 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.31 -1.314 . . . . 1.0 108.786 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.0 t -95.06 135.21 29.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.561 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.9 m -104.97 137.52 42.6 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.9 150.96 32.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.4 mp -103.12 137.67 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.741 0.781 . . . . 1.0 111.706 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -143.34 117.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.465 -1.243 . . . . 1.0 110.175 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 52.84 44.77 29.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.251 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 66.67 8.31 5.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.706 -0.225 . . . . 1.0 111.335 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -111.92 113.34 25.61 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 51.1 mt-30 -75.79 146.23 40.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.401 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.413 ' CG ' ' O ' ' A' ' 65' ' ' GLN . 98.2 m-70 -156.53 140.94 16.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.979 0.419 . . . . 1.0 110.817 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.99 128.69 36.91 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.85 123.88 49.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.401 0.619 . . . . 1.0 110.471 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.438 ' C ' HD12 ' A' ' 70' ' ' LEU . 42.6 tp10 -78.74 100.54 7.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.041 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.3 mp -114.83 149.24 37.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.462 0.649 . . . . 1.0 110.846 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -136.13 137.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 114.755 -1.112 . . . . 1.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 mt -61.16 120.44 10.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.995 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 CA--C 1.552 1.027 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.872 -179.628 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 120.783 0.325 . . . . 1.0 110.383 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.65 129.51 36.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.961 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.34 127.75 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.179 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.0 tpt -75.84 -53.04 9.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.186 -0.321 . . . . 1.0 111.278 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.1 p -148.05 165.26 31.33 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.015 0.436 . . . . 1.0 111.365 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.59 135.28 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.19 153.08 39.81 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.434 0.459 . . . . 1.0 111.176 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.64 158.75 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.558 2.172 . . . . 1.0 111.88 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.6 t30 56.27 32.45 20.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.405 -0.816 . . . . 1.0 111.116 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.9 mmm -106.88 161.13 23.87 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.174 0.296 . . . . 1.0 110.882 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.32 -30.43 91.03 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.343 2.029 . . . . 1.0 112.821 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.432 ' HB2' HD22 ' A' ' 70' ' ' LEU . . . -97.85 -14.43 20.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.922 0.391 . . . . 1.0 111.465 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 122.66 14.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.65 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.71 -8.22 65.85 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -119.73 -25.66 5.86 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.238 0.542 . . . . 1.0 110.538 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.604 HD22 ' OD2' ' A' ' 26' ' ' ASP . 14.2 mt -140.03 170.62 15.52 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.743 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 mt-10 -156.06 165.01 37.7 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.377 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.85 137.71 57.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.498 -1.228 . . . . 1.0 109.025 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.81 14.72 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.604 ' OD2' HD22 ' A' ' 22' ' ' LEU . 7.6 p-10 -72.64 154.04 40.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.791 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -121.81 151.42 40.63 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -96.69 129.24 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.78 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.5 -27.29 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.85 151.03 2.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 1.0 111.409 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.84 123.6 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.166 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.2 t0 56.59 17.16 2.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.962 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.27 42.3 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.927 -0.469 . . . . 1.0 111.927 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -96.2 110.45 52.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 119.379 -0.344 . . . . 1.0 111.399 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.88 137.53 81.45 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.336 2.024 . . . . 1.0 111.394 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mm -97.75 106.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.575 0.702 . . . . 1.0 111.744 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -104.22 -21.52 13.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.8 p -144.3 161.01 40.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.993 0.425 . . . . 1.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.0 p -66.86 -23.85 66.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.353 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.21 -34.1 77.57 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.071 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -59.95 -33.34 71.78 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.775 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -71.92 -28.16 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.942 0.401 . . . . 1.0 110.547 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.02 -42.98 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.909 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 t -62.75 -41.43 99.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.789 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -58.18 8.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.883 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.42 -43.0 81.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -62.85 -44.36 96.34 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.959 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -60.15 -58.09 10.02 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 1.0 110.25 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -81.49 170.94 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.382 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -136.41 -172.24 3.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.126 0.489 . . . . 1.0 111.42 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 129.73 40.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.143 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.39 -8.73 64.57 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 71' ' ' VAL . 20.2 t70 -70.81 174.61 5.84 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.975 0.417 . . . . 1.0 111.155 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.447 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 83.7 mtt85 -145.14 127.89 16.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.93 132.9 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.905 0.86 . . . . 1.0 111.862 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -78.12 103.01 7.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.272 -1.331 . . . . 1.0 108.496 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.1 t -95.42 135.49 29.33 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.051 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.5 m -105.08 138.87 40.62 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CD2' HD21 ' A' ' 22' ' ' LEU . 36.0 p90 -148.92 155.15 40.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.5 mp -110.19 134.59 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.629 0.728 . . . . 1.0 111.13 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -141.91 123.84 15.31 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.657 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 48.02 46.16 19.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.655 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 67.67 6.66 5.15 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.846 0.355 . . . . 1.0 110.606 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -112.29 116.12 29.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -90.55 143.21 26.97 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.91 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -152.34 148.49 27.56 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.839 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.99 127.08 36.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.632 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.93 124.54 49.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.446 0.641 . . . . 1.0 110.044 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.08 102.14 14.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.558 -1.201 . . . . 1.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 18' ' ' ALA . 36.3 mt -113.31 151.19 31.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.669 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 53' ' ' ASP . 2.9 t -124.07 130.64 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.019 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.2 mm? -56.67 120.16 7.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.134 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttp . . . . . 0 CA--C 1.551 1.014 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.547 -179.638 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 8' ' ' TYR . 21.5 t . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.699 0.285 . . . . 1.0 110.381 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.409 ' N ' HG12 ' A' ' 7' ' ' VAL . 50.7 m-85 -129.11 137.41 51.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.21 127.69 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.12 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.6 mtt -75.35 -65.46 0.89 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.733 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -128.94 160.87 31.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.166 0.507 . . . . 1.0 111.16 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -128.12 138.92 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.89 145.17 31.48 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 123.137 0.273 . . . . 1.0 111.121 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.08 -24.28 20.59 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.441 2.094 . . . . 1.0 112.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -99.05 17.93 18.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.639 -0.255 . . . . 1.0 111.159 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.8 mtt -113.17 158.53 37.83 Favored Pre-proline 0 N--CA 1.469 0.485 0 O-C-N 123.055 0.222 . . . . 1.0 110.9 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.66 -32.11 53.2 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.415 2.076 . . . . 1.0 113.295 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.78 57.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.685 0.279 . . . . 1.0 111.385 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.07 109.65 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.122 -0.631 . . . . 1.0 110.719 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.68 -14.83 64.59 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.232 -0.747 . . . . 1.0 111.232 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -108.11 -41.63 4.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.124 0.488 . . . . 1.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.47 156.84 40.04 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.484 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -144.29 158.1 43.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.157 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.81 56.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.421 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.2 18.15 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.247 -1.141 . . . . 1.0 110.247 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 150.68 42.63 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 122.782 -0.246 . . . . 1.0 110.63 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -114.61 154.58 28.11 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.161 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mm -97.35 120.14 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.024 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.47 19.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.6 158.72 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 1.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.75 125.03 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.105 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 51.22 21.72 1.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.124 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.33 57.81 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.617 -0.593 . . . . 1.0 111.617 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -89.93 124.85 62.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.75 -0.265 . . . . 1.0 111.254 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.4 132.8 15.28 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.981 1.787 . . . . 1.0 111.465 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -99.13 110.89 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.496 0.665 . . . . 1.0 112.433 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -115.53 -18.18 11.0 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.661 -1.154 . . . . 1.0 111.108 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -139.37 156.01 47.28 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.241 0.544 . . . . 1.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.1 m -66.28 -22.57 66.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.233 -0.894 . . . . 1.0 108.878 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.33 -35.34 77.63 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.523 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.482 ' H ' HG23 ' A' ' 38' ' ' THR . 69.6 tp60 -57.1 -31.71 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.859 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -74.79 -26.84 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.781 -0.191 . . . . 1.0 110.971 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.54 -41.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 1.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.2 t -65.62 -40.58 92.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.281 0.562 . . . . 1.0 109.944 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -58.18 -57.16 14.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.646 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' LYS . 29.0 m -58.55 -39.77 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.325 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -66.04 -37.61 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.707 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.77 -53.86 47.89 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.339 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 46' ' ' VAL . 72.1 mmtt -87.31 156.96 19.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.55 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.4 -178.18 3.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.295 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.27 135.91 55.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.177 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.82 -1.53 74.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 30.7 t70 -74.24 172.04 12.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.033 0.444 . . . . 1.0 110.879 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.0 mtp85 -141.76 130.04 22.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.078 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.63 133.51 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.892 0.854 . . . . 1.0 111.942 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.14 107.44 7.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.383 -1.28 . . . . 1.0 108.767 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.03 137.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.329 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -104.92 139.22 39.96 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.434 ' C ' HD12 ' A' ' 60' ' ' ILE . 34.4 p90 -150.31 151.87 33.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.5 mp -108.23 132.07 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.525 0.679 . . . . 1.0 111.472 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -138.58 124.24 19.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.4 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 49.58 43.82 24.15 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 115.291 -0.868 . . . . 1.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 70.43 -1.35 2.54 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.322 0.119 . . . . 1.0 111.322 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -107.42 106.06 16.28 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.529 0.204 . . . . 1.0 110.824 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -76.82 145.3 38.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.212 0.529 . . . . 1.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -153.88 146.09 23.8 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.327 -0.852 . . . . 1.0 111.052 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -89.12 132.11 34.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.543 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.94 124.62 52.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.91 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 39.1 mp0 -80.04 101.95 9.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.738 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tt -109.34 143.0 39.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.749 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.7 131.0 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.442 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.68 131.6 46.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.502 . . . . 1.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 CA--C 1.545 0.786 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.942 179.663 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 8' ' ' TYR . 7.8 t . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.412 ' N ' HG12 ' A' ' 7' ' ' VAL . 67.9 m-85 -120.99 125.73 48.1 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.323 -0.398 . . . . 1.0 111.091 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.55 124.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.6 mmt -70.67 -66.47 0.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.659 -0.246 . . . . 1.0 111.544 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.3 t -137.99 173.57 11.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.069 0.461 . . . . 1.0 111.064 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.15 133.58 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 mt -112.64 114.2 49.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.115 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.54 163.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.98 1.786 . . . . 1.0 112.06 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 m120 68.18 19.02 9.24 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.971 0.794 . . . . 1.0 111.027 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.8 mmt -111.1 160.28 29.58 Favored Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.239 0.337 . . . . 1.0 111.116 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.73 -39.56 90.4 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.796 1.664 . . . . 1.0 112.954 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 22' ' ' LEU . . . -84.94 -12.5 53.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.01 0.433 . . . . 1.0 111.596 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.23 131.27 45.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.551 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.53 -14.53 64.81 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.111 -0.795 . . . . 1.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 68' ' ' ALA . 6.8 ptm85 -129.06 -23.45 3.03 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.912 0.387 . . . . 1.0 110.728 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 18' ' ' ALA . 23.1 tp -122.97 148.19 45.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.441 -0.8 . . . . 1.0 110.311 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -143.79 157.9 44.06 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.687 0.756 . . . . 1.0 111.197 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.8 136.19 56.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.62 -1.173 . . . . 1.0 109.075 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.56 10.2 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 110.066 -1.214 . . . . 1.0 110.066 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -71.02 146.04 49.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.283 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -114.93 161.54 18.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.277 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -99.74 119.28 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.061 0.458 . . . . 1.0 110.303 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -93.6 -19.36 21.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.42 164.44 2.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.582 0.706 . . . . 1.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.6 mt -139.78 122.81 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.909 -1.041 . . . . 1.0 109.813 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 49.88 24.2 1.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.892 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.34 -6.12 61.18 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.801 -0.52 . . . . 1.0 111.801 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -93.0 107.88 28.17 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 116.887 0.344 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 136.42 71.03 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.905 1.737 . . . . 1.0 111.546 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.3 mm -102.84 113.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.68 0.752 . . . . 1.0 111.886 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 38' ' ' THR . 51.4 p30 -114.14 -20.65 10.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.586 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 56.4 p -134.6 160.34 38.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.015 0.436 . . . . 1.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.8 p -77.55 -27.61 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.052 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -67.8 -30.34 69.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -64.11 -27.45 69.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mm -78.06 -26.55 14.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -70.46 -41.79 78.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 123.536 0.522 . . . . 1.0 110.209 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.1 m -70.07 -39.29 75.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.307 0.575 . . . . 1.0 109.782 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.408 ' OH ' ' CG1' ' A' ' 55' ' ' VAL . 86.4 t80 -58.89 -55.74 31.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.888 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 m -55.45 -36.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 120.733 0.301 . . . . 1.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -65.58 -36.57 84.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.941 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -58.44 -43.41 88.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.013 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -93.29 149.8 20.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.309 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -101.24 178.3 4.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.143 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.58 57.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.125 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.47 -1.87 82.35 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.782 -0.927 . . . . 1.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 24.4 t70 -71.95 175.93 5.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.826 0.345 . . . . 1.0 110.716 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.478 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -139.39 129.99 25.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' OH ' ' A' ' 45' ' ' TYR . 5.9 m -136.11 130.89 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.974 0.892 . . . . 1.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -80.85 106.51 12.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.286 -1.325 . . . . 1.0 108.968 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -97.07 143.46 12.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.599 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.1 m -109.75 138.88 45.48 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.536 0.522 . . . . 1.0 109.685 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -150.24 150.91 32.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.485 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.5 mp -107.88 134.06 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.672 0.749 . . . . 1.0 111.192 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -138.05 121.9 17.66 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 114.37 -1.287 . . . . 1.0 109.885 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 49.11 43.25 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.851 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 71.67 3.11 4.54 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.886 -0.143 . . . . 1.0 111.343 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -108.61 105.36 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.72 0.295 . . . . 1.0 110.946 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -78.26 138.68 38.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 1.0 111.011 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -148.43 145.24 27.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.641 -0.708 . . . . 1.0 110.992 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -89.89 132.88 35.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.246 -0.888 . . . . 1.0 110.343 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . . . -110.13 121.3 44.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.843 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.0 102.3 7.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.394 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -115.51 149.68 37.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.876 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.8 m -128.25 135.58 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.443 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt . . . . . 0 CA--C 1.546 0.797 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.473 -179.309 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -60.72 114.01 2.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.528 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -79.54 131.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.906 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.9 ttt -81.27 -72.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 111.692 0.256 . . . . 1.0 111.692 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -129.71 162.0 29.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.17 0.51 . . . . 1.0 111.209 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.64 131.5 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.307 -0.861 . . . . 1.0 108.915 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 13' ' ' LEU . 4.2 mm? -89.09 115.2 62.99 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.771 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.04 -19.94 12.69 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.976 1.784 . . . . 1.0 112.246 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -99.19 22.28 10.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.653 -0.248 . . . . 1.0 110.982 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 mmt -121.04 159.05 50.93 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.683 -0.235 . . . . 1.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.85 -22.05 66.63 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.485 2.123 . . . . 1.0 112.772 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.11 -14.23 59.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.833 0.349 . . . . 1.0 111.671 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 132.74 48.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.915 0.388 . . . . 1.0 110.407 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.98 27.97 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -104.92 -41.49 5.6 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.15 156.63 31.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.34 155.95 48.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.101 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.21 134.29 56.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.311 -0.858 . . . . 1.0 109.469 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.37 -26.4 18.59 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.07 145.46 51.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.381 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -111.0 153.24 25.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.871 0.367 . . . . 1.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.43 119.62 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.861 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . -93.75 -16.95 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.99 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . 174.41 164.32 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.31 0.576 . . . . 1.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 45' ' ' TYR . 92.7 mt -135.93 125.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.625 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.419 ' OD2' ' CE1' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 49.97 17.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.15 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.95 -5.84 46.95 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.053 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -92.94 108.77 34.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.978 0.389 . . . . 1.0 111.318 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.04 133.28 52.32 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.219 1.946 . . . . 1.0 111.551 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mm -102.16 116.7 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.649 0.738 . . . . 1.0 111.855 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 38' ' ' THR . 48.9 p30 -107.92 -23.52 12.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.579 -1.191 . . . . 1.0 111.409 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.467 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 69.2 p -137.21 155.26 49.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.034 0.445 . . . . 1.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.2 p -68.73 -32.81 72.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.484 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -61.94 -30.87 71.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.264 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -61.99 -30.01 70.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.318 -0.553 . . . . 1.0 109.946 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.6 -29.63 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.547 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.65 -43.68 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.268 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -65.17 -42.51 93.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.419 ' CE1' ' OD2' ' A' ' 32' ' ' ASP . 64.8 t80 -57.61 -57.1 14.21 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.325 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.96 -40.93 47.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -65.97 -20.81 66.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -61.85 -56.19 21.98 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.71 -163.41 1.02 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.961 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.46 -171.62 3.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.343 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 134.72 53.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.141 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.52 63.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.42 161.79 25.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.831 0.348 . . . . 1.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -127.5 122.35 33.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.62 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.997 0.904 . . . . 1.0 111.535 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -83.34 116.34 22.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.401 -1.272 . . . . 1.0 109.033 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.0 t -107.41 131.14 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.95 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.4 m -101.48 133.4 46.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.47 ' C ' HD12 ' A' ' 60' ' ' ILE . 32.4 p90 -147.83 152.19 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.47 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -109.67 139.47 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.389 0.614 . . . . 1.0 110.651 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -142.84 121.85 12.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.192 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 52.39 40.82 30.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 69.1 13.37 8.69 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.332 0.395 . . . . 1.0 111.363 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -114.16 109.0 17.73 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -77.27 131.52 38.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.0 111.278 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -146.07 144.47 30.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.949 -0.568 . . . . 1.0 111.037 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 40.6 mp0 -90.89 137.46 32.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.649 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 120.21 41.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.321 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.86 101.44 9.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.93 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tt -110.95 140.99 44.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.959 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.85 131.97 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.456 0.645 . . . . 1.0 110.651 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -65.71 121.99 16.25 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.641 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 CA--C 1.549 0.914 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.873 -179.897 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -161.44 36.92 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 53.69 78.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.958 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.47 -63.82 1.15 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.512 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.88 86.67 0.09 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.934 0.397 . . . . 1.0 110.832 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.45 -105.6 2.54 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 111.391 -0.684 . . . . 1.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.16 142.66 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -102.33 123.07 45.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.78 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 6.2 p -45.67 164.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.097 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.538 ' N ' HG22 ' A' ' 9' ' ' VAL . 25.1 mmt -104.87 -70.27 0.78 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.609 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.9 t -156.2 175.26 14.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.712 0.291 . . . . 1.0 110.95 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.8 105.91 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.8 mt -93.71 143.96 27.41 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.857 -0.156 . . . . 1.0 110.889 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -72.9 156.42 52.55 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.159 1.906 . . . . 1.0 112.274 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.13 32.36 21.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.864 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 6.3 mtt -122.32 152.39 60.76 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 110.506 -0.183 . . . . 1.0 110.506 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.01 -16.88 57.39 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.534 2.156 . . . . 1.0 112.932 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 -24.03 27.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.96 0.409 . . . . 1.0 111.222 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 131.06 45.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.818 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.04 -21.21 35.3 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.59 -43.94 4.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.788 0.328 . . . . 1.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.646 HD13 ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -116.29 140.45 49.31 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.646 ' H ' HD13 ' A' ' 22' ' ' LEU . 61.5 mm-40 -131.53 159.21 38.83 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.301 0.572 . . . . 1.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.59 133.31 50.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.273 -0.876 . . . . 1.0 109.805 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.626 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 110.07 -23.1 21.96 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.418 ' OD1' ' NE ' ' A' ' 61' ' ' ARG . 36.3 m-20 -79.36 144.47 34.15 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.025 -0.103 . . . . 1.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 -110.34 161.4 15.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.921 0.391 . . . . 1.0 110.787 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -98.05 115.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.434 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.87 -14.89 28.94 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.12 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 177.93 168.06 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.249 0.547 . . . . 1.0 111.161 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.0 125.94 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.79 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 47.79 22.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.0 111.176 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -6.87 57.29 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.992 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -87.39 126.4 62.43 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.417 -0.325 . . . . 1.0 111.161 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.54 126.66 8.41 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.589 1.526 . . . . 1.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.463 HG21 HD11 ' A' ' 42' ' ' ILE . 29.9 mm -100.62 120.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.731 0.777 . . . . 1.0 111.933 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -116.13 -19.32 10.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.455 -1.248 . . . . 1.0 111.142 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -133.32 155.9 48.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.179 0.514 . . . . 1.0 111.093 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -71.68 -32.33 67.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.454 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -65.01 -32.45 74.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.584 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -58.86 -30.31 67.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.619 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.463 HD11 HG21 ' A' ' 36' ' ' ILE . 50.4 mm -72.16 -29.09 31.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.332 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.11 -40.02 84.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 O-C-N 123.29 0.369 . . . . 1.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.1 p -69.48 -40.86 76.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.337 0.589 . . . . 1.0 109.551 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -56.37 -56.79 16.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.56 -36.29 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 1.0 110.455 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -57.79 -41.57 82.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.293 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.71 -42.88 98.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.493 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -89.32 154.29 20.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.171 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.48 -176.17 2.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.985 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.68 138.91 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.214 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.38 0.87 81.95 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 29.7 t70 -74.67 179.62 4.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.087 0.47 . . . . 1.0 110.568 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 80.7 ttt180 -139.56 123.4 17.58 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.87 134.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.777 0.799 . . . . 1.0 111.821 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.48 122.61 32.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.502 -1.226 . . . . 1.0 108.601 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.6 t -116.17 130.3 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.0 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.7 m -96.95 136.11 37.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.308 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.489 ' C ' HD12 ' A' ' 60' ' ' ILE . 22.9 p90 -146.62 151.32 37.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -112.62 137.15 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.103 0.478 . . . . 1.0 110.356 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 17.7 ttm180 -136.66 120.48 17.42 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.789 -0.642 . . . . 1.0 109.467 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 49.97 39.42 18.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.782 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 73.33 12.64 4.77 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.53 0.196 . . . . 1.0 111.53 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -110.74 100.25 9.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.738 0.304 . . . . 1.0 110.395 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.17 127.62 33.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.47 0.652 . . . . 1.0 111.711 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.07 141.2 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.774 -0.648 . . . . 1.0 111.139 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.03 146.17 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.616 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.98 130.91 53.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.077 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 70' ' ' LEU . 77.3 tt0 -92.23 105.39 17.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.476 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.5 mp -111.3 146.33 37.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.045 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.88 130.21 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.59 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -66.11 132.91 49.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -139.51 140.38 25.22 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.78 162.14 40.11 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 122.69 2.26 . . . . 1.0 111.775 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -120.8 145.81 42.16 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.51 -28.11 45.86 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.708 1.606 . . . . 1.0 111.961 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -68.42 -33.43 74.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.152 0.501 . . . . 1.0 109.967 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -147.46 74.81 11.5 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.086 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.85 -29.78 64.86 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.608 2.205 . . . . 1.0 111.824 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -82.99 17.26 1.99 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.572 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.724 ' C ' HD13 ' A' ' 82' ' ' ILE . 94.0 mt-30 -133.28 138.86 46.61 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.724 HD13 ' C ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -118.57 133.51 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.079 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' ILE . . . 49.55 106.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.282 -0.485 . . . . 1.0 112.341 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.5 mt -97.47 0.68 48.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.78 47.9 3.3 Favored Glycine 0 N--CA 1.466 0.667 0 CA-C-N 114.754 -1.112 . . . . 1.0 111.03 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 p -108.71 149.17 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.755 -0.461 . . . . 1.0 109.755 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 118.126 -0.94 . . . . 1.0 110.466 -179.833 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -79.21 -178.95 6.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.505 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 15.4 pt-20 -163.51 154.19 16.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.258 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 3' ' ' GLU . . . 76.08 155.43 0.16 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.53 -177.56 4.48 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.324 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.33 -110.91 2.89 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t -128.58 156.76 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.11 133.81 54.26 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.988 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.99 120.81 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.943 -0.392 . . . . 1.0 109.943 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.52 -69.13 0.5 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.028 -0.269 . . . . 1.0 111.657 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.1 p -128.4 165.34 20.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.044 0.45 . . . . 1.0 111.03 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.29 122.15 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.87 153.24 52.12 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.757 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 152.63 64.7 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.611 2.207 . . . . 1.0 112.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 52.61 45.15 29.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.519 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.8 mmt -121.17 154.18 58.39 Favored Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.013 0.196 . . . . 1.0 110.706 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HD3' ' HZ1' ' A' ' 73' ' ' LYS . 28.2 Cg_endo -62.05 -19.34 65.92 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.339 2.026 . . . . 1.0 112.869 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -89.63 -24.01 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.844 0.354 . . . . 1.0 111.484 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.23 141.37 52.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.627 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -22.73 14.03 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.4 -34.01 4.44 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.533 HD13 ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -118.55 139.79 50.9 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.934 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' H ' HD13 ' A' ' 22' ' ' LEU . 97.0 mt-10 -130.18 152.65 49.38 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.511 0.672 . . . . 1.0 110.964 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.06 139.92 53.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.33 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.49 -28.88 13.19 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.206 -1.157 . . . . 1.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 61' ' ' ARG . 80.5 m-20 -70.75 147.02 49.45 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.294 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -114.58 159.71 20.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.891 0.377 . . . . 1.0 110.351 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.7 mm -97.55 118.75 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.396 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.27 -15.9 25.32 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.786 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.95 163.5 0.81 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.139 0.495 . . . . 1.0 111.076 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 98.1 mt -138.29 129.09 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.87 0.843 . . . . 1.0 110.713 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.83 15.33 0.23 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.11 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.75 -5.84 43.77 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.376 -0.375 . . . . 1.0 112.234 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -94.35 134.41 25.64 Favored Pre-proline 0 CA--C 1.556 1.175 0 CA-C-N 117.174 0.487 . . . . 1.0 110.76 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.14 134.82 13.25 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.848 1.699 . . . . 1.0 111.937 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 42' ' ' ILE . 23.9 mm -102.81 116.18 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.633 0.73 . . . . 1.0 111.36 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -110.86 -26.84 9.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.502 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 p -136.99 165.34 26.22 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.168 0.509 . . . . 1.0 110.901 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -66.5 -33.62 76.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.372 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.37 -39.14 89.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 1.0 110.405 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -51.44 -39.13 56.76 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.473 -0.491 . . . . 1.0 109.868 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 36' ' ' ILE . 50.0 mm -62.72 -34.71 67.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 121.233 -0.187 . . . . 1.0 111.031 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.62 -44.48 99.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.735 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 p -58.36 -43.55 88.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.544 0.688 . . . . 1.0 110.542 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.3 -57.6 12.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.191 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 45' ' ' TYR . 97.6 t -52.59 -40.3 33.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.95 0.405 . . . . 1.0 110.298 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -37.49 80.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.386 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.45 -48.04 82.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.798 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -89.31 175.02 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.171 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 51' ' ' ALA . 17.8 pt20 -155.41 125.32 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.705 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -2.69 124.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 125.73 1.894 . . . . 1.0 110.414 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.57 -6.53 49.24 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.609 -1.397 . . . . 1.0 109.609 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 20.6 t70 -83.89 177.22 8.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.851 0.358 . . . . 1.0 110.872 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 58.7 mtp180 -146.59 123.48 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.566 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.0 m -130.99 131.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 122.225 1.012 . . . . 1.0 111.674 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.635 ' H ' ' HE ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -75.05 116.96 16.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.763 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.65 134.92 43.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.837 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 m -101.81 133.38 46.65 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.462 ' CD1' HD21 ' A' ' 22' ' ' LEU . 31.5 p90 -146.5 150.14 34.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -108.77 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.422 0.629 . . . . 1.0 110.759 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' A' ' 26' ' ' ASP . 40.6 ttm-85 -138.04 121.27 16.92 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.598 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 53.29 39.82 30.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.932 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 69.81 10.13 7.41 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.484 0.49 . . . . 1.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -110.34 106.53 15.93 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -76.01 127.7 33.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.257 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -142.0 144.58 33.73 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.04 140.75 29.54 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.504 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.72 125.81 51.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.828 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.433 ' C ' HD22 ' A' ' 70' ' ' LEU . 38.7 tp10 -79.97 102.84 9.46 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.839 -1.073 . . . . 1.0 109.948 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.433 HD22 ' C ' ' A' ' 69' ' ' GLU . 4.4 mm? -110.29 142.63 41.64 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.484 0.659 . . . . 1.0 110.667 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.09 134.32 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.375 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -71.6 129.48 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.979 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HZ1' ' HD3' ' A' ' 17' ' ' PRO . 14.0 ptpt -137.16 139.86 29.43 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.096 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.08 166.58 29.26 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.906 2.404 . . . . 1.0 112.522 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -97.62 153.37 38.33 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.374 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 78' ' ' HIS . 37.0 Cg_endo -64.44 -71.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.617 2.211 . . . . 1.0 112.459 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.596 ' CD2' ' HD1' ' A' ' 78' ' ' HIS . 0.6 OUTLIER -68.39 10.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.909 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.596 ' HD1' ' CD2' ' A' ' 77' ' ' HIS . 39.4 m80 -157.92 73.95 4.03 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.84 -13.52 21.78 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.286 1.99 . . . . 1.0 112.089 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -91.6 11.96 22.57 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 122.236 -0.29 . . . . 1.0 110.304 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.634 ' C ' HD13 ' A' ' 82' ' ' ILE . 15.1 mp0 -131.48 148.86 52.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.639 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -107.59 -175.06 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.124 -0.944 . . . . 1.0 110.116 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.98 155.41 6.62 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 110.893 -0.883 . . . . 1.0 110.893 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.15 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.437 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.71 14.82 0.02 OUTLIER Glycine 0 CA--C 1.536 1.372 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.27 156.95 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.845 -0.428 . . . . 1.0 109.845 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.055 -0.974 . . . . 1.0 111.065 -179.368 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 54.19 101.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.804 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.03 86.49 0.54 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.704 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.87 163.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.39 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 56.89 -159.95 0.23 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.762 -0.654 . . . . 1.0 111.153 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.88 57.58 0.61 Allowed Glycine 0 C--N 1.346 1.084 0 N-CA-C 111.465 -0.654 . . . . 1.0 111.465 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 38.2 t -96.5 129.15 46.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' VAL . 32.7 m-85 -126.97 132.17 50.89 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.647 0.261 . . . . 1.0 110.671 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.645 HG21 HD12 ' A' ' 22' ' ' LEU . 41.4 t -44.47 170.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.53 ' N ' HG12 ' A' ' 9' ' ' VAL . 35.5 tpp -95.11 -65.28 0.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.392 -0.193 . . . . 1.0 111.231 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -155.15 173.84 16.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.266 -0.573 . . . . 1.0 111.095 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 t -118.03 100.74 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASN . 9.7 mp -99.86 117.93 62.63 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.84 -0.6 . . . . 1.0 110.323 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.77 49.36 0.04 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.112 2.541 . . . . 1.0 112.838 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 58.4 t30 -171.18 8.89 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.009 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.401 ' H ' ' H ' ' A' ' 15' ' ' ASN . 16.6 mmt -107.9 155.66 39.54 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 120.566 0.222 . . . . 1.0 110.507 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.83 -23.65 73.02 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.273 1.982 . . . . 1.0 113.406 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -88.4 -13.06 41.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.163 0.506 . . . . 1.0 110.819 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.57 113.87 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.712 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.46 -11.87 63.22 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -113.28 -36.65 4.95 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.017 0.437 . . . . 1.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.645 HD12 HG21 ' A' ' 9' ' ' VAL . 1.1 mm? -123.31 149.9 44.26 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.707 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -139.63 155.06 47.65 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.298 -0.865 . . . . 1.0 110.873 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 131.97 52.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.651 -1.159 . . . . 1.0 108.945 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.06 -25.48 12.72 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.032 -1.227 . . . . 1.0 110.032 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.47 ' OD1' ' NH2' ' A' ' 61' ' ' ARG . 97.1 m-20 -79.29 153.16 30.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.577 0.227 . . . . 1.0 110.437 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 26.7 ptt180 -123.25 165.24 17.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -99.38 122.65 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.374 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -98.91 -22.62 15.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.37 159.04 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.391 0.615 . . . . 1.0 111.624 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.1 mt -136.64 122.41 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.037 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 t0 51.5 23.38 1.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.146 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.09 -6.78 58.38 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -90.01 122.27 67.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 122.625 -0.338 . . . . 1.0 111.162 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.33 133.32 17.51 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.693 1.595 . . . . 1.0 111.485 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mm -100.18 111.15 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.689 0.757 . . . . 1.0 112.257 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -110.85 -16.73 13.49 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.322 -1.308 . . . . 1.0 111.302 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.8 p -141.8 155.01 45.59 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.048 0.451 . . . . 1.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -68.9 -26.01 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.441 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -66.88 -32.72 74.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.493 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -59.99 -29.9 68.76 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.772 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.09 -27.37 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.749 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.26 -44.49 77.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.484 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.2 p -68.81 -42.2 77.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.489 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -58.78 -52.82 64.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.678 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.12 -40.76 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.99 -39.25 94.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.354 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.54 -55.16 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.345 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -80.98 146.52 30.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.138 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -97.52 177.57 5.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.494 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 136.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.758 . . . . 1.0 110.076 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.07 -3.64 70.26 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 33.7 t70 -73.59 170.45 15.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.082 0.468 . . . . 1.0 111.007 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 40.2 ptt85 -138.2 131.68 30.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.169 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.35 131.64 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.854 0.835 . . . . 1.0 111.877 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -75.51 109.26 8.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.615 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.92 138.06 25.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.448 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.1 m -107.11 140.83 39.32 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.476 ' CD1' HD21 ' A' ' 22' ' ' LEU . 35.0 p90 -148.79 152.78 37.14 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.5 mp -107.17 135.54 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 121.695 0.76 . . . . 1.0 111.62 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.47 ' NH2' ' OD1' ' A' ' 26' ' ' ASP . 44.5 ttm-85 -140.83 122.09 14.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 114.543 -1.208 . . . . 1.0 109.621 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 46.25 49.09 12.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 64.05 9.37 4.6 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.554 0.534 . . . . 1.0 111.758 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -113.92 105.89 13.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.63 0.252 . . . . 1.0 110.636 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.01 146.23 32.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 111.176 -179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -153.48 145.51 23.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.968 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -89.93 129.88 36.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.445 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.1 128.24 55.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.992 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' C ' HD22 ' A' ' 70' ' ' LEU . 42.4 tp10 -80.37 102.74 9.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 1.0 109.928 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 18' ' ' ALA . 4.4 mm? -111.05 145.55 38.3 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.234 0.54 . . . . 1.0 110.791 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.81 132.55 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.39 128.68 36.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.493 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -136.33 121.85 13.39 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.746 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.96 -174.52 2.21 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 122.373 2.049 . . . . 1.0 112.02 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -106.42 147.87 35.71 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.764 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.14 -34.59 45.53 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.0 1.8 . . . . 1.0 112.196 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.559 ' ND1' ' ND1' ' A' ' 78' ' ' HIS . 6.9 p80 -77.25 -16.31 59.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 1.0 110.295 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.559 ' ND1' ' ND1' ' A' ' 77' ' ' HIS . 28.0 m80 -144.4 73.74 15.68 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.359 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.26 -12.83 37.35 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.052 1.834 . . . . 1.0 111.953 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -93.94 18.93 9.68 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -143.01 131.18 21.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.622 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.6 OUTLIER -76.15 157.83 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.648 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.93 103.76 0.63 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.218 -0.753 . . . . 1.0 111.218 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.67 -12.3 58.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.896 0.379 . . . . 1.0 110.842 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -104.45 168.34 16.33 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 111.174 -0.77 . . . . 1.0 111.174 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.7 t -137.91 151.08 25.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.787 0 N-CA-C 110.245 -0.279 . . . . 1.0 110.245 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.222 -0.382 0 CA-C-O 118.142 -0.932 . . . . 1.0 109.522 -179.962 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 56.16 52.41 10.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.352 -0.386 . . . . 1.0 111.026 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 53.6 76.15 0.23 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.982 0.42 . . . . 1.0 111.14 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.4 -64.86 0.81 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.447 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm 60.3 88.38 0.08 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.638 -0.256 . . . . 1.0 111.421 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.49 -117.13 2.56 Favored Glycine 0 N--CA 1.476 1.352 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.37 169.63 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 122.749 0.419 . . . . 1.0 110.276 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -133.87 139.76 46.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.834 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -74.47 125.63 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.031 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.4 mtt -84.8 -64.37 1.17 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.425 0.155 . . . . 1.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -123.08 149.73 44.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.279 0.561 . . . . 1.0 111.159 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.56 133.47 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 10.9 mp -93.47 150.56 39.11 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.797 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.04 -27.76 16.81 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.565 2.176 . . . . 1.0 112.788 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.57 39.91 2.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.0 162.44 21.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 123.189 0.306 . . . . 1.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.29 -33.68 94.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.262 1.975 . . . . 1.0 112.972 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.05 -11.61 54.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.743 0.306 . . . . 1.0 111.636 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 13' ' ' LEU . . . -66.74 135.22 53.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.665 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.9 -16.37 51.37 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.84 -33.86 4.65 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.327 -0.249 . . . . 1.0 110.327 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' OD2' ' A' ' 26' ' ' ASP . 14.1 tp -122.63 152.66 40.25 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.294 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 60.9 mm-40 -139.42 154.33 47.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.599 0.714 . . . . 1.0 111.087 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.15 139.02 53.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.32 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -29.69 8.93 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.209 -1.156 . . . . 1.0 110.209 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.491 ' OD2' HD11 ' A' ' 22' ' ' LEU . 1.7 p-10 -69.69 149.52 47.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.807 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.4 158.79 21.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.903 0.382 . . . . 1.0 110.445 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.7 mm -100.04 119.98 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.011 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.65 -21.94 19.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.86 163.06 2.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.109 0.48 . . . . 1.0 111.528 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 33' ' ' GLY . 89.1 mt -136.79 126.53 38.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 122.294 1.045 . . . . 1.0 110.872 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t0 51.05 11.2 0.09 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.591 -0.693 . . . . 1.0 111.405 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . 111.06 -6.48 28.99 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.986 -0.341 . . . . 1.0 112.312 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.487 ' NE2' ' CD1' ' A' ' 45' ' ' TYR . 4.4 pt20 -94.9 110.6 50.64 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 117.239 0.519 . . . . 1.0 111.789 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.78 136.15 73.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.266 1.311 . . . . 1.0 111.522 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.79 115.64 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.597 0.713 . . . . 1.0 111.429 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -112.45 -20.22 11.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.253 -1.339 . . . . 1.0 110.963 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.8 p -135.18 151.29 50.52 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.041 0.448 . . . . 1.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.0 p -69.55 -29.66 67.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.54 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.02 -29.47 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.648 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -63.4 -28.62 70.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.078 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.35 -28.35 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.706 -0.224 . . . . 1.0 111.257 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.96 -40.98 76.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.034 0.445 . . . . 1.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.9 m -69.71 -41.1 75.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 1.0 109.595 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.487 ' CD1' ' NE2' ' A' ' 34' ' ' GLN . 72.9 t80 -57.49 -56.28 23.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.727 -178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.02 -33.55 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.302 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -64.35 -40.13 95.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.506 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -57.76 -50.25 73.86 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.666 -0.413 . . . . 1.0 110.321 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -81.6 149.09 28.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -102.36 -179.43 3.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.311 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 135.69 55.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.964 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.5 -0.21 65.42 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.411 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 35.5 t70 -78.06 171.05 15.6 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.877 0.37 . . . . 1.0 110.935 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 82.2 mtp180 -139.3 125.21 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.98 132.73 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.943 0.878 . . . . 1.0 111.646 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -81.02 113.46 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.093 -1.412 . . . . 1.0 108.748 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.95 132.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.644 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.8 m -101.17 137.71 39.16 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.436 ' C ' HD12 ' A' ' 60' ' ' ILE . 32.7 p90 -150.28 152.18 34.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -106.51 138.54 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.41 0.624 . . . . 1.0 111.04 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -143.73 123.8 13.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.719 -1.128 . . . . 1.0 109.964 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 50.64 43.01 27.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.817 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 67.08 9.59 7.04 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.822 0.449 . . . . 1.0 111.841 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -115.46 106.54 14.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.919 0.39 . . . . 1.0 110.654 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' ' NE2' ' A' ' 65' ' ' GLN . 5.0 pp0? -74.13 138.52 43.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.383 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -149.16 144.28 26.5 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.362 -0.836 . . . . 1.0 111.269 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.68 136.52 32.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.037 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.18 122.55 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' HD12 ' A' ' 70' ' ' LEU . 51.3 mt-10 -84.36 102.04 12.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.933 -1.03 . . . . 1.0 110.026 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.8 mp -111.79 150.18 30.68 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.195 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 53' ' ' ASP . 9.9 p -122.29 131.77 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.292 -0.867 . . . . 1.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.66 129.51 40.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.813 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -141.5 119.75 7.84 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.104 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.21 -169.49 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.155 1.904 . . . . 1.0 112.183 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -110.65 149.15 39.9 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.091 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.73 -27.56 68.34 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.175 1.917 . . . . 1.0 111.693 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -85.35 -14.11 47.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.392 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -148.45 69.54 10.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.71 -11.5 24.1 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.421 2.08 . . . . 1.0 112.182 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -101.52 17.95 21.46 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.58 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -134.75 128.23 32.49 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -109.77 160.29 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.619 -0.718 . . . . 1.0 109.641 -179.18 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.91 64.15 0.1 OUTLIER Glycine 0 N--CA 1.468 0.79 0 CA-C-N 115.042 -0.981 . . . . 1.0 111.259 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.9 tp -96.29 -83.59 0.37 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.517 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.37 -96.6 0.01 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 123.865 0.728 . . . . 1.0 112.354 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.01 155.44 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 122.57 0.348 . . . . 1.0 110.182 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.045 -0.979 . . . . 1.0 111.013 -179.411 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 4' ' ' ALA . 75.4 m-20 55.12 14.75 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.292 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 64.55 -15.25 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.487 0.492 . . . . 1.0 111.137 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 2' ' ' ASN . . . -58.74 144.26 44.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.92 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -123.16 -52.11 1.86 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.344 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.66 -131.92 7.11 Favored Glycine 0 N--CA 1.471 1.033 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 t -135.36 111.88 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.236 0.541 . . . . 1.0 111.126 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -58.96 134.36 56.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.239 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 7.5 p -46.35 160.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.829 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' HG22 ' A' ' 9' ' ' VAL . 26.1 ttt -103.21 -62.29 1.3 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.857 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 m -151.94 154.36 35.93 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.156 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 t -122.45 101.94 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 13' ' ' LEU . 3.9 mm? -74.83 135.02 74.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.414 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.3 -20.95 42.09 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 122.32 2.013 . . . . 1.0 112.782 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -107.18 33.62 3.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.81 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.17 165.35 19.4 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.03 0.206 . . . . 1.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.491 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.2 Cg_exo -68.38 -16.6 43.7 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.403 2.069 . . . . 1.0 112.933 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.91 36.85 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.101 -0.375 . . . . 1.0 111.856 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.79 137.62 57.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.985 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.75 39.1 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.254 -0.738 . . . . 1.0 111.254 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' NH2' ' O ' ' A' ' 17' ' ' PRO . 36.0 mtm180 -113.69 -34.23 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.482 0.313 . . . . 1.0 110.806 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 mt -123.54 154.01 39.81 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.05 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -138.94 154.02 48.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.104 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.83 139.8 55.95 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.301 -0.863 . . . . 1.0 109.398 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.629 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 104.6 -26.31 23.0 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 26' ' ' ASP . 2.4 m-20 -67.49 145.35 55.05 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.937 -0.305 . . . . 1.0 110.253 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -109.09 153.39 23.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.726 0.298 . . . . 1.0 110.386 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.7 mm -96.16 118.01 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.095 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . -90.75 -16.24 28.77 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.808 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . 171.12 163.67 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.243 0.544 . . . . 1.0 110.965 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.93 126.75 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.774 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 50.77 20.68 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.036 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.0 56.31 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.852 -0.499 . . . . 1.0 111.852 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -92.85 126.33 51.96 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.961 0.381 . . . . 1.0 111.454 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.91 135.21 17.19 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.826 1.684 . . . . 1.0 111.468 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.66 115.75 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.865 0.84 . . . . 1.0 112.216 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -107.12 -23.27 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.09 -1.414 . . . . 1.0 111.161 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -134.86 154.28 51.71 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.165 0.507 . . . . 1.0 111.142 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -69.95 -33.73 72.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.337 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -62.51 -28.46 69.86 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -63.47 -30.27 71.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.628 -0.429 . . . . 1.0 109.919 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.54 -29.95 36.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 116.743 -0.208 . . . . 1.0 111.278 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.36 -42.21 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.461 . . . . 1.0 110.213 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -65.13 -40.39 94.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.161 0.505 . . . . 1.0 109.868 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.94 -57.68 11.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.895 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.0 m -55.16 -39.94 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.826 0.346 . . . . 1.0 110.202 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -40.95 94.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.72 -47.0 70.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.378 . . . . 1.0 110.46 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -81.5 -173.45 4.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.87 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' ALA . 40.3 tt0 -130.91 171.45 13.17 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.985 0.422 . . . . 1.0 110.834 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' A' ' 50' ' ' GLN . . . -64.83 136.28 56.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.771 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.3 -0.83 81.67 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.391 -1.084 . . . . 1.0 110.391 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 36.9 t70 -71.54 179.51 2.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.804 0.335 . . . . 1.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.498 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 87.4 mtm180 -138.47 123.55 19.08 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.5 130.98 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 122.06 0.933 . . . . 1.0 112.112 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -85.96 118.89 25.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.961 -1.472 . . . . 1.0 109.084 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -108.55 134.42 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.544 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.5 m -104.62 132.63 50.64 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.26 153.37 37.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.3 138.52 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.215 0.531 . . . . 1.0 110.341 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -141.31 121.78 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.304 -0.862 . . . . 1.0 109.444 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 54.37 39.6 31.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.34 -0.846 . . . . 1.0 110.873 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 68.92 9.09 7.21 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 123.161 0.288 . . . . 1.0 111.66 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -108.87 116.72 32.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.96 0.409 . . . . 1.0 110.131 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.9 128.58 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.887 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -144.18 139.12 28.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.27 0.557 . . . . 1.0 111.105 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.84 138.56 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.32 117.0 31.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.868 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' CD ' HH11 ' A' ' 21' ' ' ARG . 3.3 pt-20 -77.47 103.54 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.142 -0.935 . . . . 1.0 109.2 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.23 146.22 39.69 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.73 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.06 134.68 63.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.655 -1.157 . . . . 1.0 110.077 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -66.55 125.49 25.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.447 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.42 117.66 13.43 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.435 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.12 -170.78 0.92 Allowed 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.303 2.002 . . . . 1.0 112.353 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -125.25 145.72 51.66 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.131 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.72 -34.15 19.49 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 121.948 1.766 . . . . 1.0 111.94 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -81.45 -29.81 33.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.44 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -137.57 62.35 35.46 Favored Pre-proline 0 N--CA 1.467 0.422 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.272 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.29 -26.79 71.69 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.944 1.763 . . . . 1.0 111.954 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -56.53 -13.38 2.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.52 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.757 ' C ' HD13 ' A' ' 82' ' ' ILE . 86.9 mt-30 -114.29 170.86 7.98 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.808 -0.442 . . . . 1.0 109.808 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.757 HD13 ' C ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -118.06 -177.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.192 -179.214 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -47.9 86.54 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.894 -0.594 . . . . 1.0 112.079 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.679 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -97.9 -3.22 39.0 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.761 0.424 . . . . 1.0 111.168 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.14 -32.97 85.95 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 111.941 -0.464 . . . . 1.0 111.941 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 t -108.18 144.8 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.845 0.355 . . . . 1.0 110.255 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.418 -179.707 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -81.13 70.22 7.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.475 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 73.52 -155.83 0.07 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.129 0.893 . . . . 1.0 111.256 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.8 -140.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.705 0.288 . . . . 1.0 111.535 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -62.68 -48.98 76.96 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.622 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.39 -120.43 2.64 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 111.43 -0.668 . . . . 1.0 111.43 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 8' ' ' TYR . 36.0 t -134.15 168.55 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 120.824 0.345 . . . . 1.0 110.397 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.571 ' N ' HG12 ' A' ' 7' ' ' VAL . 97.4 m-85 -130.2 140.37 50.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.71 128.02 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.502 ' H ' HG22 ' A' ' 87' ' ' THR . 23.4 ttt -78.03 -64.74 1.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.194 -0.316 . . . . 1.0 111.723 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -133.6 160.77 36.49 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.031 0.443 . . . . 1.0 111.535 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.6 136.52 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.99 148.91 38.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 O-C-N 123.42 0.45 . . . . 1.0 111.854 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' SD ' ' A' ' 16' ' ' MET . 74.4 Cg_endo -73.23 157.43 50.17 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.288 1.992 . . . . 1.0 111.351 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 64.15 28.0 14.07 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.296 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -106.59 157.94 33.91 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-O 120.748 0.309 . . . . 1.0 110.357 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 -19.55 64.16 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.157 1.905 . . . . 1.0 112.979 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 22' ' ' LEU . . . -100.25 -17.72 17.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.65 0.738 . . . . 1.0 111.091 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.32 129.57 42.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.819 -1.082 . . . . 1.0 109.337 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.33 -7.94 62.2 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -134.27 -24.36 1.62 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.826 0.346 . . . . 1.0 110.537 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -117.41 134.07 55.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.011 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 97.5 mt-10 -134.45 148.0 50.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.549 0.69 . . . . 1.0 110.405 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.2 136.89 48.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.931 -1.032 . . . . 1.0 109.483 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.62 -26.63 13.95 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 2.8 p-10 -64.78 145.0 56.86 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.72 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -109.69 142.22 41.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.933 0.397 . . . . 1.0 109.979 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.23 122.26 43.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.569 -0.742 . . . . 1.0 109.191 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.552 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -94.54 -22.45 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.125 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.02 154.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.2 mt -129.55 125.46 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.878 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 17.12 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.529 -0.76 . . . . 1.0 111.013 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.73 -5.29 47.17 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.72 -0.552 . . . . 1.0 111.72 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -95.19 111.19 54.06 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.026 0.413 . . . . 1.0 111.486 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.18 136.45 74.81 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 122.326 2.017 . . . . 1.0 111.484 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.69 106.37 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.578 0.704 . . . . 1.0 111.805 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -102.68 -25.02 13.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.605 -1.18 . . . . 1.0 111.419 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -140.53 160.18 40.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.078 0.466 . . . . 1.0 111.051 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -67.39 -23.04 65.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.103 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -66.01 -32.96 74.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.209 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -61.55 -31.35 71.37 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.511 -0.476 . . . . 1.0 109.82 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.43 -27.96 19.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 CA-C-O 120.983 0.421 . . . . 1.0 110.485 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.52 -42.74 83.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.734 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 59.2 p -64.21 -39.73 94.58 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' CE1' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -58.23 -56.21 24.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.505 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.82 -44.0 76.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.946 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -69.62 -35.79 75.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.68 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.42 -62.53 1.59 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.224 -0.287 . . . . 1.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.32 -169.21 2.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.635 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -131.91 176.37 8.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.676 0.75 . . . . 1.0 112.039 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.62 134.84 57.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.889 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.5 -0.78 74.89 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.441 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 19.3 t0 -68.62 169.95 10.17 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.888 0.375 . . . . 1.0 111.16 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 76.4 mtp180 -140.73 117.75 11.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG21 ' CE1' ' A' ' 45' ' ' TYR . 6.7 m -129.23 135.14 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.855 0.836 . . . . 1.0 111.88 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.434 ' NH1' ' OE2' ' A' ' 69' ' ' GLU . 83.9 mmt-85 -76.75 105.84 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.31 -1.314 . . . . 1.0 108.786 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.0 t -95.06 135.21 29.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.561 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.9 m -104.97 137.52 42.6 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.9 150.96 32.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.4 mp -103.12 137.67 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.741 0.781 . . . . 1.0 111.706 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -143.34 117.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.465 -1.243 . . . . 1.0 110.175 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 52.84 44.77 29.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.251 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 66.67 8.31 5.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.706 -0.225 . . . . 1.0 111.335 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -111.92 113.34 25.61 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 51.1 mt-30 -75.79 146.23 40.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.401 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.413 ' CG ' ' O ' ' A' ' 65' ' ' GLN . 98.2 m-70 -156.53 140.94 16.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.979 0.419 . . . . 1.0 110.817 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.99 128.69 36.91 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.85 123.88 49.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.401 0.619 . . . . 1.0 110.471 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' C ' HD12 ' A' ' 70' ' ' LEU . 42.6 tp10 -78.74 100.54 7.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.041 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.3 mp -114.83 149.24 37.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.462 0.649 . . . . 1.0 110.846 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -136.13 137.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 114.755 -1.112 . . . . 1.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 mt -61.16 120.44 10.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.995 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 83' ' ' GLY . 84.4 tttt -118.62 119.94 32.22 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.872 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.22 174.0 13.56 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.744 2.296 . . . . 1.0 112.713 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -85.5 159.13 56.37 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.759 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -44.46 -86.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.393 2.062 . . . . 1.0 113.612 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' A' ' 77' ' ' HIS . 60.9 t60 -101.38 8.06 42.41 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.771 0.32 . . . . 1.0 110.692 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.431 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 58.6 m-70 -121.93 50.7 2.55 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.849 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 81' ' ' GLN . 25.5 Cg_endo -60.89 -6.65 6.36 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.869 2.379 . . . . 1.0 111.353 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -50.16 -13.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.53 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.534 ' O ' HD13 ' A' ' 82' ' ' ILE . 12.4 tp60 -131.06 -167.34 1.83 Allowed 'General case' 0 C--N 1.347 0.491 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.534 HD13 ' O ' ' A' ' 81' ' ' GLN . 1.2 mm -129.72 170.4 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.821 -0.627 . . . . 1.0 109.695 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 73' ' ' LYS . . . -47.37 82.01 0.01 OUTLIER Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.418 -0.81 . . . . 1.0 112.153 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -99.59 -3.68 32.72 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.373 0.269 . . . . 1.0 110.348 -179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.83 -25.17 3.43 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.959 -0.639 . . . . 1.0 112.041 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 t -107.98 145.74 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.668 0.271 . . . . 1.0 110.474 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 10' ' ' MET . 13.2 t . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.124 -0.941 . . . . 1.0 111.253 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -81.03 167.66 19.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.216 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -73.39 -76.79 0.12 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.871 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.63 140.57 47.18 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.664 -0.244 . . . . 1.0 110.582 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.29 172.69 10.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.67 0.272 . . . . 1.0 110.85 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.49 -119.12 3.36 Favored Glycine 0 N--CA 1.474 1.18 0 N-CA-C 111.474 -0.651 . . . . 1.0 111.474 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -130.82 170.39 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.783 0.325 . . . . 1.0 110.383 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.65 129.51 36.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.961 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.34 127.75 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.179 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.529 ' H ' ' CG2' ' A' ' 87' ' ' THR . 11.0 tpt -75.84 -53.04 9.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.186 -0.321 . . . . 1.0 111.278 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.1 p -148.05 165.26 31.33 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.015 0.436 . . . . 1.0 111.365 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.59 135.28 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.19 153.08 39.81 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.434 0.459 . . . . 1.0 111.176 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.64 158.75 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.558 2.172 . . . . 1.0 111.88 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.6 t30 56.27 32.45 20.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.405 -0.816 . . . . 1.0 111.116 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.9 mmm -106.88 161.13 23.87 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.174 0.296 . . . . 1.0 110.882 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.32 -30.43 91.03 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.343 2.029 . . . . 1.0 112.821 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.432 ' HB2' HD22 ' A' ' 70' ' ' LEU . . . -97.85 -14.43 20.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.922 0.391 . . . . 1.0 111.465 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 122.66 14.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.65 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.71 -8.22 65.85 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -119.73 -25.66 5.86 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.238 0.542 . . . . 1.0 110.538 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.604 HD22 ' OD2' ' A' ' 26' ' ' ASP . 14.2 mt -140.03 170.62 15.52 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.743 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 mt-10 -156.06 165.01 37.7 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.377 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.85 137.71 57.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.498 -1.228 . . . . 1.0 109.025 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.81 14.72 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.604 ' OD2' HD22 ' A' ' 22' ' ' LEU . 7.6 p-10 -72.64 154.04 40.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.791 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -121.81 151.42 40.63 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -96.69 129.24 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.78 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.5 -27.29 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.85 151.03 2.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 1.0 111.409 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.84 123.6 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.166 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.2 t0 56.59 17.16 2.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.962 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.27 42.3 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.927 -0.469 . . . . 1.0 111.927 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -96.2 110.45 52.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 119.379 -0.344 . . . . 1.0 111.399 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.88 137.53 81.45 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.336 2.024 . . . . 1.0 111.394 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mm -97.75 106.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.575 0.702 . . . . 1.0 111.744 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -104.22 -21.52 13.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.8 p -144.3 161.01 40.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.993 0.425 . . . . 1.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.0 p -66.86 -23.85 66.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.353 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.21 -34.1 77.57 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.071 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -59.95 -33.34 71.78 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.775 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -71.92 -28.16 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.942 0.401 . . . . 1.0 110.547 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.02 -42.98 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.909 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 t -62.75 -41.43 99.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.789 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -58.18 8.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.883 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.42 -43.0 81.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -62.85 -44.36 96.34 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.959 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -60.15 -58.09 10.02 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 1.0 110.25 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -81.49 170.94 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.382 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -136.41 -172.24 3.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.126 0.489 . . . . 1.0 111.42 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 129.73 40.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.143 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.39 -8.73 64.57 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 71' ' ' VAL . 20.2 t70 -70.81 174.61 5.84 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.975 0.417 . . . . 1.0 111.155 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.447 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 83.7 mtt85 -145.14 127.89 16.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.93 132.9 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.905 0.86 . . . . 1.0 111.862 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -78.12 103.01 7.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.272 -1.331 . . . . 1.0 108.496 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.1 t -95.42 135.49 29.33 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.051 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.5 m -105.08 138.87 40.62 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CD2' HD21 ' A' ' 22' ' ' LEU . 36.0 p90 -148.92 155.15 40.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.5 mp -110.19 134.59 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.629 0.728 . . . . 1.0 111.13 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -141.91 123.84 15.31 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.657 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 48.02 46.16 19.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.655 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 67.67 6.66 5.15 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.846 0.355 . . . . 1.0 110.606 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -112.29 116.12 29.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -90.55 143.21 26.97 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.91 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -152.34 148.49 27.56 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.839 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.99 127.08 36.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.632 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.93 124.54 49.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.446 0.641 . . . . 1.0 110.044 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.08 102.14 14.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.558 -1.201 . . . . 1.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 18' ' ' ALA . 36.3 mt -113.31 151.19 31.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.669 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 53' ' ' ASP . 2.9 t -124.07 130.64 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.019 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.2 mm? -56.67 120.16 7.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.134 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -121.74 117.15 30.07 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.547 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.1 179.27 6.28 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.913 2.409 . . . . 1.0 112.244 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.8 152.23 46.45 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.603 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.27 -60.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.349 2.032 . . . . 1.0 112.612 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -100.31 21.21 13.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.514 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -164.2 45.12 0.12 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.373 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 78' ' ' HIS . 15.1 Cg_endo -53.82 -10.63 1.83 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.679 2.252 . . . . 1.0 112.107 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -56.0 -8.64 0.47 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.587 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 79' ' ' PRO . 6.5 mp0 -130.52 156.38 44.9 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.4 mt -142.53 142.57 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.623 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.55 2.89 52.22 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.601 -0.6 . . . . 1.0 111.601 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -66.19 -40.17 90.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.144 -0.222 . . . . 1.0 111.492 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -33.66 -47.48 0.46 Allowed Glycine 0 N--CA 1.47 0.9 0 O-C-N 123.621 0.575 . . . . 1.0 112.32 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 87' ' ' THR . 40.1 t -111.92 157.17 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.932 0.396 . . . . 1.0 110.705 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.529 ' CG2' ' H ' ' A' ' 10' ' ' MET . 6.7 t . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.87 -1.062 . . . . 1.0 111.097 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 tmm? . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -164.59 -76.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.931 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 60.25 56.38 3.27 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.445 0.465 . . . . 1.0 110.363 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.81 -63.16 1.12 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.545 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -119.19 -43.93 2.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 111.357 0.132 . . . . 1.0 111.357 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -116.6 -112.71 2.72 Favored Glycine 0 N--CA 1.476 1.321 0 N-CA-C 111.463 -0.655 . . . . 1.0 111.463 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 8' ' ' TYR . 21.5 t -137.31 158.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.699 0.285 . . . . 1.0 110.381 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.409 ' N ' HG12 ' A' ' 7' ' ' VAL . 50.7 m-85 -129.11 137.41 51.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.21 127.69 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.12 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.6 mtt -75.35 -65.46 0.89 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.733 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -128.94 160.87 31.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.166 0.507 . . . . 1.0 111.16 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -128.12 138.92 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.89 145.17 31.48 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 123.137 0.273 . . . . 1.0 111.121 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.08 -24.28 20.59 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.441 2.094 . . . . 1.0 112.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -99.05 17.93 18.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.639 -0.255 . . . . 1.0 111.159 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 85' ' ' GLY . 27.8 mtt -113.17 158.53 37.83 Favored Pre-proline 0 N--CA 1.469 0.485 0 O-C-N 123.055 0.222 . . . . 1.0 110.9 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.66 -32.11 53.2 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.415 2.076 . . . . 1.0 113.295 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.78 57.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.685 0.279 . . . . 1.0 111.385 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.07 109.65 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.122 -0.631 . . . . 1.0 110.719 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.68 -14.83 64.59 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.232 -0.747 . . . . 1.0 111.232 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -108.11 -41.63 4.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.124 0.488 . . . . 1.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.47 156.84 40.04 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.484 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -144.29 158.1 43.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.157 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.81 56.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.421 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.2 18.15 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.247 -1.141 . . . . 1.0 110.247 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 150.68 42.63 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 122.782 -0.246 . . . . 1.0 110.63 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -114.61 154.58 28.11 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.161 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mm -97.35 120.14 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.024 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.47 19.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.6 158.72 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 1.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.75 125.03 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.105 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 51.22 21.72 1.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.124 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.33 57.81 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.617 -0.593 . . . . 1.0 111.617 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -89.93 124.85 62.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.75 -0.265 . . . . 1.0 111.254 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.4 132.8 15.28 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.981 1.787 . . . . 1.0 111.465 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -99.13 110.89 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.496 0.665 . . . . 1.0 112.433 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -115.53 -18.18 11.0 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.661 -1.154 . . . . 1.0 111.108 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -139.37 156.01 47.28 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.241 0.544 . . . . 1.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.1 m -66.28 -22.57 66.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.233 -0.894 . . . . 1.0 108.878 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.33 -35.34 77.63 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.523 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.482 ' H ' HG23 ' A' ' 38' ' ' THR . 69.6 tp60 -57.1 -31.71 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.859 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -74.79 -26.84 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.781 -0.191 . . . . 1.0 110.971 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.54 -41.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 1.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.2 t -65.62 -40.58 92.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.281 0.562 . . . . 1.0 109.944 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -58.18 -57.16 14.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.646 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' LYS . 29.0 m -58.55 -39.77 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.325 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -66.04 -37.61 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.707 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.77 -53.86 47.89 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.339 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 46' ' ' VAL . 72.1 mmtt -87.31 156.96 19.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.55 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.4 -178.18 3.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.295 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.27 135.91 55.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.177 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.82 -1.53 74.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 30.7 t70 -74.24 172.04 12.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.033 0.444 . . . . 1.0 110.879 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.0 mtp85 -141.76 130.04 22.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.078 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.63 133.51 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.892 0.854 . . . . 1.0 111.942 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.14 107.44 7.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.383 -1.28 . . . . 1.0 108.767 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.03 137.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.329 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -104.92 139.22 39.96 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' C ' HD12 ' A' ' 60' ' ' ILE . 34.4 p90 -150.31 151.87 33.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.5 mp -108.23 132.07 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.525 0.679 . . . . 1.0 111.472 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -138.58 124.24 19.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.4 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 49.58 43.82 24.15 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 115.291 -0.868 . . . . 1.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 70.43 -1.35 2.54 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.322 0.119 . . . . 1.0 111.322 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -107.42 106.06 16.28 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.529 0.204 . . . . 1.0 110.824 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -76.82 145.3 38.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.212 0.529 . . . . 1.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -153.88 146.09 23.8 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.327 -0.852 . . . . 1.0 111.052 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -89.12 132.11 34.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.543 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.94 124.62 52.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.91 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 39.1 mp0 -80.04 101.95 9.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.738 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tt -109.34 143.0 39.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.749 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.7 131.0 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.442 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.68 131.6 46.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.502 . . . . 1.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -145.09 135.21 11.8 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.942 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.55 171.82 16.98 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.811 2.341 . . . . 1.0 112.356 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -109.43 137.28 20.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -48.65 -40.05 38.0 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.051 1.834 . . . . 1.0 112.269 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -73.4 -39.01 65.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.848 0.356 . . . . 1.0 110.479 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -118.96 70.07 9.87 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.997 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.56 -29.58 78.44 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.135 1.89 . . . . 1.0 111.859 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -86.66 25.88 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.21 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.649 ' C ' HD13 ' A' ' 82' ' ' ILE . 59.7 tt0 -144.4 149.77 36.63 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.762 -0.458 . . . . 1.0 109.762 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.649 HD13 ' C ' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -124.1 138.96 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.055 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.81 -179.01 28.01 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.4 mp -68.7 -89.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.257 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.483 ' O ' ' SD ' ' A' ' 16' ' ' MET . . . 177.18 -10.74 0.03 OUTLIER Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.3 m -108.09 171.54 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 122.595 -0.356 . . . . 1.0 110.079 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.689 -179.285 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.751 -0.833 . . . . 1.0 108.751 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -151.89 86.18 1.31 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.851 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 4' ' ' ALA . 97.0 mt-10 -101.95 165.08 11.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.193 -0.458 . . . . 1.0 109.831 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' GLU . . . -24.0 126.17 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.855 0.722 . . . . 1.0 112.141 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 8' ' ' TYR . 54.6 mtmt -85.54 -164.96 1.09 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.909 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.586 ' N ' ' NH2' ' A' ' 27' ' ' ARG . . . -110.39 -122.28 4.37 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.102 -0.799 . . . . 1.0 111.102 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 8' ' ' TYR . 7.8 t -120.63 164.06 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.451 ' OH ' ' NZ ' ' A' ' 5' ' ' LYS . 67.9 m-85 -120.99 125.73 48.1 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.323 -0.398 . . . . 1.0 111.091 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.55 124.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.6 mmt -70.67 -66.47 0.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.659 -0.246 . . . . 1.0 111.544 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.3 t -137.99 173.57 11.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.069 0.461 . . . . 1.0 111.064 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.15 133.58 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 mt -112.64 114.2 49.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.115 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.54 163.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.98 1.786 . . . . 1.0 112.06 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 m120 68.18 19.02 9.24 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.971 0.794 . . . . 1.0 111.027 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.8 mmt -111.1 160.28 29.58 Favored Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.239 0.337 . . . . 1.0 111.116 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.73 -39.56 90.4 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.796 1.664 . . . . 1.0 112.954 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 22' ' ' LEU . . . -84.94 -12.5 53.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.01 0.433 . . . . 1.0 111.596 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.23 131.27 45.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.551 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.53 -14.53 64.81 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.111 -0.795 . . . . 1.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 68' ' ' ALA . 6.8 ptm85 -129.06 -23.45 3.03 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.912 0.387 . . . . 1.0 110.728 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 18' ' ' ALA . 23.1 tp -122.97 148.19 45.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.441 -0.8 . . . . 1.0 110.311 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -143.79 157.9 44.06 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.687 0.756 . . . . 1.0 111.197 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.8 136.19 56.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.62 -1.173 . . . . 1.0 109.075 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.56 10.2 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 110.066 -1.214 . . . . 1.0 110.066 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -71.02 146.04 49.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.283 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.586 ' NH2' ' N ' ' A' ' 6' ' ' GLY . 14.8 ptm180 -114.93 161.54 18.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.277 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -99.74 119.28 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.061 0.458 . . . . 1.0 110.303 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -93.6 -19.36 21.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.42 164.44 2.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.582 0.706 . . . . 1.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.6 mt -139.78 122.81 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.909 -1.041 . . . . 1.0 109.813 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 49.88 24.2 1.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.892 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.34 -6.12 61.18 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.801 -0.52 . . . . 1.0 111.801 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -93.0 107.88 28.17 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 116.887 0.344 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 136.42 71.03 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.905 1.737 . . . . 1.0 111.546 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.3 mm -102.84 113.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.68 0.752 . . . . 1.0 111.886 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 38' ' ' THR . 51.4 p30 -114.14 -20.65 10.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.586 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 56.4 p -134.6 160.34 38.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.015 0.436 . . . . 1.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.8 p -77.55 -27.61 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.052 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -67.8 -30.34 69.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -64.11 -27.45 69.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mm -78.06 -26.55 14.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -70.46 -41.79 78.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 123.536 0.522 . . . . 1.0 110.209 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.1 m -70.07 -39.29 75.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.307 0.575 . . . . 1.0 109.782 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.408 ' OH ' ' CG1' ' A' ' 55' ' ' VAL . 86.4 t80 -58.89 -55.74 31.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.888 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 m -55.45 -36.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 120.733 0.301 . . . . 1.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.655 ' NH2' HE22 ' A' ' 81' ' ' GLN . 30.1 mmt180 -65.58 -36.57 84.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.941 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -58.44 -43.41 88.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.013 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -93.29 149.8 20.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.309 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.58 ' CD ' ' H ' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -101.24 178.3 4.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.143 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.58 57.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.125 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.47 -1.87 82.35 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.782 -0.927 . . . . 1.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 24.4 t70 -71.95 175.93 5.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.826 0.345 . . . . 1.0 110.716 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.478 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -139.39 129.99 25.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' OH ' ' A' ' 45' ' ' TYR . 5.9 m -136.11 130.89 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.974 0.892 . . . . 1.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -80.85 106.51 12.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.286 -1.325 . . . . 1.0 108.968 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -97.07 143.46 12.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.599 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.1 m -109.75 138.88 45.48 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.536 0.522 . . . . 1.0 109.685 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -150.24 150.91 32.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.485 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.5 mp -107.88 134.06 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.672 0.749 . . . . 1.0 111.192 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -138.05 121.9 17.66 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 114.37 -1.287 . . . . 1.0 109.885 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 49.11 43.25 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.851 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 71.67 3.11 4.54 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.886 -0.143 . . . . 1.0 111.343 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -108.61 105.36 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.72 0.295 . . . . 1.0 110.946 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -78.26 138.68 38.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 1.0 111.011 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -148.43 145.24 27.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.641 -0.708 . . . . 1.0 110.992 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -89.89 132.88 35.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.246 -0.888 . . . . 1.0 110.343 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . . . -110.13 121.3 44.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.843 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.0 102.3 7.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.394 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -115.51 149.68 37.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.876 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.8 m -128.25 135.58 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.443 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -143.59 92.91 6.41 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.473 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.3 177.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.719 2.279 . . . . 1.0 112.424 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -109.65 148.3 37.86 Favored Pre-proline 0 N--CA 1.474 0.763 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.06 -30.84 76.23 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.103 1.869 . . . . 1.0 111.845 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -74.05 -33.5 63.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.965 0.412 . . . . 1.0 109.988 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -132.66 72.22 77.84 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.888 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.14 -20.69 68.95 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.231 1.954 . . . . 1.0 111.878 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -93.63 17.08 12.36 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.956 -0.387 . . . . 1.0 109.956 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.655 HE22 ' NH2' ' A' ' 47' ' ' ARG . 9.3 tp-100 -136.02 124.57 23.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.003 0.43 . . . . 1.0 110.094 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.757 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -84.97 -175.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.003 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.31 172.99 31.48 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 84' ' ' LEU . 3.6 mm? -78.24 -88.67 0.05 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.53 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -179.23 -11.12 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 N-CA-C 110.967 -0.853 . . . . 1.0 110.967 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.0 m -109.63 170.87 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.469 0.308 . . . . 1.0 110.262 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.218 -0.597 0 CA-C-O 118.029 -0.986 . . . . 1.0 111.051 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' ASN . 83.1 mmm . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' MET . 65.9 m-80 57.54 118.72 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.777 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 50.39 64.36 1.83 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.108 0.48 . . . . 1.0 110.694 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.74 166.66 11.56 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -134.7 -112.1 0.21 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' A' ' 8' ' ' TYR . . . 108.73 111.32 3.45 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.575 -0.61 . . . . 1.0 111.575 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.2 96.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 6' ' ' GLY . 4.1 m-85 -60.72 114.01 2.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.528 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -79.54 131.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.906 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.9 ttt -81.27 -72.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 111.692 0.256 . . . . 1.0 111.692 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -129.71 162.0 29.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.17 0.51 . . . . 1.0 111.209 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.64 131.5 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.307 -0.861 . . . . 1.0 108.915 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 13' ' ' LEU . 4.2 mm? -89.09 115.2 62.99 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.771 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.04 -19.94 12.69 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.976 1.784 . . . . 1.0 112.246 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -99.19 22.28 10.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.653 -0.248 . . . . 1.0 110.982 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 mmt -121.04 159.05 50.93 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.683 -0.235 . . . . 1.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.85 -22.05 66.63 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.485 2.123 . . . . 1.0 112.772 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.11 -14.23 59.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.833 0.349 . . . . 1.0 111.671 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 132.74 48.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.915 0.388 . . . . 1.0 110.407 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.98 27.97 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -104.92 -41.49 5.6 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.15 156.63 31.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.34 155.95 48.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.101 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.21 134.29 56.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.311 -0.858 . . . . 1.0 109.469 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.37 -26.4 18.59 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.07 145.46 51.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.381 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -111.0 153.24 25.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.871 0.367 . . . . 1.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.43 119.62 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.861 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . -93.75 -16.95 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.99 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . 174.41 164.32 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.31 0.576 . . . . 1.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 45' ' ' TYR . 92.7 mt -135.93 125.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.625 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.419 ' OD2' ' CE1' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 49.97 17.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.15 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.95 -5.84 46.95 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.053 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -92.94 108.77 34.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.978 0.389 . . . . 1.0 111.318 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.04 133.28 52.32 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.219 1.946 . . . . 1.0 111.551 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mm -102.16 116.7 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.649 0.738 . . . . 1.0 111.855 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 38' ' ' THR . 48.9 p30 -107.92 -23.52 12.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.579 -1.191 . . . . 1.0 111.409 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.467 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 69.2 p -137.21 155.26 49.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.034 0.445 . . . . 1.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.2 p -68.73 -32.81 72.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.484 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -61.94 -30.87 71.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.264 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -61.99 -30.01 70.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.318 -0.553 . . . . 1.0 109.946 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.6 -29.63 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.547 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.65 -43.68 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.268 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -65.17 -42.51 93.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.419 ' CE1' ' OD2' ' A' ' 32' ' ' ASP . 64.8 t80 -57.61 -57.1 14.21 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.325 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.96 -40.93 47.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -65.97 -20.81 66.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -61.85 -56.19 21.98 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.71 -163.41 1.02 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.961 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.46 -171.62 3.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.343 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 134.72 53.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.141 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.52 63.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.42 161.79 25.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.831 0.348 . . . . 1.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -127.5 122.35 33.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.62 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.997 0.904 . . . . 1.0 111.535 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -83.34 116.34 22.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.401 -1.272 . . . . 1.0 109.033 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.0 t -107.41 131.14 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.95 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.4 m -101.48 133.4 46.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.47 ' C ' HD12 ' A' ' 60' ' ' ILE . 32.4 p90 -147.83 152.19 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.47 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -109.67 139.47 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.389 0.614 . . . . 1.0 110.651 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -142.84 121.85 12.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.192 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 52.39 40.82 30.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 69.1 13.37 8.69 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.332 0.395 . . . . 1.0 111.363 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -114.16 109.0 17.73 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -77.27 131.52 38.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.0 111.278 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -146.07 144.47 30.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.949 -0.568 . . . . 1.0 111.037 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 40.6 mp0 -90.89 137.46 32.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.649 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 120.21 41.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.321 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.86 101.44 9.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.93 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tt -110.95 140.99 44.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.959 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.85 131.97 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.456 0.645 . . . . 1.0 110.651 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -65.71 121.99 16.25 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.641 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -132.23 124.53 19.39 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.19 -177.0 3.36 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.824 2.349 . . . . 1.0 112.565 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -118.75 144.6 35.88 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.275 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.27 -36.43 16.33 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.997 1.798 . . . . 1.0 111.934 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -70.42 -39.16 74.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.066 0.46 . . . . 1.0 110.119 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -139.9 74.05 32.48 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 115.708 -0.678 . . . . 1.0 110.715 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.07 -23.34 60.34 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.658 2.239 . . . . 1.0 111.703 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -59.34 -17.36 28.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.748 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' C ' HD13 ' A' ' 82' ' ' ILE . 66.5 tp60 -111.97 147.61 35.54 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 121.171 0.51 . . . . 1.0 109.877 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.671 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -94.05 179.62 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.418 -0.81 . . . . 1.0 110.602 -179.034 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.71 130.0 36.44 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.402 -0.679 . . . . 1.0 111.402 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.63 -17.94 20.06 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.719 0.295 . . . . 1.0 110.692 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.61 -94.45 0.34 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.74 -0.544 . . . . 1.0 111.74 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.42 172.2 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.489 0.316 . . . . 1.0 110.68 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.108 -0.949 . . . . 1.0 110.967 -178.91 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -102.33 123.07 45.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.78 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 6.2 p -45.67 164.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.097 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.538 ' N ' HG22 ' A' ' 9' ' ' VAL . 25.1 mmt -104.87 -70.27 0.78 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.609 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.9 t -156.2 175.26 14.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.712 0.291 . . . . 1.0 110.95 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.8 105.91 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.8 mt -93.71 143.96 27.41 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.857 -0.156 . . . . 1.0 110.889 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -72.9 156.42 52.55 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.159 1.906 . . . . 1.0 112.274 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.13 32.36 21.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.864 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 6.3 mtt -122.32 152.39 60.76 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 110.506 -0.183 . . . . 1.0 110.506 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.01 -16.88 57.39 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.534 2.156 . . . . 1.0 112.932 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 -24.03 27.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.96 0.409 . . . . 1.0 111.222 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 131.06 45.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.818 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.04 -21.21 35.3 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.59 -43.94 4.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.788 0.328 . . . . 1.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.646 HD13 ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -116.29 140.45 49.31 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.646 ' H ' HD13 ' A' ' 22' ' ' LEU . 61.5 mm-40 -131.53 159.21 38.83 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.301 0.572 . . . . 1.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.59 133.31 50.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.273 -0.876 . . . . 1.0 109.805 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.626 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 110.07 -23.1 21.96 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.418 ' OD1' ' NE ' ' A' ' 61' ' ' ARG . 36.3 m-20 -79.36 144.47 34.15 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.025 -0.103 . . . . 1.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 -110.34 161.4 15.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.921 0.391 . . . . 1.0 110.787 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -98.05 115.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.434 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.87 -14.89 28.94 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.12 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 177.93 168.06 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.249 0.547 . . . . 1.0 111.161 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.0 125.94 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.79 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 47.79 22.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.0 111.176 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -6.87 57.29 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.992 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -87.39 126.4 62.43 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.417 -0.325 . . . . 1.0 111.161 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.54 126.66 8.41 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.589 1.526 . . . . 1.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.463 HG21 HD11 ' A' ' 42' ' ' ILE . 29.9 mm -100.62 120.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.731 0.777 . . . . 1.0 111.933 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -116.13 -19.32 10.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.455 -1.248 . . . . 1.0 111.142 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -133.32 155.9 48.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.179 0.514 . . . . 1.0 111.093 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -71.68 -32.33 67.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.454 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -65.01 -32.45 74.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.584 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -58.86 -30.31 67.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.619 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.463 HD11 HG21 ' A' ' 36' ' ' ILE . 50.4 mm -72.16 -29.09 31.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.332 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.11 -40.02 84.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 O-C-N 123.29 0.369 . . . . 1.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.1 p -69.48 -40.86 76.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.337 0.589 . . . . 1.0 109.551 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -56.37 -56.79 16.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.56 -36.29 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 1.0 110.455 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -57.79 -41.57 82.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.293 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.71 -42.88 98.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.493 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -89.32 154.29 20.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.171 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.48 -176.17 2.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.985 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.68 138.91 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.214 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.38 0.87 81.95 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 29.7 t70 -74.67 179.62 4.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.087 0.47 . . . . 1.0 110.568 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 80.7 ttt180 -139.56 123.4 17.58 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.87 134.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.777 0.799 . . . . 1.0 111.821 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.48 122.61 32.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.502 -1.226 . . . . 1.0 108.601 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.6 t -116.17 130.3 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.0 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.7 m -96.95 136.11 37.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.308 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.489 ' C ' HD12 ' A' ' 60' ' ' ILE . 22.9 p90 -146.62 151.32 37.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -112.62 137.15 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.103 0.478 . . . . 1.0 110.356 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 17.7 ttm180 -136.66 120.48 17.42 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.789 -0.642 . . . . 1.0 109.467 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 49.97 39.42 18.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.782 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 73.33 12.64 4.77 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.53 0.196 . . . . 1.0 111.53 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -110.74 100.25 9.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.738 0.304 . . . . 1.0 110.395 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.17 127.62 33.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.47 0.652 . . . . 1.0 111.711 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.07 141.2 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.774 -0.648 . . . . 1.0 111.139 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.03 146.17 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.616 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.98 130.91 53.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.077 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 70' ' ' LEU . 77.3 tt0 -92.23 105.39 17.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.476 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.5 mp -111.3 146.33 37.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.045 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.88 130.21 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.59 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -66.11 132.91 49.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp . . . . . 0 CA--C 1.55 0.961 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.802 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t . . . . . 0 N--CA 1.471 0.614 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.11 133.81 54.26 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.988 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.99 120.81 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.943 -0.392 . . . . 1.0 109.943 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.52 -69.13 0.5 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.028 -0.269 . . . . 1.0 111.657 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.1 p -128.4 165.34 20.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.044 0.45 . . . . 1.0 111.03 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.29 122.15 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.87 153.24 52.12 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.757 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 152.63 64.7 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.611 2.207 . . . . 1.0 112.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 52.61 45.15 29.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.519 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.8 mmt -121.17 154.18 58.39 Favored Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.013 0.196 . . . . 1.0 110.706 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HD3' ' HZ1' ' A' ' 73' ' ' LYS . 28.2 Cg_endo -62.05 -19.34 65.92 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.339 2.026 . . . . 1.0 112.869 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -89.63 -24.01 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.844 0.354 . . . . 1.0 111.484 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.23 141.37 52.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.627 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -22.73 14.03 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.4 -34.01 4.44 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.533 HD13 ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -118.55 139.79 50.9 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.934 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' H ' HD13 ' A' ' 22' ' ' LEU . 97.0 mt-10 -130.18 152.65 49.38 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.511 0.672 . . . . 1.0 110.964 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.06 139.92 53.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.33 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.49 -28.88 13.19 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.206 -1.157 . . . . 1.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 61' ' ' ARG . 80.5 m-20 -70.75 147.02 49.45 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.294 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -114.58 159.71 20.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.891 0.377 . . . . 1.0 110.351 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.7 mm -97.55 118.75 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.396 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.27 -15.9 25.32 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.786 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.95 163.5 0.81 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.139 0.495 . . . . 1.0 111.076 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 98.1 mt -138.29 129.09 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.87 0.843 . . . . 1.0 110.713 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.83 15.33 0.23 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.11 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.75 -5.84 43.77 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.376 -0.375 . . . . 1.0 112.234 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -94.35 134.41 25.64 Favored Pre-proline 0 CA--C 1.556 1.175 0 CA-C-N 117.174 0.487 . . . . 1.0 110.76 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.14 134.82 13.25 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.848 1.699 . . . . 1.0 111.937 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 42' ' ' ILE . 23.9 mm -102.81 116.18 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.633 0.73 . . . . 1.0 111.36 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -110.86 -26.84 9.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.502 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 p -136.99 165.34 26.22 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.168 0.509 . . . . 1.0 110.901 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -66.5 -33.62 76.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.372 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.37 -39.14 89.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 1.0 110.405 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -51.44 -39.13 56.76 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.473 -0.491 . . . . 1.0 109.868 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 36' ' ' ILE . 50.0 mm -62.72 -34.71 67.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 121.233 -0.187 . . . . 1.0 111.031 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.62 -44.48 99.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.735 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 p -58.36 -43.55 88.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.544 0.688 . . . . 1.0 110.542 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.3 -57.6 12.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.191 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 45' ' ' TYR . 97.6 t -52.59 -40.3 33.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.95 0.405 . . . . 1.0 110.298 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -37.49 80.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.386 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.45 -48.04 82.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.798 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -89.31 175.02 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.171 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 51' ' ' ALA . 17.8 pt20 -155.41 125.32 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.705 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -2.69 124.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 125.73 1.894 . . . . 1.0 110.414 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.57 -6.53 49.24 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.609 -1.397 . . . . 1.0 109.609 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 20.6 t70 -83.89 177.22 8.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.851 0.358 . . . . 1.0 110.872 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 58.7 mtp180 -146.59 123.48 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.566 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.0 m -130.99 131.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 122.225 1.012 . . . . 1.0 111.674 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.635 ' H ' ' HE ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -75.05 116.96 16.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.763 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.65 134.92 43.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.837 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 m -101.81 133.38 46.65 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.462 ' CD1' HD21 ' A' ' 22' ' ' LEU . 31.5 p90 -146.5 150.14 34.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -108.77 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.422 0.629 . . . . 1.0 110.759 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' A' ' 26' ' ' ASP . 40.6 ttm-85 -138.04 121.27 16.92 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.598 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 53.29 39.82 30.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.932 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 69.81 10.13 7.41 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.484 0.49 . . . . 1.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -110.34 106.53 15.93 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.497 HE21 ' C ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.01 127.7 33.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.257 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -142.0 144.58 33.73 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.04 140.75 29.54 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.504 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.72 125.81 51.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.828 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.433 ' C ' HD22 ' A' ' 70' ' ' LEU . 38.7 tp10 -79.97 102.84 9.46 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.839 -1.073 . . . . 1.0 109.948 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.433 HD22 ' C ' ' A' ' 69' ' ' GLU . 4.4 mm? -110.29 142.63 41.64 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.484 0.659 . . . . 1.0 110.667 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.09 134.32 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.375 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -71.6 129.48 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.979 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HZ1' ' HD3' ' A' ' 17' ' ' PRO . 14.0 ptpt . . . . . 0 CA--C 1.552 1.03 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.096 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 38.2 t . . . . . 0 C--O 1.217 -0.629 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' VAL . 32.7 m-85 -126.97 132.17 50.89 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.647 0.261 . . . . 1.0 110.671 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.645 HG21 HD12 ' A' ' 22' ' ' LEU . 41.4 t -44.47 170.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.53 ' N ' HG12 ' A' ' 9' ' ' VAL . 35.5 tpp -95.11 -65.28 0.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.392 -0.193 . . . . 1.0 111.231 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -155.15 173.84 16.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.266 -0.573 . . . . 1.0 111.095 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 t -118.03 100.74 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASN . 9.7 mp -99.86 117.93 62.63 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.84 -0.6 . . . . 1.0 110.323 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.77 49.36 0.04 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.112 2.541 . . . . 1.0 112.838 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 58.4 t30 -171.18 8.89 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.009 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.401 ' H ' ' H ' ' A' ' 15' ' ' ASN . 16.6 mmt -107.9 155.66 39.54 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 120.566 0.222 . . . . 1.0 110.507 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.83 -23.65 73.02 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.273 1.982 . . . . 1.0 113.406 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -88.4 -13.06 41.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.163 0.506 . . . . 1.0 110.819 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.57 113.87 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.712 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.46 -11.87 63.22 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -113.28 -36.65 4.95 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.017 0.437 . . . . 1.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.645 HD12 HG21 ' A' ' 9' ' ' VAL . 1.1 mm? -123.31 149.9 44.26 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.707 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -139.63 155.06 47.65 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.298 -0.865 . . . . 1.0 110.873 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 131.97 52.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.651 -1.159 . . . . 1.0 108.945 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.06 -25.48 12.72 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.032 -1.227 . . . . 1.0 110.032 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.47 ' OD1' ' NH2' ' A' ' 61' ' ' ARG . 97.1 m-20 -79.29 153.16 30.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.577 0.227 . . . . 1.0 110.437 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 26.7 ptt180 -123.25 165.24 17.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -99.38 122.65 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.374 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -98.91 -22.62 15.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.37 159.04 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.391 0.615 . . . . 1.0 111.624 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.1 mt -136.64 122.41 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.037 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 t0 51.5 23.38 1.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.146 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.09 -6.78 58.38 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -90.01 122.27 67.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 122.625 -0.338 . . . . 1.0 111.162 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.33 133.32 17.51 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.693 1.595 . . . . 1.0 111.485 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mm -100.18 111.15 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.689 0.757 . . . . 1.0 112.257 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -110.85 -16.73 13.49 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.322 -1.308 . . . . 1.0 111.302 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.8 p -141.8 155.01 45.59 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.048 0.451 . . . . 1.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -68.9 -26.01 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.441 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -66.88 -32.72 74.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.493 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -59.99 -29.9 68.76 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.772 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.09 -27.37 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.749 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.26 -44.49 77.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.484 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.2 p -68.81 -42.2 77.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.489 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -58.78 -52.82 64.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.678 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.12 -40.76 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.99 -39.25 94.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.354 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.54 -55.16 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.345 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -80.98 146.52 30.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.138 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -97.52 177.57 5.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.494 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 136.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.758 . . . . 1.0 110.076 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.07 -3.64 70.26 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 33.7 t70 -73.59 170.45 15.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.082 0.468 . . . . 1.0 111.007 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 40.2 ptt85 -138.2 131.68 30.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.169 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.35 131.64 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.854 0.835 . . . . 1.0 111.877 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -75.51 109.26 8.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.615 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.92 138.06 25.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.448 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.1 m -107.11 140.83 39.32 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.476 ' CD1' HD21 ' A' ' 22' ' ' LEU . 35.0 p90 -148.79 152.78 37.14 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.5 mp -107.17 135.54 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 121.695 0.76 . . . . 1.0 111.62 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.47 ' NH2' ' OD1' ' A' ' 26' ' ' ASP . 44.5 ttm-85 -140.83 122.09 14.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 114.543 -1.208 . . . . 1.0 109.621 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 46.25 49.09 12.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 64.05 9.37 4.6 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.554 0.534 . . . . 1.0 111.758 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -113.92 105.89 13.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.63 0.252 . . . . 1.0 110.636 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -80.01 146.23 32.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 111.176 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -153.48 145.51 23.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.968 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -89.93 129.88 36.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.445 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.1 128.24 55.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.992 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' C ' HD22 ' A' ' 70' ' ' LEU . 42.4 tp10 -80.37 102.74 9.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 1.0 109.928 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 18' ' ' ALA . 4.4 mm? -111.05 145.55 38.3 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.234 0.54 . . . . 1.0 110.791 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.81 132.55 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.39 128.68 36.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.493 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt . . . . . 0 CA--C 1.551 0.997 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.746 -179.461 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 120.783 0.325 . . . . 1.0 110.276 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -133.87 139.76 46.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.834 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -74.47 125.63 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.031 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.4 mtt -84.8 -64.37 1.17 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.425 0.155 . . . . 1.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -123.08 149.73 44.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.279 0.561 . . . . 1.0 111.159 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.56 133.47 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 10.9 mp -93.47 150.56 39.11 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.797 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.04 -27.76 16.81 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.565 2.176 . . . . 1.0 112.788 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.57 39.91 2.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.0 162.44 21.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 123.189 0.306 . . . . 1.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.29 -33.68 94.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.262 1.975 . . . . 1.0 112.972 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.05 -11.61 54.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.743 0.306 . . . . 1.0 111.636 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 13' ' ' LEU . . . -66.74 135.22 53.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.665 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.9 -16.37 51.37 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.84 -33.86 4.65 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.327 -0.249 . . . . 1.0 110.327 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' OD2' ' A' ' 26' ' ' ASP . 14.1 tp -122.63 152.66 40.25 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.294 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 60.9 mm-40 -139.42 154.33 47.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.599 0.714 . . . . 1.0 111.087 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.15 139.02 53.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.32 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -29.69 8.93 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.209 -1.156 . . . . 1.0 110.209 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.491 ' OD2' HD11 ' A' ' 22' ' ' LEU . 1.7 p-10 -69.69 149.52 47.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.807 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.4 158.79 21.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.903 0.382 . . . . 1.0 110.445 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.7 mm -100.04 119.98 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.011 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.65 -21.94 19.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.86 163.06 2.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.109 0.48 . . . . 1.0 111.528 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 33' ' ' GLY . 89.1 mt -136.79 126.53 38.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 122.294 1.045 . . . . 1.0 110.872 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t0 51.05 11.2 0.09 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.591 -0.693 . . . . 1.0 111.405 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . 111.06 -6.48 28.99 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.986 -0.341 . . . . 1.0 112.312 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 0.4 OUTLIER -94.9 110.6 50.64 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 117.239 0.519 . . . . 1.0 111.789 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.78 136.15 73.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.266 1.311 . . . . 1.0 111.522 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.79 115.64 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.597 0.713 . . . . 1.0 111.429 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -112.45 -20.22 11.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.253 -1.339 . . . . 1.0 110.963 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.8 p -135.18 151.29 50.52 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.041 0.448 . . . . 1.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.0 p -69.55 -29.66 67.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.54 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.02 -29.47 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.648 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -63.4 -28.62 70.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.078 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.35 -28.35 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.706 -0.224 . . . . 1.0 111.257 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.96 -40.98 76.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.034 0.445 . . . . 1.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.9 m -69.71 -41.1 75.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 1.0 109.595 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.49 -56.28 23.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.727 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.02 -33.55 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.302 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -64.35 -40.13 95.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.506 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -57.76 -50.25 73.86 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.666 -0.413 . . . . 1.0 110.321 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -81.6 149.09 28.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.36 -179.43 3.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.311 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 135.69 55.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.964 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.5 -0.21 65.42 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.411 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 35.5 t70 -78.06 171.05 15.6 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.877 0.37 . . . . 1.0 110.935 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 82.2 mtp180 -139.3 125.21 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.98 132.73 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.943 0.878 . . . . 1.0 111.646 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -81.02 113.46 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.093 -1.412 . . . . 1.0 108.748 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.95 132.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.644 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.8 m -101.17 137.71 39.16 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.436 ' C ' HD12 ' A' ' 60' ' ' ILE . 32.7 p90 -150.28 152.18 34.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -106.51 138.54 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.41 0.624 . . . . 1.0 111.04 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -143.73 123.8 13.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.719 -1.128 . . . . 1.0 109.964 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 50.64 43.01 27.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.817 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 67.08 9.59 7.04 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.822 0.449 . . . . 1.0 111.841 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -115.46 106.54 14.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.919 0.39 . . . . 1.0 110.654 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' ' NE2' ' A' ' 65' ' ' GLN . 5.0 pp0? -74.13 138.52 43.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.383 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -149.16 144.28 26.5 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.362 -0.836 . . . . 1.0 111.269 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.68 136.52 32.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.037 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.18 122.55 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' HD12 ' A' ' 70' ' ' LEU . 51.3 mt-10 -84.36 102.04 12.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.933 -1.03 . . . . 1.0 110.026 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.8 mp -111.79 150.18 30.68 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.195 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 53' ' ' ASP . 9.9 p -122.29 131.77 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.292 -0.867 . . . . 1.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.66 129.51 40.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.813 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt . . . . . 0 CA--C 1.551 0.992 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.104 179.724 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.236 0.541 . . . . 1.0 111.126 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -58.96 134.36 56.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.239 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.629 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 7.5 p -46.35 160.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.829 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' HG22 ' A' ' 9' ' ' VAL . 26.1 ttt -103.21 -62.29 1.3 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.857 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 m -151.94 154.36 35.93 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.156 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 t -122.45 101.94 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 13' ' ' LEU . 3.9 mm? -74.83 135.02 74.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.414 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.3 -20.95 42.09 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 122.32 2.013 . . . . 1.0 112.782 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -107.18 33.62 3.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.81 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.17 165.35 19.4 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.03 0.206 . . . . 1.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.491 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.2 Cg_exo -68.38 -16.6 43.7 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.403 2.069 . . . . 1.0 112.933 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.91 36.85 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.101 -0.375 . . . . 1.0 111.856 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.79 137.62 57.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.985 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.75 39.1 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.254 -0.738 . . . . 1.0 111.254 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.491 ' NH2' ' O ' ' A' ' 17' ' ' PRO . 36.0 mtm180 -113.69 -34.23 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.482 0.313 . . . . 1.0 110.806 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 mt -123.54 154.01 39.81 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.05 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -138.94 154.02 48.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.104 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.83 139.8 55.95 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.301 -0.863 . . . . 1.0 109.398 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.629 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 104.6 -26.31 23.0 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 26' ' ' ASP . 2.4 m-20 -67.49 145.35 55.05 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.937 -0.305 . . . . 1.0 110.253 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -109.09 153.39 23.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.726 0.298 . . . . 1.0 110.386 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.7 mm -96.16 118.01 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.095 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . -90.75 -16.24 28.77 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.808 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . 171.12 163.67 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.243 0.544 . . . . 1.0 110.965 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.93 126.75 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.774 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 50.77 20.68 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.036 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.0 56.31 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.852 -0.499 . . . . 1.0 111.852 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -92.85 126.33 51.96 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.961 0.381 . . . . 1.0 111.454 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.91 135.21 17.19 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.826 1.684 . . . . 1.0 111.468 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.66 115.75 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.865 0.84 . . . . 1.0 112.216 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -107.12 -23.27 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.09 -1.414 . . . . 1.0 111.161 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -134.86 154.28 51.71 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.165 0.507 . . . . 1.0 111.142 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -69.95 -33.73 72.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.337 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -62.51 -28.46 69.86 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -63.47 -30.27 71.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.628 -0.429 . . . . 1.0 109.919 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.54 -29.95 36.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 116.743 -0.208 . . . . 1.0 111.278 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.36 -42.21 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.461 . . . . 1.0 110.213 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -65.13 -40.39 94.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.161 0.505 . . . . 1.0 109.868 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.94 -57.68 11.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.895 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.0 m -55.16 -39.94 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.826 0.346 . . . . 1.0 110.202 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -40.95 94.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.72 -47.0 70.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.378 . . . . 1.0 110.46 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -81.5 -173.45 4.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.87 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' ALA . 40.3 tt0 -130.91 171.45 13.17 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.985 0.422 . . . . 1.0 110.834 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' A' ' 50' ' ' GLN . . . -64.83 136.28 56.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.771 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.3 -0.83 81.67 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.391 -1.084 . . . . 1.0 110.391 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 36.9 t70 -71.54 179.51 2.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.804 0.335 . . . . 1.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.498 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 87.4 mtm180 -138.47 123.55 19.08 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.5 130.98 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 122.06 0.933 . . . . 1.0 112.112 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -85.96 118.89 25.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.961 -1.472 . . . . 1.0 109.084 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -108.55 134.42 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.544 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.5 m -104.62 132.63 50.64 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.26 153.37 37.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.3 138.52 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.215 0.531 . . . . 1.0 110.341 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -141.31 121.78 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.304 -0.862 . . . . 1.0 109.444 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 54.37 39.6 31.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.34 -0.846 . . . . 1.0 110.873 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 68.92 9.09 7.21 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 123.161 0.288 . . . . 1.0 111.66 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -108.87 116.72 32.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.96 0.409 . . . . 1.0 110.131 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.9 128.58 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.887 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -144.18 139.12 28.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.27 0.557 . . . . 1.0 111.105 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.84 138.56 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.32 117.0 31.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.868 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' CD ' HH11 ' A' ' 21' ' ' ARG . 3.3 pt-20 -77.47 103.54 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.142 -0.935 . . . . 1.0 109.2 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.23 146.22 39.69 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.73 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.06 134.68 63.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.655 -1.157 . . . . 1.0 110.077 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -66.55 125.49 25.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.447 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.7 tttt . . . . . 0 CA--C 1.55 0.978 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.435 -179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 8' ' ' TYR . 36.0 t . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.824 0.345 . . . . 1.0 110.397 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.571 ' N ' HG12 ' A' ' 7' ' ' VAL . 97.4 m-85 -130.2 140.37 50.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.71 128.02 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.4 ttt -78.03 -64.74 1.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.194 -0.316 . . . . 1.0 111.723 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -133.6 160.77 36.49 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.031 0.443 . . . . 1.0 111.535 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.6 136.52 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.99 148.91 38.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 O-C-N 123.42 0.45 . . . . 1.0 111.854 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' SD ' ' A' ' 16' ' ' MET . 74.4 Cg_endo -73.23 157.43 50.17 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.288 1.992 . . . . 1.0 111.351 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 64.15 28.0 14.07 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.296 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -106.59 157.94 33.91 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-O 120.748 0.309 . . . . 1.0 110.357 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 -19.55 64.16 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.157 1.905 . . . . 1.0 112.979 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 22' ' ' LEU . . . -100.25 -17.72 17.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.65 0.738 . . . . 1.0 111.091 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.32 129.57 42.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.819 -1.082 . . . . 1.0 109.337 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.33 -7.94 62.2 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -134.27 -24.36 1.62 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.826 0.346 . . . . 1.0 110.537 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -117.41 134.07 55.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.011 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 97.5 mt-10 -134.45 148.0 50.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.549 0.69 . . . . 1.0 110.405 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.2 136.89 48.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.931 -1.032 . . . . 1.0 109.483 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.62 -26.63 13.95 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 2.8 p-10 -64.78 145.0 56.86 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.72 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -109.69 142.22 41.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.933 0.397 . . . . 1.0 109.979 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.23 122.26 43.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.569 -0.742 . . . . 1.0 109.191 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.552 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -94.54 -22.45 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.125 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.02 154.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.2 mt -129.55 125.46 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.878 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 17.12 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.529 -0.76 . . . . 1.0 111.013 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.73 -5.29 47.17 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.72 -0.552 . . . . 1.0 111.72 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -95.19 111.19 54.06 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.026 0.413 . . . . 1.0 111.486 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.18 136.45 74.81 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 122.326 2.017 . . . . 1.0 111.484 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.69 106.37 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.578 0.704 . . . . 1.0 111.805 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -102.68 -25.02 13.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.605 -1.18 . . . . 1.0 111.419 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -140.53 160.18 40.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.078 0.466 . . . . 1.0 111.051 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -67.39 -23.04 65.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.103 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -66.01 -32.96 74.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.209 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -61.55 -31.35 71.37 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.511 -0.476 . . . . 1.0 109.82 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.43 -27.96 19.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 CA-C-O 120.983 0.421 . . . . 1.0 110.485 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.52 -42.74 83.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.734 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 59.2 p -64.21 -39.73 94.58 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' CE1' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -58.23 -56.21 24.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.505 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.82 -44.0 76.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.946 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -69.62 -35.79 75.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.68 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.42 -62.53 1.59 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.224 -0.287 . . . . 1.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.32 -169.21 2.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.635 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -131.91 176.37 8.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.676 0.75 . . . . 1.0 112.039 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.62 134.84 57.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.889 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.5 -0.78 74.89 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.441 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 19.3 t0 -68.62 169.95 10.17 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.888 0.375 . . . . 1.0 111.16 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 76.4 mtp180 -140.73 117.75 11.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.449 HG21 ' CE1' ' A' ' 45' ' ' TYR . 6.7 m -129.23 135.14 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.855 0.836 . . . . 1.0 111.88 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.434 ' NH1' ' OE2' ' A' ' 69' ' ' GLU . 83.9 mmt-85 -76.75 105.84 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.31 -1.314 . . . . 1.0 108.786 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.0 t -95.06 135.21 29.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.561 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.9 m -104.97 137.52 42.6 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.9 150.96 32.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.4 mp -103.12 137.67 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.741 0.781 . . . . 1.0 111.706 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -143.34 117.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.465 -1.243 . . . . 1.0 110.175 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 52.84 44.77 29.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.251 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 66.67 8.31 5.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.706 -0.225 . . . . 1.0 111.335 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -111.92 113.34 25.61 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 51.1 mt-30 -75.79 146.23 40.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.401 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.413 ' CG ' ' O ' ' A' ' 65' ' ' GLN . 98.2 m-70 -156.53 140.94 16.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.979 0.419 . . . . 1.0 110.817 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.99 128.69 36.91 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.85 123.88 49.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.401 0.619 . . . . 1.0 110.471 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.438 ' C ' HD12 ' A' ' 70' ' ' LEU . 42.6 tp10 -78.74 100.54 7.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.041 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.3 mp -114.83 149.24 37.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.462 0.649 . . . . 1.0 110.846 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -136.13 137.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 114.755 -1.112 . . . . 1.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 mt -61.16 120.44 10.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.995 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt . . . . . 0 CA--C 1.552 1.027 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.872 -179.628 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.468 0.441 0 CA-C-O 120.783 0.325 . . . . 1.0 110.383 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.65 129.51 36.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.961 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.34 127.75 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.179 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 11.0 tpt -75.84 -53.04 9.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.186 -0.321 . . . . 1.0 111.278 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.1 p -148.05 165.26 31.33 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.015 0.436 . . . . 1.0 111.365 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.59 135.28 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.19 153.08 39.81 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.434 0.459 . . . . 1.0 111.176 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.64 158.75 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.558 2.172 . . . . 1.0 111.88 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.6 t30 56.27 32.45 20.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.405 -0.816 . . . . 1.0 111.116 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.9 mmm -106.88 161.13 23.87 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.174 0.296 . . . . 1.0 110.882 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.32 -30.43 91.03 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.343 2.029 . . . . 1.0 112.821 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.432 ' HB2' HD22 ' A' ' 70' ' ' LEU . . . -97.85 -14.43 20.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.922 0.391 . . . . 1.0 111.465 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 122.66 14.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.65 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.71 -8.22 65.85 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -119.73 -25.66 5.86 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.238 0.542 . . . . 1.0 110.538 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.604 HD22 ' OD2' ' A' ' 26' ' ' ASP . 14.2 mt -140.03 170.62 15.52 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.743 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 mt-10 -156.06 165.01 37.7 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.377 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.85 137.71 57.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.498 -1.228 . . . . 1.0 109.025 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.81 14.72 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.604 ' OD2' HD22 ' A' ' 22' ' ' LEU . 7.6 p-10 -72.64 154.04 40.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.791 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -121.81 151.42 40.63 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -96.69 129.24 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.78 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.5 -27.29 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.85 151.03 2.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 1.0 111.409 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.84 123.6 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.166 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.2 t0 56.59 17.16 2.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.962 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.27 42.3 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.927 -0.469 . . . . 1.0 111.927 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -96.2 110.45 52.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 119.379 -0.344 . . . . 1.0 111.399 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.88 137.53 81.45 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.336 2.024 . . . . 1.0 111.394 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mm -97.75 106.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.575 0.702 . . . . 1.0 111.744 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -104.22 -21.52 13.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.8 p -144.3 161.01 40.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.993 0.425 . . . . 1.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.0 p -66.86 -23.85 66.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.353 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.21 -34.1 77.57 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.071 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -59.95 -33.34 71.78 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.775 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -71.92 -28.16 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.942 0.401 . . . . 1.0 110.547 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.02 -42.98 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.909 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 t -62.75 -41.43 99.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.789 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -58.18 8.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.883 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.42 -43.0 81.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -62.85 -44.36 96.34 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.959 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -60.15 -58.09 10.02 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 1.0 110.25 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -81.49 170.94 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.382 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -136.41 -172.24 3.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.126 0.489 . . . . 1.0 111.42 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 129.73 40.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.143 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.39 -8.73 64.57 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 71' ' ' VAL . 20.2 t70 -70.81 174.61 5.84 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.975 0.417 . . . . 1.0 111.155 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.447 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 83.7 mtt85 -145.14 127.89 16.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.93 132.9 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.905 0.86 . . . . 1.0 111.862 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -78.12 103.01 7.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.272 -1.331 . . . . 1.0 108.496 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.1 t -95.42 135.49 29.33 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.051 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.5 m -105.08 138.87 40.62 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CD2' HD21 ' A' ' 22' ' ' LEU . 36.0 p90 -148.92 155.15 40.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.5 mp -110.19 134.59 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.629 0.728 . . . . 1.0 111.13 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -141.91 123.84 15.31 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.657 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 48.02 46.16 19.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.655 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 67.67 6.66 5.15 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.846 0.355 . . . . 1.0 110.606 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -112.29 116.12 29.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -90.55 143.21 26.97 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.91 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -152.34 148.49 27.56 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.839 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.99 127.08 36.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.632 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.93 124.54 49.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.446 0.641 . . . . 1.0 110.044 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.08 102.14 14.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.558 -1.201 . . . . 1.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 18' ' ' ALA . 36.3 mt -113.31 151.19 31.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.669 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 53' ' ' ASP . 2.9 t -124.07 130.64 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.019 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.2 mm? -56.67 120.16 7.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.134 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttp . . . . . 0 CA--C 1.551 1.014 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.547 -179.638 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 8' ' ' TYR . 21.5 t . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 120.699 0.285 . . . . 1.0 110.381 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.409 ' N ' HG12 ' A' ' 7' ' ' VAL . 50.7 m-85 -129.11 137.41 51.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.21 127.69 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.12 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.6 mtt -75.35 -65.46 0.89 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.733 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -128.94 160.87 31.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.166 0.507 . . . . 1.0 111.16 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -128.12 138.92 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.89 145.17 31.48 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 123.137 0.273 . . . . 1.0 111.121 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.08 -24.28 20.59 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.441 2.094 . . . . 1.0 112.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -99.05 17.93 18.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.639 -0.255 . . . . 1.0 111.159 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 27.8 mtt -113.17 158.53 37.83 Favored Pre-proline 0 N--CA 1.469 0.485 0 O-C-N 123.055 0.222 . . . . 1.0 110.9 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.66 -32.11 53.2 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.415 2.076 . . . . 1.0 113.295 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.78 57.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.685 0.279 . . . . 1.0 111.385 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.07 109.65 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.122 -0.631 . . . . 1.0 110.719 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.68 -14.83 64.59 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.232 -0.747 . . . . 1.0 111.232 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -108.11 -41.63 4.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.124 0.488 . . . . 1.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.47 156.84 40.04 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.484 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -144.29 158.1 43.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.157 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.81 56.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.421 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.2 18.15 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.247 -1.141 . . . . 1.0 110.247 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 150.68 42.63 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 122.782 -0.246 . . . . 1.0 110.63 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -114.61 154.58 28.11 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.161 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mm -97.35 120.14 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.024 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.47 19.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.6 158.72 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 1.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.75 125.03 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.105 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 51.22 21.72 1.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.124 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.33 57.81 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.617 -0.593 . . . . 1.0 111.617 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -89.93 124.85 62.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.75 -0.265 . . . . 1.0 111.254 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.4 132.8 15.28 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.981 1.787 . . . . 1.0 111.465 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -99.13 110.89 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.496 0.665 . . . . 1.0 112.433 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -115.53 -18.18 11.0 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.661 -1.154 . . . . 1.0 111.108 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -139.37 156.01 47.28 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.241 0.544 . . . . 1.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.1 m -66.28 -22.57 66.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.233 -0.894 . . . . 1.0 108.878 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.33 -35.34 77.63 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.523 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.482 ' H ' HG23 ' A' ' 38' ' ' THR . 69.6 tp60 -57.1 -31.71 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.859 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -74.79 -26.84 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.781 -0.191 . . . . 1.0 110.971 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.54 -41.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 1.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.2 t -65.62 -40.58 92.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.281 0.562 . . . . 1.0 109.944 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -58.18 -57.16 14.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.646 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' LYS . 29.0 m -58.55 -39.77 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.325 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -66.04 -37.61 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.707 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.77 -53.86 47.89 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.339 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 46' ' ' VAL . 72.1 mmtt -87.31 156.96 19.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.55 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.4 -178.18 3.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.295 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.27 135.91 55.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.177 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.82 -1.53 74.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 30.7 t70 -74.24 172.04 12.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.033 0.444 . . . . 1.0 110.879 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.0 mtp85 -141.76 130.04 22.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.078 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.63 133.51 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.892 0.854 . . . . 1.0 111.942 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.14 107.44 7.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.383 -1.28 . . . . 1.0 108.767 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.03 137.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.329 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -104.92 139.22 39.96 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.434 ' C ' HD12 ' A' ' 60' ' ' ILE . 34.4 p90 -150.31 151.87 33.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.5 mp -108.23 132.07 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.525 0.679 . . . . 1.0 111.472 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -138.58 124.24 19.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.4 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 49.58 43.82 24.15 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 115.291 -0.868 . . . . 1.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 70.43 -1.35 2.54 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.322 0.119 . . . . 1.0 111.322 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -107.42 106.06 16.28 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.529 0.204 . . . . 1.0 110.824 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -76.82 145.3 38.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.212 0.529 . . . . 1.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -153.88 146.09 23.8 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.327 -0.852 . . . . 1.0 111.052 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -89.12 132.11 34.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.543 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.94 124.62 52.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.91 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 39.1 mp0 -80.04 101.95 9.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.738 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tt -109.34 143.0 39.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.749 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.7 131.0 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.442 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.68 131.6 46.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.502 . . . . 1.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt . . . . . 0 CA--C 1.545 0.786 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.942 179.663 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 8' ' ' TYR . 7.8 t . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.412 ' N ' HG12 ' A' ' 7' ' ' VAL . 67.9 m-85 -120.99 125.73 48.1 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.323 -0.398 . . . . 1.0 111.091 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.55 124.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.6 mmt -70.67 -66.47 0.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.659 -0.246 . . . . 1.0 111.544 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.3 t -137.99 173.57 11.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.069 0.461 . . . . 1.0 111.064 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.15 133.58 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 mt -112.64 114.2 49.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.115 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.54 163.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.98 1.786 . . . . 1.0 112.06 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 m120 68.18 19.02 9.24 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.971 0.794 . . . . 1.0 111.027 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.8 mmt -111.1 160.28 29.58 Favored Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.239 0.337 . . . . 1.0 111.116 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.73 -39.56 90.4 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.796 1.664 . . . . 1.0 112.954 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 22' ' ' LEU . . . -84.94 -12.5 53.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.01 0.433 . . . . 1.0 111.596 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.23 131.27 45.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.551 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.53 -14.53 64.81 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.111 -0.795 . . . . 1.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 68' ' ' ALA . 6.8 ptm85 -129.06 -23.45 3.03 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.912 0.387 . . . . 1.0 110.728 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 18' ' ' ALA . 23.1 tp -122.97 148.19 45.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.441 -0.8 . . . . 1.0 110.311 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -143.79 157.9 44.06 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.687 0.756 . . . . 1.0 111.197 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.8 136.19 56.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.62 -1.173 . . . . 1.0 109.075 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.56 10.2 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 110.066 -1.214 . . . . 1.0 110.066 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -71.02 146.04 49.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.283 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -114.93 161.54 18.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.277 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -99.74 119.28 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.061 0.458 . . . . 1.0 110.303 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -93.6 -19.36 21.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.42 164.44 2.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.582 0.706 . . . . 1.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.6 mt -139.78 122.81 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.909 -1.041 . . . . 1.0 109.813 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 49.88 24.2 1.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.892 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.34 -6.12 61.18 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.801 -0.52 . . . . 1.0 111.801 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -93.0 107.88 28.17 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 116.887 0.344 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 136.42 71.03 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.905 1.737 . . . . 1.0 111.546 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.3 mm -102.84 113.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.68 0.752 . . . . 1.0 111.886 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.464 ' OD1' ' NE2' ' A' ' 41' ' ' GLN . 51.4 p30 -114.14 -20.65 10.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.586 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 56.4 p -134.6 160.34 38.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.015 0.436 . . . . 1.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.8 p -77.55 -27.61 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.052 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -67.8 -30.34 69.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.464 ' NE2' ' OD1' ' A' ' 37' ' ' ASN . 16.0 mt-30 -64.11 -27.45 69.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mm -78.06 -26.55 14.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -70.46 -41.79 78.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 123.536 0.522 . . . . 1.0 110.209 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.1 m -70.07 -39.29 75.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.307 0.575 . . . . 1.0 109.782 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.408 ' OH ' ' CG1' ' A' ' 55' ' ' VAL . 86.4 t80 -58.89 -55.74 31.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.888 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 m -55.45 -36.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 120.733 0.301 . . . . 1.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -65.58 -36.57 84.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.941 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -58.44 -43.41 88.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.013 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -93.29 149.8 20.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.309 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.58 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -101.24 178.3 4.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.143 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.58 57.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.125 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.47 -1.87 82.35 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.782 -0.927 . . . . 1.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 24.4 t70 -71.95 175.93 5.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.826 0.345 . . . . 1.0 110.716 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.478 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -139.39 129.99 25.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' OH ' ' A' ' 45' ' ' TYR . 5.9 m -136.11 130.89 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.974 0.892 . . . . 1.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -80.85 106.51 12.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.286 -1.325 . . . . 1.0 108.968 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -97.07 143.46 12.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.599 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.1 m -109.75 138.88 45.48 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.536 0.522 . . . . 1.0 109.685 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -150.24 150.91 32.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.485 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.5 mp -107.88 134.06 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.672 0.749 . . . . 1.0 111.192 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -138.05 121.9 17.66 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 114.37 -1.287 . . . . 1.0 109.885 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 49.11 43.25 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.851 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 71.67 3.11 4.54 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.886 -0.143 . . . . 1.0 111.343 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -108.61 105.36 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.72 0.295 . . . . 1.0 110.946 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -78.26 138.68 38.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 1.0 111.011 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -148.43 145.24 27.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.641 -0.708 . . . . 1.0 110.992 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -89.89 132.88 35.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.246 -0.888 . . . . 1.0 110.343 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . . . -110.13 121.3 44.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.843 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.0 102.3 7.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.394 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -115.51 149.68 37.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.876 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.8 m -128.25 135.58 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.443 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt . . . . . 0 CA--C 1.546 0.797 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.473 -179.309 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -60.72 114.01 2.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.528 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -79.54 131.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.906 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.9 ttt -81.27 -72.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 111.692 0.256 . . . . 1.0 111.692 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -129.71 162.0 29.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.17 0.51 . . . . 1.0 111.209 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.64 131.5 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.307 -0.861 . . . . 1.0 108.915 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 13' ' ' LEU . 4.2 mm? -89.09 115.2 62.99 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.771 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.04 -19.94 12.69 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.976 1.784 . . . . 1.0 112.246 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -99.19 22.28 10.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.653 -0.248 . . . . 1.0 110.982 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 mmt -121.04 159.05 50.93 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.683 -0.235 . . . . 1.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.85 -22.05 66.63 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.485 2.123 . . . . 1.0 112.772 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.11 -14.23 59.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.833 0.349 . . . . 1.0 111.671 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 132.74 48.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.915 0.388 . . . . 1.0 110.407 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.98 27.97 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -104.92 -41.49 5.6 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.15 156.63 31.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.34 155.95 48.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.101 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.21 134.29 56.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.311 -0.858 . . . . 1.0 109.469 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.37 -26.4 18.59 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.07 145.46 51.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.381 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -111.0 153.24 25.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.871 0.367 . . . . 1.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.43 119.62 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.861 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . -93.75 -16.95 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.99 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . 174.41 164.32 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.31 0.576 . . . . 1.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 45' ' ' TYR . 92.7 mt -135.93 125.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.625 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.419 ' OD2' ' CE1' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 49.97 17.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.15 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.95 -5.84 46.95 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.053 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -92.94 108.77 34.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.978 0.389 . . . . 1.0 111.318 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.04 133.28 52.32 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.219 1.946 . . . . 1.0 111.551 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mm -102.16 116.7 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.649 0.738 . . . . 1.0 111.855 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 38' ' ' THR . 48.9 p30 -107.92 -23.52 12.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.579 -1.191 . . . . 1.0 111.409 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.467 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 69.2 p -137.21 155.26 49.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.034 0.445 . . . . 1.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.2 p -68.73 -32.81 72.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.484 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -61.94 -30.87 71.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.264 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -61.99 -30.01 70.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.318 -0.553 . . . . 1.0 109.946 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.6 -29.63 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.547 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.65 -43.68 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.268 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -65.17 -42.51 93.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.419 ' CE1' ' OD2' ' A' ' 32' ' ' ASP . 64.8 t80 -57.61 -57.1 14.21 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.325 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.96 -40.93 47.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -65.97 -20.81 66.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -61.85 -56.19 21.98 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.71 -163.41 1.02 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.961 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.46 -171.62 3.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.343 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 134.72 53.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.141 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.52 63.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.42 161.79 25.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.831 0.348 . . . . 1.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -127.5 122.35 33.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.62 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.997 0.904 . . . . 1.0 111.535 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -83.34 116.34 22.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.401 -1.272 . . . . 1.0 109.033 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.0 t -107.41 131.14 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.95 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.4 m -101.48 133.4 46.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.47 ' C ' HD12 ' A' ' 60' ' ' ILE . 32.4 p90 -147.83 152.19 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.47 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -109.67 139.47 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.389 0.614 . . . . 1.0 110.651 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -142.84 121.85 12.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.192 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 52.39 40.82 30.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 69.1 13.37 8.69 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.332 0.395 . . . . 1.0 111.363 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -114.16 109.0 17.73 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -77.27 131.52 38.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.0 111.278 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -146.07 144.47 30.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.949 -0.568 . . . . 1.0 111.037 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 40.6 mp0 -90.89 137.46 32.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.649 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 120.21 41.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.321 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.86 101.44 9.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.93 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tt -110.95 140.99 44.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.959 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.85 131.97 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.456 0.645 . . . . 1.0 110.651 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -65.71 121.99 16.25 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.641 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 CA--C 1.549 0.914 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.873 -179.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 50.2 p30 -161.44 36.92 0.14 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.407 -0.361 . . . . 1.0 110.84 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 53.69 78.26 0.16 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.958 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.47 -63.82 1.15 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.046 -0.525 . . . . 1.0 111.512 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.3 mttp 59.88 86.67 0.09 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.934 0.397 . . . . 1.0 110.832 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -115.45 -105.6 2.54 Favored Glycine 0 N--CA 1.472 1.058 0 N-CA-C 111.391 -0.684 . . . . 1.0 111.391 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.16 142.66 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -102.33 123.07 45.47 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.78 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.626 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 6.2 p -45.67 164.92 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.097 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.538 ' N ' HG22 ' A' ' 9' ' ' VAL . 25.1 mmt -104.87 -70.27 0.78 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.609 -178.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.9 t -156.2 175.26 14.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.712 0.291 . . . . 1.0 110.95 -179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.8 105.91 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.554 -0.906 . . . . 1.0 108.554 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.8 mt -93.71 143.96 27.41 Favored Pre-proline 0 CA--C 1.54 0.58 0 CA-C-N 116.857 -0.156 . . . . 1.0 110.889 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -72.9 156.42 52.55 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.159 1.906 . . . . 1.0 112.274 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.13 32.36 21.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.777 -0.647 . . . . 1.0 111.864 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 6.3 mtt -122.32 152.39 60.76 Favored Pre-proline 0 N--CA 1.476 0.854 0 N-CA-C 110.506 -0.183 . . . . 1.0 110.506 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -64.01 -16.88 57.39 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.534 2.156 . . . . 1.0 112.932 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.37 -24.03 27.75 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.96 0.409 . . . . 1.0 111.222 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 131.06 45.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.818 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.04 -21.21 35.3 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 111.348 -0.701 . . . . 1.0 111.348 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.59 -43.94 4.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.788 0.328 . . . . 1.0 110.218 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.646 HD13 ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -116.29 140.45 49.31 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.253 -0.647 . . . . 1.0 109.253 -179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.646 ' H ' HD13 ' A' ' 22' ' ' LEU . 61.5 mm-40 -131.53 159.21 38.83 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.301 0.572 . . . . 1.0 110.696 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.59 133.31 50.91 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.273 -0.876 . . . . 1.0 109.805 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.626 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 110.07 -23.1 21.96 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 110.394 -1.083 . . . . 1.0 110.394 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.418 ' OD1' ' NE ' ' A' ' 61' ' ' ARG . 36.3 m-20 -79.36 144.47 34.15 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.025 -0.103 . . . . 1.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 -110.34 161.4 15.67 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.921 0.391 . . . . 1.0 110.787 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -98.05 115.06 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.434 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.87 -14.89 28.94 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.989 -0.551 . . . . 1.0 111.12 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 177.93 168.06 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.249 0.547 . . . . 1.0 111.161 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 97.6 mt -137.0 125.94 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 115.472 -0.785 . . . . 1.0 109.79 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 p30 47.79 22.87 0.38 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.55 -0.75 . . . . 1.0 111.176 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.76 -6.87 57.29 Favored Glycine 0 CA--C 1.533 1.208 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.992 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -87.39 126.4 62.43 Favored Pre-proline 0 CA--C 1.543 0.69 0 CA-C-O 119.417 -0.325 . . . . 1.0 111.161 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -77.54 126.66 8.41 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.589 1.526 . . . . 1.0 111.899 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.463 HG21 HD11 ' A' ' 42' ' ' ILE . 29.9 mm -100.62 120.37 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.731 0.777 . . . . 1.0 111.933 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -116.13 -19.32 10.32 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.455 -1.248 . . . . 1.0 111.142 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -133.32 155.9 48.58 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.179 0.514 . . . . 1.0 111.093 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -71.68 -32.33 67.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.646 -0.706 . . . . 1.0 109.454 178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.1 mp0 -65.01 -32.45 74.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.584 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -58.86 -30.31 67.61 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.406 -0.518 . . . . 1.0 109.619 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.463 HD11 HG21 ' A' ' 36' ' ' ILE . 50.4 mm -72.16 -29.09 31.13 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.215 0 CA-C-N 116.627 -0.261 . . . . 1.0 111.332 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -67.11 -40.02 84.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 O-C-N 123.29 0.369 . . . . 1.0 110.757 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 77.1 p -69.48 -40.86 76.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.337 0.589 . . . . 1.0 109.551 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -56.37 -56.79 16.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.392 -0.822 . . . . 1.0 110.196 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.8 m -59.56 -36.29 64.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 1.0 110.455 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -57.79 -41.57 82.36 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.293 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -60.71 -42.88 98.1 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.493 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -89.32 154.29 20.21 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.171 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' H ' ' CD ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -113.48 -176.17 2.84 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.985 -179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.68 138.91 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.214 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.38 0.87 81.95 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.507 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 29.7 t70 -74.67 179.62 4.66 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 121.087 0.47 . . . . 1.0 110.568 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 80.7 ttt180 -139.56 123.4 17.58 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.899 -0.778 . . . . 1.0 108.899 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.5 m -129.87 134.61 62.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.777 0.799 . . . . 1.0 111.821 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.48 122.61 32.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.502 -1.226 . . . . 1.0 108.601 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.6 t -116.17 130.3 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.0 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.7 m -96.95 136.11 37.98 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.308 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.489 ' C ' HD12 ' A' ' 60' ' ' ILE . 22.9 p90 -146.62 151.32 37.08 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.544 -0.539 . . . . 1.0 109.544 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -112.62 137.15 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 121.103 0.478 . . . . 1.0 110.356 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' NE ' ' OD1' ' A' ' 26' ' ' ASP . 17.7 ttm180 -136.66 120.48 17.42 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.789 -0.642 . . . . 1.0 109.467 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 49.97 39.42 18.75 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.782 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 73.33 12.64 4.77 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.53 0.196 . . . . 1.0 111.53 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -110.74 100.25 9.04 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.738 0.304 . . . . 1.0 110.395 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -72.17 127.62 33.12 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.47 0.652 . . . . 1.0 111.711 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -145.07 141.2 28.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.774 -0.648 . . . . 1.0 111.139 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -90.03 146.17 24.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.165 -0.925 . . . . 1.0 110.616 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -122.98 130.91 53.41 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.21 -0.904 . . . . 1.0 111.077 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' C ' HD12 ' A' ' 70' ' ' LEU . 77.3 tt0 -92.23 105.39 17.62 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.244 -0.889 . . . . 1.0 110.592 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.476 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.5 mp -111.3 146.33 37.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.045 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.2 t -115.88 130.21 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 115.52 -0.764 . . . . 1.0 109.59 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.508 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -66.11 132.91 49.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.489 -0.778 . . . . 1.0 110.78 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp -139.51 140.38 25.22 Favored Pre-proline 0 CA--C 1.55 0.961 0 N-CA-C 109.841 -0.429 . . . . 1.0 109.841 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.78 162.14 40.11 Favored 'Trans proline' 0 N--CA 1.503 2.054 0 C-N-CA 122.69 2.26 . . . . 1.0 111.775 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -120.8 145.81 42.16 Favored Pre-proline 0 N--CA 1.474 0.739 0 CA-C-N 116.114 -0.493 . . . . 1.0 110.82 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -66.51 -28.11 45.86 Favored 'Trans proline' 0 N--CA 1.498 1.758 0 C-N-CA 121.708 1.606 . . . . 1.0 111.961 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -68.42 -33.43 74.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.152 0.501 . . . . 1.0 109.967 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -147.46 74.81 11.5 Favored Pre-proline 0 N--CA 1.465 0.293 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.086 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.85 -29.78 64.86 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.608 2.205 . . . . 1.0 111.824 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.6 m-80 -82.99 17.26 1.99 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.572 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.724 ' C ' HD13 ' A' ' 82' ' ' ILE . 27.9 mt-30 -133.28 138.86 46.61 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.724 HD13 ' C ' ' A' ' 81' ' ' GLN . 0.1 OUTLIER -118.57 133.51 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.079 -179.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' ILE . . . 49.55 106.3 0.01 OUTLIER Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.282 -0.485 . . . . 1.0 112.341 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.5 mt -97.47 0.68 48.05 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.78 47.9 3.3 Favored Glycine 0 N--CA 1.466 0.667 0 CA-C-N 114.754 -1.112 . . . . 1.0 111.03 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.0 p -108.71 149.17 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.755 -0.461 . . . . 1.0 109.755 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 118.126 -0.94 . . . . 1.0 110.466 -179.833 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' C ' HD22 ' A' ' 2' ' ' ASN . 0.5 OUTLIER -79.21 -178.95 6.45 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.028 -0.533 . . . . 1.0 110.505 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 15.4 pt-20 -163.51 154.19 16.07 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.258 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 3' ' ' GLU . . . 76.08 155.43 0.16 Allowed 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.11 -0.495 . . . . 1.0 111.152 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.53 -177.56 4.48 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.842 -0.617 . . . . 1.0 111.324 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.33 -110.91 2.89 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 111.16 -0.776 . . . . 1.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 19.5 t -128.58 156.76 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.716 -0.476 . . . . 1.0 109.716 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -123.11 133.81 54.26 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.988 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 72.3 t -76.99 120.81 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 109.943 -0.392 . . . . 1.0 109.943 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 3.2 mmt -75.52 -69.13 0.5 Allowed 'General case' 0 C--O 1.231 0.131 0 C-N-CA 121.028 -0.269 . . . . 1.0 111.657 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.1 p -128.4 165.34 20.82 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.044 0.45 . . . . 1.0 111.03 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.5 t -123.29 122.15 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.8 mp -87.87 153.24 52.12 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.757 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 152.63 64.7 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 122.611 2.207 . . . . 1.0 112.397 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 62.4 t-20 52.61 45.15 29.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.246 -0.888 . . . . 1.0 111.519 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 12.8 mmt -121.17 154.18 58.39 Favored Pre-proline 0 N--CA 1.474 0.743 0 O-C-N 123.013 0.196 . . . . 1.0 110.706 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HD3' ' HZ1' ' A' ' 73' ' ' LYS . 28.2 Cg_endo -62.05 -19.34 65.92 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.339 2.026 . . . . 1.0 112.869 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -89.63 -24.01 21.76 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.844 0.354 . . . . 1.0 111.484 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.23 141.37 52.49 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.627 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.25 -22.73 14.03 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -117.4 -34.01 4.44 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.533 HD13 ' H ' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -118.55 139.79 50.9 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.934 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' H ' HD13 ' A' ' 22' ' ' LEU . 97.0 mt-10 -130.18 152.65 49.38 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.511 0.672 . . . . 1.0 110.964 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.06 139.92 53.63 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.781 -1.1 . . . . 1.0 109.33 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.49 -28.88 13.19 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.206 -1.157 . . . . 1.0 110.206 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 61' ' ' ARG . 80.5 m-20 -70.75 147.02 49.45 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 120.694 -0.403 . . . . 1.0 110.294 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -114.58 159.71 20.12 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.891 0.377 . . . . 1.0 110.351 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.7 mm -97.55 118.75 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.697 -0.683 . . . . 1.0 110.396 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.27 -15.9 25.32 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.786 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 178.95 163.5 0.81 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.139 0.495 . . . . 1.0 111.076 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 98.1 mt -138.29 129.09 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.87 0.843 . . . . 1.0 110.713 178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.7 t70 50.83 15.33 0.23 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.11 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.75 -5.84 43.77 Favored Glycine 0 N--CA 1.473 1.108 0 CA-C-N 116.376 -0.375 . . . . 1.0 112.234 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -94.35 134.41 25.64 Favored Pre-proline 0 CA--C 1.556 1.175 0 CA-C-N 117.174 0.487 . . . . 1.0 110.76 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -78.14 134.82 13.25 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.848 1.699 . . . . 1.0 111.937 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 42' ' ' ILE . 23.9 mm -102.81 116.18 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.633 0.73 . . . . 1.0 111.36 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -110.86 -26.84 9.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.502 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 p -136.99 165.34 26.22 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.168 0.509 . . . . 1.0 110.901 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 77.9 p -66.5 -33.62 76.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.648 -0.705 . . . . 1.0 109.372 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -61.37 -39.14 89.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.015 0.436 . . . . 1.0 110.405 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -51.44 -39.13 56.76 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.473 -0.491 . . . . 1.0 109.868 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.423 HD11 HG21 ' A' ' 36' ' ' ILE . 50.0 mm -62.72 -34.71 67.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 C-N-CA 121.233 -0.187 . . . . 1.0 111.031 178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.62 -44.48 99.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.75 -0.38 . . . . 1.0 110.735 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 65.7 p -58.36 -43.55 88.46 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 121.544 0.688 . . . . 1.0 110.542 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -58.3 -57.6 12.2 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.568 -0.742 . . . . 1.0 109.191 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' N ' ' CG ' ' A' ' 45' ' ' TYR . 97.6 t -52.59 -40.3 33.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.95 0.405 . . . . 1.0 110.298 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -37.49 80.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.386 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.45 -48.04 82.95 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.798 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -89.31 175.02 7.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.171 -179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.493 ' O ' ' O ' ' A' ' 51' ' ' ALA . 17.8 pt20 -155.41 125.32 6.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.784 -0.644 . . . . 1.0 111.705 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 50' ' ' GLN . . . -2.69 124.29 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 125.73 1.894 . . . . 1.0 110.414 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 103.57 -6.53 49.24 Favored Glycine 0 CA--C 1.534 1.226 0 N-CA-C 109.609 -1.397 . . . . 1.0 109.609 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 20.6 t70 -83.89 177.22 8.4 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.851 0.358 . . . . 1.0 110.872 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.48 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 58.7 mtp180 -146.59 123.48 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.566 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.0 m -130.99 131.96 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 122.225 1.012 . . . . 1.0 111.674 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.635 ' H ' ' HE ' ' A' ' 56' ' ' ARG . 0.3 OUTLIER -75.05 116.96 16.37 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.122 -1.399 . . . . 1.0 107.763 179.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.65 134.92 43.54 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.588 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.837 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.4 m -101.81 133.38 46.65 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.462 ' CD1' HD21 ' A' ' 22' ' ' LEU . 31.5 p90 -146.5 150.14 34.99 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -108.77 135.25 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.422 0.629 . . . . 1.0 110.759 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.474 HH21 ' CG ' ' A' ' 26' ' ' ASP . 40.6 ttm-85 -138.04 121.27 16.92 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 114.954 -1.021 . . . . 1.0 109.598 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 53.29 39.82 30.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.507 -0.77 . . . . 1.0 110.932 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 69.81 10.13 7.41 Favored 'General case' 0 C--O 1.232 0.18 0 O-C-N 123.484 0.49 . . . . 1.0 111.45 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -110.34 106.53 15.93 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.497 HE21 ' C ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -76.01 127.7 33.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.257 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -142.0 144.58 33.73 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.753 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -91.04 140.75 29.54 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.373 -0.83 . . . . 1.0 110.504 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.72 125.81 51.34 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.0 110.828 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.433 ' C ' HD22 ' A' ' 70' ' ' LEU . 38.7 tp10 -79.97 102.84 9.46 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.839 -1.073 . . . . 1.0 109.948 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.433 HD22 ' C ' ' A' ' 69' ' ' GLU . 4.4 mm? -110.29 142.63 41.64 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.484 0.659 . . . . 1.0 110.667 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.09 134.32 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 114.694 -1.139 . . . . 1.0 110.375 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.7 mm? -71.6 129.48 38.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.979 -178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' HZ1' ' HD3' ' A' ' 17' ' ' PRO . 14.0 ptpt -137.16 139.86 29.43 Favored Pre-proline 0 CA--C 1.552 1.03 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.096 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -74.08 166.58 29.26 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.906 2.404 . . . . 1.0 112.522 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -97.62 153.37 38.33 Favored Pre-proline 0 CA--C 1.543 0.699 0 CA-C-N 115.607 -0.724 . . . . 1.0 110.374 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 78' ' ' HIS . 37.0 Cg_endo -64.44 -71.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.504 2.11 0 C-N-CA 122.617 2.211 . . . . 1.0 112.459 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.596 ' CD2' ' HD1' ' A' ' 78' ' ' HIS . 0.6 OUTLIER -68.39 10.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.909 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.596 ' HD1' ' CD2' ' A' ' 77' ' ' HIS . 39.4 m80 -157.92 73.95 4.03 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 108.747 -0.834 . . . . 1.0 108.747 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.84 -13.52 21.78 Favored 'Trans proline' 0 N--CA 1.489 1.264 0 C-N-CA 122.286 1.99 . . . . 1.0 112.089 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -91.6 11.96 22.57 Favored 'General case' 0 C--O 1.231 0.091 0 O-C-N 122.236 -0.29 . . . . 1.0 110.304 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.634 ' C ' HD13 ' A' ' 82' ' ' ILE . 15.1 mp0 -131.48 148.86 52.68 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.639 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -107.59 -175.06 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 115.124 -0.944 . . . . 1.0 110.116 -178.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 147.98 155.41 6.62 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 110.893 -0.883 . . . . 1.0 110.893 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.15 -86.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.723 -0.391 . . . . 1.0 110.437 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 174.71 14.82 0.02 OUTLIER Glycine 0 CA--C 1.536 1.372 0 N-CA-C 110.903 -0.879 . . . . 1.0 110.903 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 t -108.27 156.95 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 109.845 -0.428 . . . . 1.0 109.845 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.055 -0.974 . . . . 1.0 111.065 -179.368 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.438 ' SD ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 108.772 -0.825 . . . . 1.0 108.772 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 54.19 101.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.804 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -70.03 86.49 0.54 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.704 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 53.87 163.01 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.39 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.2 mttm 56.89 -159.95 0.23 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.762 -0.654 . . . . 1.0 111.153 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.88 57.58 0.61 Allowed Glycine 0 C--N 1.346 1.084 0 N-CA-C 111.465 -0.654 . . . . 1.0 111.465 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 27' ' ' ARG . 38.2 t -96.5 129.15 46.96 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.629 0 N-CA-C 108.068 -1.086 . . . . 1.0 108.068 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.401 ' O ' ' O ' ' A' ' 9' ' ' VAL . 32.7 m-85 -126.97 132.17 50.89 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.647 0.261 . . . . 1.0 110.671 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.645 HG21 HD12 ' A' ' 22' ' ' LEU . 41.4 t -44.47 170.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.26 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.53 ' N ' HG12 ' A' ' 9' ' ' VAL . 35.5 tpp -95.11 -65.28 0.99 Allowed 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.392 -0.193 . . . . 1.0 111.231 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.7 m -155.15 173.84 16.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.266 -0.573 . . . . 1.0 111.095 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.5 t -118.03 100.74 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASN . 9.7 mp -99.86 117.93 62.63 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 118.84 -0.6 . . . . 1.0 110.323 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.77 49.36 0.04 OUTLIER 'Trans proline' 0 N--CA 1.511 2.527 0 C-N-CA 123.112 2.541 . . . . 1.0 112.838 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 13' ' ' LEU . 58.4 t30 -171.18 8.89 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.009 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.401 ' H ' ' H ' ' A' ' 15' ' ' ASN . 16.6 mmt -107.9 155.66 39.54 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-O 120.566 0.222 . . . . 1.0 110.507 -178.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.83 -23.65 73.02 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.273 1.982 . . . . 1.0 113.406 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.674 ' HB2' HD11 ' A' ' 70' ' ' LEU . . . -88.4 -13.06 41.47 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.163 0.506 . . . . 1.0 110.819 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.57 113.87 2.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.587 -0.733 . . . . 1.0 109.712 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.46 -11.87 63.22 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 97.1 mtt-85 -113.28 -36.65 4.95 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.017 0.437 . . . . 1.0 110.295 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.645 HD12 HG21 ' A' ' 9' ' ' VAL . 1.1 mm? -123.31 149.9 44.26 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.453 -0.794 . . . . 1.0 110.707 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -139.63 155.06 47.65 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 115.298 -0.865 . . . . 1.0 110.873 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.25 131.97 52.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.651 -1.159 . . . . 1.0 108.945 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.06 -25.48 12.72 Favored Glycine 0 N--CA 1.471 0.985 0 N-CA-C 110.032 -1.227 . . . . 1.0 110.032 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.47 ' OD1' ' NH2' ' A' ' 61' ' ' ARG . 97.1 m-20 -79.29 153.16 30.09 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.577 0.227 . . . . 1.0 110.437 179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 7' ' ' VAL . 26.7 ptt180 -123.25 165.24 17.25 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.162 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -99.38 122.65 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.374 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -98.91 -22.62 15.7 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.82 -0.627 . . . . 1.0 110.791 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.37 159.04 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.391 0.615 . . . . 1.0 111.624 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 88.1 mt -136.64 122.41 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 115.266 -0.879 . . . . 1.0 110.037 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.8 t0 51.5 23.38 1.82 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.146 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.09 -6.78 58.38 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.473 -0.651 . . . . 1.0 111.473 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -90.01 122.27 67.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 O-C-N 122.625 -0.338 . . . . 1.0 111.162 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.33 133.32 17.51 Favored 'Trans proline' 0 N--CA 1.501 1.926 0 C-N-CA 121.693 1.595 . . . . 1.0 111.485 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mm -100.18 111.15 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 121.689 0.757 . . . . 1.0 112.257 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -110.85 -16.73 13.49 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.322 -1.308 . . . . 1.0 111.302 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 43.8 p -141.8 155.01 45.59 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.048 0.451 . . . . 1.0 110.798 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.9 t -68.9 -26.01 64.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.441 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -66.88 -32.72 74.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.493 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -59.99 -29.9 68.76 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.499 -0.48 . . . . 1.0 109.772 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.0 mm -77.09 -27.37 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.749 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.7 t -70.26 -44.49 77.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.484 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 78.2 p -68.81 -42.2 77.61 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.489 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -58.78 -52.82 64.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.678 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.12 -40.76 56.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.649 -0.5 . . . . 1.0 109.649 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -62.99 -39.25 94.18 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.354 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.54 -55.16 32.08 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.341 -0.544 . . . . 1.0 110.345 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -80.98 146.52 30.67 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.138 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -97.52 177.57 5.47 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.878 -0.601 . . . . 1.0 111.494 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.42 136.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.531 -0.758 . . . . 1.0 110.076 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.07 -3.64 70.26 Favored Glycine 0 N--CA 1.47 0.941 0 N-CA-C 110.708 -0.957 . . . . 1.0 110.708 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.407 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 33.7 t70 -73.59 170.45 15.16 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.082 0.468 . . . . 1.0 111.007 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 40.2 ptt85 -138.2 131.68 30.68 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.169 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.2 m -136.35 131.64 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-O 121.854 0.835 . . . . 1.0 111.877 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.0 mmt85 -75.51 109.26 8.91 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.234 -1.348 . . . . 1.0 108.615 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.92 138.06 25.45 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.448 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.1 m -107.11 140.83 39.32 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.571 -0.529 . . . . 1.0 109.571 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.476 ' CD1' HD21 ' A' ' 22' ' ' LEU . 35.0 p90 -148.79 152.78 37.14 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.731 -0.47 . . . . 1.0 109.731 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.467 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.5 mp -107.17 135.54 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-O 121.695 0.76 . . . . 1.0 111.62 -178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.47 ' NH2' ' OD1' ' A' ' 26' ' ' ASP . 44.5 ttm-85 -140.83 122.09 14.84 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 114.543 -1.208 . . . . 1.0 109.621 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 46.25 49.09 12.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.682 -0.69 . . . . 1.0 110.681 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 64.05 9.37 4.6 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 123.554 0.534 . . . . 1.0 111.758 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.0 mtpt -113.92 105.89 13.79 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.63 0.252 . . . . 1.0 110.636 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -80.01 146.23 32.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.064 0.459 . . . . 1.0 111.176 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -153.48 145.51 23.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.529 -0.76 . . . . 1.0 110.968 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -89.93 129.88 36.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.445 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.1 128.24 55.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.315 -0.857 . . . . 1.0 110.992 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' C ' HD22 ' A' ' 70' ' ' LEU . 42.4 tp10 -80.37 102.74 9.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.82 -1.082 . . . . 1.0 109.928 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.674 HD11 ' HB2' ' A' ' 18' ' ' ALA . 4.4 mm? -111.05 145.55 38.3 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.234 0.54 . . . . 1.0 110.791 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.6 p -123.81 132.55 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 114.989 -1.005 . . . . 1.0 110.208 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.39 128.68 36.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.834 -0.621 . . . . 1.0 110.493 -179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -136.33 121.85 13.39 Favored Pre-proline 0 CA--C 1.551 0.997 0 CA-C-N 115.39 -0.823 . . . . 1.0 110.746 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -76.96 -174.52 2.21 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 122.373 2.049 . . . . 1.0 112.02 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -106.42 147.87 35.71 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 116.004 -0.544 . . . . 1.0 110.764 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.14 -34.59 45.53 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.0 1.8 . . . . 1.0 112.196 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.559 ' ND1' ' ND1' ' A' ' 78' ' ' HIS . 6.9 p80 -77.25 -16.31 59.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.028 0.442 . . . . 1.0 110.295 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.559 ' ND1' ' ND1' ' A' ' 77' ' ' HIS . 28.0 m80 -144.4 73.74 15.68 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 115.838 -0.619 . . . . 1.0 109.359 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.26 -12.83 37.35 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.052 1.834 . . . . 1.0 111.953 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -93.94 18.93 9.68 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 110.006 -0.368 . . . . 1.0 110.006 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -143.01 131.18 21.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.622 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.6 OUTLIER -76.15 157.83 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.648 -178.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.93 103.76 0.63 Allowed Glycine 0 CA--C 1.521 0.425 0 N-CA-C 111.218 -0.753 . . . . 1.0 111.218 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.3 tt -81.67 -12.3 58.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.896 0.379 . . . . 1.0 110.842 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -104.45 168.34 16.33 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 111.174 -0.77 . . . . 1.0 111.174 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 90.7 t -137.91 151.08 25.24 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.787 0 N-CA-C 110.245 -0.279 . . . . 1.0 110.245 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.222 -0.382 0 CA-C-O 118.142 -0.932 . . . . 1.0 109.522 -179.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 56.16 52.41 10.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.352 -0.386 . . . . 1.0 111.026 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 53.6 76.15 0.23 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.982 0.42 . . . . 1.0 111.14 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -61.4 -64.86 0.81 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.918 -0.583 . . . . 1.0 111.447 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.8 mtmm 60.3 88.38 0.08 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.638 -0.256 . . . . 1.0 111.421 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.49 -117.13 2.56 Favored Glycine 0 N--CA 1.476 1.352 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.0 m -131.37 169.63 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 122.749 0.419 . . . . 1.0 110.276 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -133.87 139.76 46.41 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.834 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.8 t -74.47 125.63 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.031 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.4 mtt -84.8 -64.37 1.17 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.425 0.155 . . . . 1.0 111.029 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.6 m -123.08 149.73 44.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.279 0.561 . . . . 1.0 111.159 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.0 t -126.56 133.47 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 10.9 mp -93.47 150.56 39.11 Favored Pre-proline 0 CA--C 1.538 0.505 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.797 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.04 -27.76 16.81 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.565 2.176 . . . . 1.0 112.788 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -112.57 39.91 2.37 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 111.827 0.306 . . . . 1.0 111.827 -178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.0 162.44 21.84 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 123.189 0.306 . . . . 1.0 110.758 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.29 -33.68 94.33 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 122.262 1.975 . . . . 1.0 112.972 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.05 -11.61 54.95 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.743 0.306 . . . . 1.0 111.636 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 13' ' ' LEU . . . -66.74 135.22 53.67 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.665 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.9 -16.37 51.37 Favored Glycine 0 N--CA 1.466 0.659 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -116.84 -33.86 4.65 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 110.327 -0.249 . . . . 1.0 110.327 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' OD2' ' A' ' 26' ' ' ASP . 14.1 tp -122.63 152.66 40.25 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.294 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 60.9 mm-40 -139.42 154.33 47.77 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.599 0.714 . . . . 1.0 111.087 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.15 139.02 53.77 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.653 -1.158 . . . . 1.0 109.32 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.29 -29.69 8.93 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.209 -1.156 . . . . 1.0 110.209 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.491 ' OD2' HD11 ' A' ' 22' ' ' LEU . 1.7 p-10 -69.69 149.52 47.96 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 120.223 -0.591 . . . . 1.0 110.807 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -115.4 158.79 21.97 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.903 0.382 . . . . 1.0 110.445 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.7 mm -100.04 119.98 48.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.011 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.65 -21.94 19.07 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.601 -0.727 . . . . 1.0 110.836 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -176.86 163.06 2.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.109 0.48 . . . . 1.0 111.528 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.421 ' C ' ' H ' ' A' ' 33' ' ' GLY . 89.1 mt -136.79 126.53 38.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 CA-C-O 122.294 1.045 . . . . 1.0 110.872 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t0 51.05 11.2 0.09 Allowed 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.591 -0.693 . . . . 1.0 111.405 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 31' ' ' ILE . . . 111.06 -6.48 28.99 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-O 119.986 -0.341 . . . . 1.0 112.312 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' O ' ' CG ' ' A' ' 34' ' ' GLN . 0.4 OUTLIER -94.9 110.6 50.64 Favored Pre-proline 0 CA--C 1.556 1.203 0 CA-C-N 117.239 0.519 . . . . 1.0 111.789 -179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.78 136.15 73.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 121.266 1.311 . . . . 1.0 111.522 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.2 mm -102.79 115.64 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-O 121.597 0.713 . . . . 1.0 111.429 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -112.45 -20.22 11.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.253 -1.339 . . . . 1.0 110.963 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 60.8 p -135.18 151.29 50.52 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.041 0.448 . . . . 1.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.0 p -69.55 -29.66 67.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.54 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.02 -29.47 70.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.468 -0.787 . . . . 1.0 110.648 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -63.4 -28.62 70.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.078 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.9 mm -75.35 -28.35 20.19 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.706 -0.224 . . . . 1.0 111.257 179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.96 -40.98 76.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.034 0.445 . . . . 1.0 110.238 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.9 m -69.71 -41.1 75.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.226 0.536 . . . . 1.0 109.595 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.49 -56.28 23.98 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.753 -0.658 . . . . 1.0 110.727 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.9 m -58.02 -33.55 46.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 C-N-CA 120.865 -0.334 . . . . 1.0 110.302 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 tpm_? -64.35 -40.13 95.26 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.506 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -57.76 -50.25 73.86 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.666 -0.413 . . . . 1.0 110.321 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -81.6 149.09 28.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.048 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -102.36 -179.43 3.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.311 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.02 135.69 55.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.964 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.5 -0.21 65.42 Favored Glycine 0 N--CA 1.469 0.894 0 N-CA-C 110.822 -0.911 . . . . 1.0 110.822 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.411 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 35.5 t70 -78.06 171.05 15.6 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.877 0.37 . . . . 1.0 110.935 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 82.2 mtp180 -139.3 125.21 19.74 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.475 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 m -126.98 132.73 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-O 121.943 0.878 . . . . 1.0 111.646 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 73.6 mmt-85 -81.02 113.46 19.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.093 -1.412 . . . . 1.0 108.748 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.95 132.43 53.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.644 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.8 m -101.17 137.71 39.16 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 109.759 -0.46 . . . . 1.0 109.759 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.436 ' C ' HD12 ' A' ' 60' ' ' ILE . 32.7 p90 -150.28 152.18 34.11 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.436 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -106.51 138.54 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 CA-C-O 121.41 0.624 . . . . 1.0 111.04 -179.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 43.8 ttm-85 -143.73 123.8 13.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.719 -1.128 . . . . 1.0 109.964 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 50.64 43.01 27.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.817 178.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 67.08 9.59 7.04 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 122.822 0.449 . . . . 1.0 111.841 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.0 mtmm -115.46 106.54 14.09 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.919 0.39 . . . . 1.0 110.654 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.444 ' O ' ' NE2' ' A' ' 65' ' ' GLN . 5.0 pp0? -74.13 138.52 43.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.383 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -149.16 144.28 26.5 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.362 -0.836 . . . . 1.0 111.269 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.68 136.52 32.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.048 -0.978 . . . . 1.0 110.037 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.18 122.55 48.07 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.755 -1.111 . . . . 1.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' HD12 ' A' ' 70' ' ' LEU . 51.3 mt-10 -84.36 102.04 12.43 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 114.933 -1.03 . . . . 1.0 110.026 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.464 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.8 mp -111.79 150.18 30.68 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.195 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 53' ' ' ASP . 9.9 p -122.29 131.77 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 115.292 -0.867 . . . . 1.0 110.36 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.66 129.51 40.01 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.813 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -141.5 119.75 7.84 Favored Pre-proline 0 CA--C 1.551 0.992 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.104 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.21 -169.49 0.52 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.155 1.904 . . . . 1.0 112.183 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -110.65 149.15 39.9 Favored Pre-proline 0 N--CA 1.472 0.651 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.091 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.73 -27.56 68.34 Favored 'Trans proline' 0 N--CA 1.499 1.799 0 C-N-CA 122.175 1.917 . . . . 1.0 111.693 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.51 ' ND1' ' N ' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -85.35 -14.11 47.42 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.392 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 44.7 m80 -148.45 69.54 10.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.71 -11.5 24.1 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 122.421 2.08 . . . . 1.0 112.182 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -101.52 17.95 21.46 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.58 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -134.75 128.23 32.49 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 110.077 -0.342 . . . . 1.0 110.077 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.461 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -109.77 160.29 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.619 -0.718 . . . . 1.0 109.641 -179.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 130.91 64.15 0.1 OUTLIER Glycine 0 N--CA 1.468 0.79 0 CA-C-N 115.042 -0.981 . . . . 1.0 111.259 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.9 tp -96.29 -83.59 0.37 Allowed 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.609 -0.436 . . . . 1.0 110.517 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 28.37 -96.6 0.01 OUTLIER Glycine 0 N--CA 1.475 1.298 0 O-C-N 123.865 0.728 . . . . 1.0 112.354 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.01 155.44 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 122.57 0.348 . . . . 1.0 110.182 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 39.4 m . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 118.045 -0.979 . . . . 1.0 111.013 -179.411 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 4' ' ' ALA . 15.3 m120 55.12 14.75 1.05 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.786 -0.643 . . . . 1.0 111.292 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 64.55 -15.25 0.09 Allowed 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.487 0.492 . . . . 1.0 111.137 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.567 ' H ' ' C ' ' A' ' 2' ' ' ASN . . . -58.74 144.26 44.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.92 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 24.9 tttp -123.16 -52.11 1.86 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.344 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.66 -131.92 7.11 Favored Glycine 0 N--CA 1.471 1.033 0 N-CA-C 111.214 -0.754 . . . . 1.0 111.214 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 27.4 t -135.36 111.88 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.236 0.541 . . . . 1.0 111.126 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -58.96 134.36 56.89 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.346 -0.843 . . . . 1.0 110.239 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.629 ' CG1' ' H ' ' A' ' 25' ' ' GLY . 7.5 p -46.35 160.15 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.829 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.448 ' N ' HG22 ' A' ' 9' ' ' VAL . 26.1 ttt -103.21 -62.29 1.3 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.857 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 m -151.94 154.36 35.93 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 120.961 -0.295 . . . . 1.0 111.156 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 t -122.45 101.94 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 108.827 -0.805 . . . . 1.0 108.827 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 13' ' ' LEU . 3.9 mm? -74.83 135.02 74.65 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.835 -0.621 . . . . 1.0 110.414 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.3 -20.95 42.09 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 122.32 2.013 . . . . 1.0 112.782 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -107.18 33.62 3.9 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.81 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.17 165.35 19.4 Favored Pre-proline 0 N--CA 1.472 0.671 0 O-C-N 123.03 0.206 . . . . 1.0 110.514 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.491 ' O ' ' NH2' ' A' ' 21' ' ' ARG . 8.2 Cg_exo -68.38 -16.6 43.7 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.403 2.069 . . . . 1.0 112.933 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.73 -17.91 36.85 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.101 -0.375 . . . . 1.0 111.856 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.79 137.62 57.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.034 -0.53 . . . . 1.0 109.985 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.21 -18.75 39.1 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.254 -0.738 . . . . 1.0 111.254 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.491 ' NH2' ' O ' ' A' ' 17' ' ' PRO . 36.0 mtm180 -113.69 -34.23 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.482 0.313 . . . . 1.0 110.806 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 mt -123.54 154.01 39.81 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.831 -0.622 . . . . 1.0 110.05 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -138.94 154.02 48.28 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.592 -0.731 . . . . 1.0 111.104 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.83 139.8 55.95 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.301 -0.863 . . . . 1.0 109.398 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.629 ' H ' ' CG1' ' A' ' 9' ' ' VAL . . . 104.6 -26.31 23.0 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.338 -1.105 . . . . 1.0 110.338 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 26' ' ' ASP . 2.4 m-20 -67.49 145.35 55.05 Favored 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 120.937 -0.305 . . . . 1.0 110.253 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 52.8 ptt85 -109.09 153.39 23.75 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 120.726 0.298 . . . . 1.0 110.386 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.7 mm -96.16 118.01 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.095 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . -90.75 -16.24 28.77 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.808 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . 171.12 163.67 0.08 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.243 0.544 . . . . 1.0 110.965 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.93 126.75 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 115.599 -0.728 . . . . 1.0 109.774 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 50.77 20.68 0.79 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.544 -0.753 . . . . 1.0 111.036 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.88 -5.0 56.31 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.852 -0.499 . . . . 1.0 111.852 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -92.85 126.33 51.96 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.961 0.381 . . . . 1.0 111.454 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -75.91 135.21 17.19 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 121.826 1.684 . . . . 1.0 111.468 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.4 mm -103.66 115.75 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.865 0.84 . . . . 1.0 112.216 -178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -107.12 -23.27 12.35 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.09 -1.414 . . . . 1.0 111.161 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 61.4 p -134.86 154.28 51.71 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.165 0.507 . . . . 1.0 111.142 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.2 t -69.95 -33.73 72.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.566 -0.743 . . . . 1.0 109.337 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -62.51 -28.46 69.86 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.273 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -63.47 -30.27 71.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.628 -0.429 . . . . 1.0 109.919 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.54 -29.95 36.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.332 0 CA-C-N 116.743 -0.208 . . . . 1.0 111.278 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.36 -42.21 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.069 0.461 . . . . 1.0 110.213 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -65.13 -40.39 94.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.161 0.505 . . . . 1.0 109.868 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -57.94 -57.68 11.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.539 -0.755 . . . . 1.0 110.895 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.0 m -55.16 -39.94 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-O 120.826 0.346 . . . . 1.0 110.202 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -40.95 94.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.421 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -53.72 -47.0 70.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.895 0.378 . . . . 1.0 110.46 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -81.5 -173.45 4.39 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.87 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.456 ' CG ' ' N ' ' A' ' 51' ' ' ALA . 40.3 tt0 -130.91 171.45 13.17 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.985 0.422 . . . . 1.0 110.834 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' N ' ' CG ' ' A' ' 50' ' ' GLN . . . -64.83 136.28 56.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.119 -0.491 . . . . 1.0 109.771 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.3 -0.83 81.67 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.391 -1.084 . . . . 1.0 110.391 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.498 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 36.9 t70 -71.54 179.51 2.99 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.804 0.335 . . . . 1.0 110.719 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.498 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 87.4 mtm180 -138.47 123.55 19.08 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.5 130.98 60.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-O 122.06 0.933 . . . . 1.0 112.112 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -85.96 118.89 25.72 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 113.961 -1.472 . . . . 1.0 109.084 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.2 t -108.55 134.42 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 CA-C-N 115.35 -0.841 . . . . 1.0 110.544 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 28.5 m -104.62 132.63 50.64 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -149.26 153.37 37.45 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.3 138.52 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 121.215 0.531 . . . . 1.0 110.341 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -141.31 121.78 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.304 -0.862 . . . . 1.0 109.444 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 54.37 39.6 31.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.34 -0.846 . . . . 1.0 110.873 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.1 mmm-85 68.92 9.09 7.21 Favored 'General case' 0 C--O 1.231 0.125 0 O-C-N 123.161 0.288 . . . . 1.0 111.66 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -108.87 116.72 32.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.96 0.409 . . . . 1.0 110.131 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -73.9 128.58 35.9 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.887 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -144.18 139.12 28.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.27 0.557 . . . . 1.0 111.105 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -92.84 138.56 31.38 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.137 -0.938 . . . . 1.0 110.561 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.32 117.0 31.93 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.528 -0.76 . . . . 1.0 110.868 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' CD ' HH11 ' A' ' 21' ' ' ARG . 3.3 pt-20 -77.47 103.54 7.46 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.142 -0.935 . . . . 1.0 109.2 178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mt -113.23 146.22 39.69 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.73 -179.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.7 m -129.06 134.68 63.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 114.655 -1.157 . . . . 1.0 110.077 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -66.55 125.49 25.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.738 -0.665 . . . . 1.0 110.447 -178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -134.42 117.66 13.43 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.435 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -76.12 -170.78 0.92 Allowed 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.303 2.002 . . . . 1.0 112.353 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -125.25 145.72 51.66 Favored Pre-proline 0 N--CA 1.478 0.931 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.131 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.72 -34.15 19.49 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 121.948 1.766 . . . . 1.0 111.94 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -81.45 -29.81 33.64 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.44 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -137.57 62.35 35.46 Favored Pre-proline 0 N--CA 1.467 0.422 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.272 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.29 -26.79 71.69 Favored 'Trans proline' 0 N--CA 1.497 1.715 0 C-N-CA 121.944 1.763 . . . . 1.0 111.954 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -56.53 -13.38 2.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.693 -0.685 . . . . 1.0 110.52 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.757 ' C ' HD13 ' A' ' 82' ' ' ILE . 86.9 mt-30 -114.29 170.86 7.98 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.808 -0.442 . . . . 1.0 109.808 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.757 HD13 ' C ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -118.06 -177.41 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.192 -179.214 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -47.9 86.54 0.01 OUTLIER Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.894 -0.594 . . . . 1.0 112.079 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.679 ' H ' ' CD1' ' A' ' 84' ' ' LEU . 0.0 OUTLIER -97.9 -3.22 39.0 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 122.761 0.424 . . . . 1.0 111.168 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.14 -32.97 85.95 Favored Glycine 0 CA--C 1.518 0.245 0 N-CA-C 111.941 -0.464 . . . . 1.0 111.941 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 t -108.18 144.8 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.845 0.355 . . . . 1.0 110.255 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 N--CA 1.468 0.471 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.418 -179.707 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.747 -0.835 . . . . 1.0 108.747 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 61.3 t-20 -81.13 70.22 7.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.475 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 73.52 -155.83 0.07 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.129 0.893 . . . . 1.0 111.256 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.8 -140.07 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.705 0.288 . . . . 1.0 111.535 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -62.68 -48.98 76.96 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.622 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -122.39 -120.43 2.64 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 111.43 -0.668 . . . . 1.0 111.43 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.571 HG12 ' N ' ' A' ' 8' ' ' TYR . 36.0 t -134.15 168.55 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 120.824 0.345 . . . . 1.0 110.397 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.571 ' N ' HG12 ' A' ' 7' ' ' VAL . 97.4 m-85 -130.2 140.37 50.74 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.71 128.02 32.46 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.071 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.502 ' H ' HG22 ' A' ' 87' ' ' THR . 23.4 ttt -78.03 -64.74 1.09 Allowed 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 122.194 -0.316 . . . . 1.0 111.723 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.3 p -133.6 160.77 36.49 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.031 0.443 . . . . 1.0 111.535 -178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -125.6 136.52 60.57 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 108.474 -0.936 . . . . 1.0 108.474 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 21.4 mt -107.99 148.91 38.37 Favored Pre-proline 0 N--CA 1.466 0.333 0 O-C-N 123.42 0.45 . . . . 1.0 111.854 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.472 ' O ' ' SD ' ' A' ' 16' ' ' MET . 74.4 Cg_endo -73.23 157.43 50.17 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.288 1.992 . . . . 1.0 111.351 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 64.15 28.0 14.07 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.296 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.472 ' SD ' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -106.59 157.94 33.91 Favored Pre-proline 0 N--CA 1.472 0.628 0 CA-C-O 120.748 0.309 . . . . 1.0 110.357 -179.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.88 -19.55 64.16 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.157 1.905 . . . . 1.0 112.979 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 22' ' ' LEU . . . -100.25 -17.72 17.2 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.65 0.738 . . . . 1.0 111.091 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.32 129.57 42.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.819 -1.082 . . . . 1.0 109.337 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.33 -7.94 62.2 Favored Glycine 0 N--CA 1.469 0.866 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -134.27 -24.36 1.62 Allowed 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.826 0.346 . . . . 1.0 110.537 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . 0.8 OUTLIER -117.41 134.07 55.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.626 -0.715 . . . . 1.0 110.011 -179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 97.5 mt-10 -134.45 148.0 50.51 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 121.549 0.69 . . . . 1.0 110.405 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.2 136.89 48.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.931 -1.032 . . . . 1.0 109.483 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 109.62 -26.63 13.95 Favored Glycine 0 N--CA 1.47 0.916 0 N-CA-C 110.353 -1.099 . . . . 1.0 110.353 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 23' ' ' GLU . 2.8 p-10 -64.78 145.0 56.86 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.604 -0.438 . . . . 1.0 110.72 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -109.69 142.22 41.17 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.933 0.397 . . . . 1.0 109.979 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.0 mm -92.23 122.26 43.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 115.569 -0.742 . . . . 1.0 109.191 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.552 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -94.54 -22.45 18.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.73 -0.668 . . . . 1.0 111.125 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . 179.02 154.07 0.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.133 0.492 . . . . 1.0 110.985 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 91.2 mt -129.55 125.46 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.514 -0.766 . . . . 1.0 109.878 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.7 t70 54.52 17.12 1.52 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.529 -0.76 . . . . 1.0 111.013 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.73 -5.29 47.17 Favored Glycine 0 N--CA 1.469 0.872 0 N-CA-C 111.72 -0.552 . . . . 1.0 111.72 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 75.6 mm-40 -95.19 111.19 54.06 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 117.026 0.413 . . . . 1.0 111.486 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.18 136.45 74.81 Favored 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 122.326 2.017 . . . . 1.0 111.484 178.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.4 mm -97.69 106.37 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.578 0.704 . . . . 1.0 111.805 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -102.68 -25.02 13.7 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.605 -1.18 . . . . 1.0 111.419 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.3 p -140.53 160.18 40.56 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.078 0.466 . . . . 1.0 111.051 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 35.1 m -67.39 -23.04 65.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.615 -0.721 . . . . 1.0 109.103 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -66.01 -32.96 74.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.209 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -61.55 -31.35 71.37 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.511 -0.476 . . . . 1.0 109.82 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.1 mm -75.43 -27.96 19.67 Favored 'Isoleucine or valine' 0 C--N 1.339 0.111 0 CA-C-O 120.983 0.421 . . . . 1.0 110.485 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -68.52 -42.74 83.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.832 -0.622 . . . . 1.0 109.734 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 59.2 p -64.21 -39.73 94.58 Favored 'General case' 0 C--O 1.222 -0.382 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.066 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' CE1' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -58.23 -56.21 24.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.505 -179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 98.6 t -55.82 -44.0 76.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 120.373 -0.531 . . . . 1.0 109.946 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -69.62 -35.79 75.57 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.68 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.42 -62.53 1.59 Allowed 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 110.224 -0.287 . . . . 1.0 110.224 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -85.32 -169.21 2.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.635 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -131.91 176.37 8.42 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.676 0.75 . . . . 1.0 112.039 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.62 134.84 57.47 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.889 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.5 -0.78 74.89 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.124 -0.79 . . . . 1.0 111.124 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.441 ' CG ' ' N ' ' A' ' 54' ' ' ARG . 19.3 t0 -68.62 169.95 10.17 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.888 0.375 . . . . 1.0 111.16 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' N ' ' CG ' ' A' ' 53' ' ' ASP . 76.4 mtp180 -140.73 117.75 11.18 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.754 -0.461 . . . . 1.0 109.754 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG21 ' CE1' ' A' ' 45' ' ' TYR . 6.7 m -129.23 135.14 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.855 0.836 . . . . 1.0 111.88 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.434 ' NH1' ' OE2' ' A' ' 69' ' ' GLU . 83.9 mmt-85 -76.75 105.84 8.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.31 -1.314 . . . . 1.0 108.786 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.0 t -95.06 135.21 29.82 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.561 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.9 m -104.97 137.52 42.6 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 109.961 -0.385 . . . . 1.0 109.961 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -149.9 150.96 32.66 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 109.856 -0.424 . . . . 1.0 109.856 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.4 mp -103.12 137.67 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 121.741 0.781 . . . . 1.0 111.706 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 53.2 ttm-85 -143.34 117.63 9.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.465 -1.243 . . . . 1.0 110.175 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 52.84 44.77 29.9 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.271 -0.877 . . . . 1.0 110.251 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 66.67 8.31 5.8 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.706 -0.225 . . . . 1.0 111.335 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -111.92 113.34 25.61 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.952 -0.388 . . . . 1.0 109.952 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.413 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 51.1 mt-30 -75.79 146.23 40.11 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.401 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.413 ' CG ' ' O ' ' A' ' 65' ' ' GLN . 98.2 m-70 -156.53 140.94 16.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.979 0.419 . . . . 1.0 110.817 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -90.99 128.69 36.91 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.556 -0.747 . . . . 1.0 110.673 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.85 123.88 49.25 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.401 0.619 . . . . 1.0 110.471 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.438 ' C ' HD12 ' A' ' 70' ' ' LEU . 42.6 tp10 -78.74 100.54 7.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.782 -1.099 . . . . 1.0 110.041 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.438 HD12 ' C ' ' A' ' 69' ' ' GLU . 10.3 mp -114.83 149.24 37.38 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.462 0.649 . . . . 1.0 110.846 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.2 m -136.13 137.84 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 114.755 -1.112 . . . . 1.0 111.505 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.0 mt -61.16 120.44 10.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.995 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 83' ' ' GLY . 84.4 tttt -118.62 119.94 32.22 Favored Pre-proline 0 CA--C 1.552 1.027 0 CA-C-N 115.264 -0.88 . . . . 1.0 111.872 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.22 174.0 13.56 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.744 2.296 . . . . 1.0 112.713 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -85.5 159.13 56.37 Favored Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.537 -0.756 . . . . 1.0 110.759 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -44.46 -86.16 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.393 2.062 . . . . 1.0 113.612 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' A' ' 77' ' ' HIS . 60.9 t60 -101.38 8.06 42.41 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-O 120.771 0.32 . . . . 1.0 110.692 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.431 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 58.6 m-70 -121.93 50.7 2.55 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.849 179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.44 ' C ' ' N ' ' A' ' 81' ' ' GLN . 25.5 Cg_endo -60.89 -6.65 6.36 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 122.869 2.379 . . . . 1.0 111.353 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -50.16 -13.07 0.1 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.53 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.534 ' O ' HD13 ' A' ' 82' ' ' ILE . 12.4 tp60 -131.06 -167.34 1.83 Allowed 'General case' 0 C--N 1.347 0.491 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.534 HD13 ' O ' ' A' ' 81' ' ' GLN . 1.2 mm -129.72 170.4 19.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 115.821 -0.627 . . . . 1.0 109.695 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 73' ' ' LYS . . . -47.37 82.01 0.01 OUTLIER Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.418 -0.81 . . . . 1.0 112.153 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 82' ' ' ILE . 0.6 OUTLIER -99.59 -3.68 32.72 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.373 0.269 . . . . 1.0 110.348 -179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -47.83 -25.17 3.43 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.959 -0.639 . . . . 1.0 112.041 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.0 t -107.98 145.74 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.668 0.271 . . . . 1.0 110.474 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 10' ' ' MET . 13.2 t . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.124 -0.941 . . . . 1.0 111.253 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.807 ' H ' HD22 ' A' ' 2' ' ' ASN . 0.0 OUTLIER -81.03 167.66 19.54 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.216 -179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -73.39 -76.79 0.12 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.871 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.63 140.57 47.18 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.664 -0.244 . . . . 1.0 110.582 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.29 172.69 10.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.67 0.272 . . . . 1.0 110.85 -179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -114.49 -119.12 3.36 Favored Glycine 0 N--CA 1.474 1.18 0 N-CA-C 111.474 -0.651 . . . . 1.0 111.474 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 31.2 m -130.82 170.39 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.783 0.325 . . . . 1.0 110.383 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -133.65 129.51 36.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.961 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.34 127.75 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.179 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.529 ' H ' ' CG2' ' A' ' 87' ' ' THR . 11.0 tpt -75.84 -53.04 9.07 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 122.186 -0.321 . . . . 1.0 111.278 -178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.1 p -148.05 165.26 31.33 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.015 0.436 . . . . 1.0 111.365 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.8 p -126.59 135.28 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 108.566 -0.901 . . . . 1.0 108.566 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.19 153.08 39.81 Favored Pre-proline 0 CA--C 1.538 0.508 0 O-C-N 123.434 0.459 . . . . 1.0 111.176 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.64 158.75 52.81 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.558 2.172 . . . . 1.0 111.88 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.6 t30 56.27 32.45 20.39 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.405 -0.816 . . . . 1.0 111.116 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 45.9 mmm -106.88 161.13 23.87 Favored Pre-proline 0 N--CA 1.469 0.502 0 O-C-N 123.174 0.296 . . . . 1.0 110.882 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -58.32 -30.43 91.03 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.343 2.029 . . . . 1.0 112.821 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.432 ' HB2' HD22 ' A' ' 70' ' ' LEU . . . -97.85 -14.43 20.73 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.922 0.391 . . . . 1.0 111.465 -178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.99 122.66 14.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.984 -0.553 . . . . 1.0 109.65 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.71 -8.22 65.85 Favored Glycine 0 N--CA 1.47 0.96 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -119.73 -25.66 5.86 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.238 0.542 . . . . 1.0 110.538 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.604 HD22 ' OD2' ' A' ' 26' ' ' ASP . 14.2 mt -140.03 170.62 15.52 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.743 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' O ' ' OD1' ' A' ' 26' ' ' ASP . 7.1 mt-10 -156.06 165.01 37.7 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.15 -0.932 . . . . 1.0 111.377 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.85 137.71 57.64 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.498 -1.228 . . . . 1.0 109.025 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.4 -25.81 14.72 Favored Glycine 0 N--CA 1.469 0.882 0 N-CA-C 110.55 -1.02 . . . . 1.0 110.55 -179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.604 ' OD2' HD22 ' A' ' 22' ' ' LEU . 7.6 p-10 -72.64 154.04 40.94 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.791 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.5 ptt-85 -121.81 151.42 40.63 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.77 -0.455 . . . . 1.0 109.77 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.5 mm -96.69 129.24 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 115.732 -0.667 . . . . 1.0 109.78 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -98.5 -27.29 14.11 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.693 -0.685 . . . . 1.0 111.173 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -172.85 151.03 2.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.898 0.38 . . . . 1.0 111.409 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.4 mt -127.84 123.6 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 115.711 -0.677 . . . . 1.0 110.166 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 49.2 t0 56.59 17.16 2.91 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.363 -0.835 . . . . 1.0 110.962 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.98 -5.27 42.3 Favored Glycine 0 N--CA 1.473 1.119 0 N-CA-C 111.927 -0.469 . . . . 1.0 111.927 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 -96.2 110.45 52.33 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-O 119.379 -0.344 . . . . 1.0 111.399 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.88 137.53 81.45 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.336 2.024 . . . . 1.0 111.394 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mm -97.75 106.71 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 121.575 0.702 . . . . 1.0 111.744 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -104.22 -21.52 13.53 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.759 -1.109 . . . . 1.0 111.276 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.8 p -144.3 161.01 40.03 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.993 0.425 . . . . 1.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 79.0 p -66.86 -23.85 66.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.833 -0.621 . . . . 1.0 109.353 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.21 -34.1 77.57 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.071 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -59.95 -33.34 71.78 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.775 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.9 mm -71.92 -28.16 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.942 0.401 . . . . 1.0 110.547 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -66.02 -42.98 92.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.954 -0.566 . . . . 1.0 109.909 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 t -62.75 -41.43 99.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.789 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -55.65 -58.18 8.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.883 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.42 -43.0 81.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -62.85 -44.36 96.34 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.959 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -60.15 -58.09 10.02 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.005 0.431 . . . . 1.0 110.25 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -81.49 170.94 15.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.382 -178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -136.41 -172.24 3.1 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.126 0.489 . . . . 1.0 111.42 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.95 129.73 40.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.465 -0.789 . . . . 1.0 110.143 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.39 -8.73 64.57 Favored Glycine 0 N--CA 1.472 1.033 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.475 ' O ' HG13 ' A' ' 71' ' ' VAL . 20.2 t70 -70.81 174.61 5.84 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.975 0.417 . . . . 1.0 111.155 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.447 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 83.7 mtt85 -145.14 127.89 16.26 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.885 -0.598 . . . . 1.0 109.789 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.93 132.9 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 121.905 0.86 . . . . 1.0 111.862 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.8 mmm-85 -78.12 103.01 7.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.272 -1.331 . . . . 1.0 108.496 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 99.1 t -95.42 135.49 29.33 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.762 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.051 -178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 39.5 m -105.08 138.87 40.62 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.645 -0.502 . . . . 1.0 109.645 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CD2' HD21 ' A' ' 22' ' ' LEU . 36.0 p90 -148.92 155.15 40.44 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 110.026 -0.361 . . . . 1.0 110.026 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.5 mp -110.19 134.59 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 121.629 0.728 . . . . 1.0 111.13 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -141.91 123.84 15.31 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 114.611 -1.177 . . . . 1.0 110.657 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 48.02 46.16 19.22 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.576 -0.738 . . . . 1.0 110.655 179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 57.4 ttt-85 67.67 6.66 5.15 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.846 0.355 . . . . 1.0 110.606 179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -112.29 116.12 29.88 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 109.802 -0.444 . . . . 1.0 109.802 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -90.55 143.21 26.97 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.91 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -152.34 148.49 27.56 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.839 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -90.99 127.08 36.28 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.507 -0.769 . . . . 1.0 110.632 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.93 124.54 49.77 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.446 0.641 . . . . 1.0 110.044 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -87.08 102.14 14.14 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 114.558 -1.201 . . . . 1.0 109.703 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 18' ' ' ALA . 36.3 mt -113.31 151.19 31.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.669 -178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 53' ' ' ASP . 2.9 t -124.07 130.64 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-N 115.595 -0.73 . . . . 1.0 111.019 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.2 mm? -56.67 120.16 7.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.134 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -121.74 117.15 30.07 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-N 115.794 -0.639 . . . . 1.0 111.547 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.1 179.27 6.28 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.913 2.409 . . . . 1.0 112.244 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -89.8 152.23 46.45 Favored Pre-proline 0 CA--C 1.543 0.702 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.603 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.27 -60.39 0.07 OUTLIER 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.349 2.032 . . . . 1.0 112.612 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -100.31 21.21 13.4 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.514 ' N ' ' CD ' ' A' ' 79' ' ' PRO . 0.7 OUTLIER -164.2 45.12 0.12 Allowed Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.373 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 78' ' ' HIS . 15.1 Cg_endo -53.82 -10.63 1.83 Allowed 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.679 2.252 . . . . 1.0 112.107 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -56.0 -8.64 0.47 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.587 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 79' ' ' PRO . 1.1 mp0 -130.52 156.38 44.9 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.4 mt -142.53 142.57 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 115.415 -0.811 . . . . 1.0 110.623 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.55 2.89 52.22 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.601 -0.6 . . . . 1.0 111.601 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.1 tp -66.19 -40.17 90.24 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.144 -0.222 . . . . 1.0 111.492 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -33.66 -47.48 0.46 Allowed Glycine 0 N--CA 1.47 0.9 0 O-C-N 123.621 0.575 . . . . 1.0 112.32 -178.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 87' ' ' THR . 40.1 t -111.92 157.17 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 120.932 0.396 . . . . 1.0 110.705 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.529 ' CG2' ' H ' ' A' ' 10' ' ' MET . 6.7 t . . . . . 0 C--O 1.219 -0.523 0 CA-C-O 117.87 -1.062 . . . . 1.0 111.097 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 tmm? . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 108.805 -0.813 . . . . 1.0 108.805 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -164.59 -76.32 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.931 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 60.25 56.38 3.27 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 123.445 0.465 . . . . 1.0 110.363 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -66.81 -63.16 1.12 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.917 -0.583 . . . . 1.0 111.545 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -119.19 -43.93 2.61 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 111.357 0.132 . . . . 1.0 111.357 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -116.6 -112.71 2.72 Favored Glycine 0 N--CA 1.476 1.321 0 N-CA-C 111.463 -0.655 . . . . 1.0 111.463 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 8' ' ' TYR . 21.5 t -137.31 158.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.699 0.285 . . . . 1.0 110.381 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.409 ' N ' HG12 ' A' ' 7' ' ' VAL . 50.7 m-85 -129.11 137.41 51.21 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.8 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.21 127.69 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.12 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 34.6 mtt -75.35 -65.46 0.89 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.733 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -128.94 160.87 31.3 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.166 0.507 . . . . 1.0 111.16 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -128.12 138.92 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.0 mp -109.89 145.17 31.48 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 123.137 0.273 . . . . 1.0 111.121 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.08 -24.28 20.59 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.441 2.094 . . . . 1.0 112.396 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -99.05 17.93 18.56 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.639 -0.255 . . . . 1.0 111.159 -178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.483 ' SD ' ' O ' ' A' ' 85' ' ' GLY . 27.8 mtt -113.17 158.53 37.83 Favored Pre-proline 0 N--CA 1.469 0.485 0 O-C-N 123.055 0.222 . . . . 1.0 110.9 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.66 -32.11 53.2 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.415 2.076 . . . . 1.0 113.295 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -74.25 -8.78 57.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.685 0.279 . . . . 1.0 111.385 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.07 109.65 1.57 Allowed 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.122 -0.631 . . . . 1.0 110.719 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.68 -14.83 64.59 Favored Glycine 0 N--CA 1.469 0.852 0 N-CA-C 111.232 -0.747 . . . . 1.0 111.232 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -108.11 -41.63 4.87 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.124 0.488 . . . . 1.0 110.802 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.47 156.84 40.04 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.377 -0.829 . . . . 1.0 110.484 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -144.29 158.1 43.92 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.545 -0.752 . . . . 1.0 111.157 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.28 134.81 56.46 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.112 -0.949 . . . . 1.0 109.421 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.95 -26.2 18.15 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 110.247 -1.141 . . . . 1.0 110.247 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -72.75 150.68 42.63 Favored 'General case' 0 N--CA 1.465 0.285 0 O-C-N 122.782 -0.246 . . . . 1.0 110.63 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -114.61 154.58 28.11 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.161 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.8 mm -97.35 120.14 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.024 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.21 -20.47 19.19 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.894 -0.594 . . . . 1.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -175.6 158.72 2.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.226 0.536 . . . . 1.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 96.5 mt -135.75 125.03 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 115.28 -0.873 . . . . 1.0 110.105 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.0 t0 51.22 21.72 1.17 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.124 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.59 -7.33 57.81 Favored Glycine 0 N--CA 1.471 0.992 0 N-CA-C 111.617 -0.593 . . . . 1.0 111.617 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.3 mm100 -89.93 124.85 62.53 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.75 -0.265 . . . . 1.0 111.254 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.4 132.8 15.28 Favored 'Trans proline' 0 N--CA 1.497 1.714 0 C-N-CA 121.981 1.787 . . . . 1.0 111.465 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mm -99.13 110.89 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.496 0.665 . . . . 1.0 112.433 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -115.53 -18.18 11.0 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 114.661 -1.154 . . . . 1.0 111.108 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -139.37 156.01 47.28 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.241 0.544 . . . . 1.0 111.1 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 72.1 m -66.28 -22.57 66.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.233 -0.894 . . . . 1.0 108.878 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -68.33 -35.34 77.63 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.523 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.482 ' H ' HG23 ' A' ' 38' ' ' THR . 69.6 tp60 -57.1 -31.71 65.55 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.859 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.7 mm -74.79 -26.84 19.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.781 -0.191 . . . . 1.0 110.971 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 64.9 t -69.54 -41.7 80.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.052 0.453 . . . . 1.0 110.273 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.2 t -65.62 -40.58 92.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.281 0.562 . . . . 1.0 109.944 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' CD1' ' C ' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -58.18 -57.16 14.09 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.356 -0.838 . . . . 1.0 110.646 -179.14 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 49' ' ' LYS . 29.0 m -58.55 -39.77 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.325 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 74.6 mtp85 -66.04 -37.61 86.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.707 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.77 -53.86 47.89 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.339 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 46' ' ' VAL . 72.1 mmtt -87.31 156.96 19.4 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.55 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.4 -178.18 3.34 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.295 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.27 135.91 55.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.567 -0.742 . . . . 1.0 110.177 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.82 -1.53 74.97 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.853 -0.899 . . . . 1.0 110.853 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 30.7 t70 -74.24 172.04 12.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.033 0.444 . . . . 1.0 110.879 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 77.0 mtp85 -141.76 130.04 22.31 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.078 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 m -138.63 133.51 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.892 0.854 . . . . 1.0 111.942 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.14 107.44 7.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.383 -1.28 . . . . 1.0 108.767 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.03 137.36 24.92 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.819 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.329 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 60.2 m -104.92 139.22 39.96 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.679 -0.489 . . . . 1.0 109.679 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' C ' HD12 ' A' ' 60' ' ' ILE . 34.4 p90 -150.31 151.87 33.59 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 110.116 -0.327 . . . . 1.0 110.116 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.5 mp -108.23 132.07 57.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-O 121.525 0.679 . . . . 1.0 111.472 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 70.2 ttp85 -138.58 124.24 19.7 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.4 178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 49.58 43.82 24.15 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 115.291 -0.868 . . . . 1.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 70.43 -1.35 2.54 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 111.322 0.119 . . . . 1.0 111.322 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -107.42 106.06 16.28 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 120.529 0.204 . . . . 1.0 110.824 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -76.82 145.3 38.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.212 0.529 . . . . 1.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -153.88 146.09 23.8 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.327 -0.852 . . . . 1.0 111.052 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -89.12 132.11 34.96 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.543 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.94 124.62 52.77 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.91 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 39.1 mp0 -80.04 101.95 9.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.232 -0.894 . . . . 1.0 109.738 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.3 tt -109.34 143.0 39.46 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.749 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.7 131.0 71.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.442 -179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.533 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.1 mm? -65.68 131.6 46.73 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.502 . . . . 1.0 111.08 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -145.09 135.21 11.8 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 115.589 -0.732 . . . . 1.0 110.942 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.55 171.82 16.98 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.811 2.341 . . . . 1.0 112.356 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -109.43 137.28 20.24 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.929 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -48.65 -40.05 38.0 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.051 1.834 . . . . 1.0 112.269 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 10.2 m80 -73.4 -39.01 65.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.848 0.356 . . . . 1.0 110.479 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -118.96 70.07 9.87 Favored Pre-proline 0 N--CA 1.472 0.644 0 CA-C-N 116.092 -0.504 . . . . 1.0 109.997 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.56 -29.58 78.44 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.135 1.89 . . . . 1.0 111.859 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -86.66 25.88 1.19 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.286 -0.415 . . . . 1.0 110.21 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.649 ' C ' HD13 ' A' ' 82' ' ' ILE . 59.7 tt0 -144.4 149.77 36.63 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.762 -0.458 . . . . 1.0 109.762 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.649 HD13 ' C ' ' A' ' 81' ' ' GLN . 0.3 OUTLIER -124.1 138.96 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.055 -179.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -152.81 -179.01 28.01 Favored Glycine 0 N--CA 1.466 0.634 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 84' ' ' LEU . 6.4 mp -68.7 -89.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.257 -178.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.483 ' O ' ' SD ' ' A' ' 16' ' ' MET . . . 177.18 -10.74 0.03 OUTLIER Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.3 m -108.09 171.54 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 O-C-N 122.595 -0.356 . . . . 1.0 110.079 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 46.1 m . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.689 -179.285 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.751 -0.833 . . . . 1.0 108.751 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -151.89 86.18 1.31 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.851 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 4' ' ' ALA . 97.0 mt-10 -101.95 165.08 11.37 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.193 -0.458 . . . . 1.0 109.831 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 3' ' ' GLU . . . -24.0 126.17 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 O-C-N 123.855 0.722 . . . . 1.0 112.141 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 8' ' ' TYR . 54.6 mtmt -85.54 -164.96 1.09 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.909 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.586 ' N ' ' NH2' ' A' ' 27' ' ' ARG . . . -110.39 -122.28 4.37 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 111.102 -0.799 . . . . 1.0 111.102 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.412 HG12 ' N ' ' A' ' 8' ' ' TYR . 7.8 t -120.63 164.06 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.451 ' OH ' ' NZ ' ' A' ' 5' ' ' LYS . 67.9 m-85 -120.99 125.73 48.1 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.323 -0.398 . . . . 1.0 111.091 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.8 t -76.55 124.8 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.842 -0.617 . . . . 1.0 109.782 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 19.6 mmt -70.67 -66.47 0.6 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.659 -0.246 . . . . 1.0 111.544 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.3 t -137.99 173.57 11.49 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.069 0.461 . . . . 1.0 111.064 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -125.15 133.58 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 108.331 -0.988 . . . . 1.0 108.331 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.1 mt -112.64 114.2 49.98 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.115 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -45.54 163.16 0.09 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.98 1.786 . . . . 1.0 112.06 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.5 m120 68.18 19.02 9.24 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 123.971 0.794 . . . . 1.0 111.027 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 13.8 mmt -111.1 160.28 29.58 Favored Pre-proline 0 N--CA 1.471 0.617 0 O-C-N 123.239 0.337 . . . . 1.0 111.116 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -55.73 -39.56 90.4 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.796 1.664 . . . . 1.0 112.954 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB1' ' HB3' ' A' ' 22' ' ' LEU . . . -84.94 -12.5 53.21 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.01 0.433 . . . . 1.0 111.596 -177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.23 131.27 45.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.551 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.53 -14.53 64.81 Favored Glycine 0 N--CA 1.472 1.042 0 N-CA-C 111.111 -0.795 . . . . 1.0 111.111 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.463 ' HE ' ' HA ' ' A' ' 68' ' ' ALA . 6.8 ptm85 -129.06 -23.45 3.03 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.912 0.387 . . . . 1.0 110.728 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.532 ' HB3' ' HB1' ' A' ' 18' ' ' ALA . 23.1 tp -122.97 148.19 45.77 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.441 -0.8 . . . . 1.0 110.311 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -143.79 157.9 44.06 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.687 0.756 . . . . 1.0 111.197 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.8 136.19 56.92 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.62 -1.173 . . . . 1.0 109.075 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.19 -28.56 10.2 Favored Glycine 0 N--CA 1.469 0.884 0 N-CA-C 110.066 -1.214 . . . . 1.0 110.066 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -71.02 146.04 49.62 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.283 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.586 ' NH2' ' N ' ' A' ' 6' ' ' GLY . 14.8 ptm180 -114.93 161.54 18.14 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.277 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.6 mm -99.74 119.28 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 121.061 0.458 . . . . 1.0 110.303 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HB2' HD13 ' A' ' 60' ' ' ILE . . . -93.6 -19.36 21.23 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.787 -0.642 . . . . 1.0 110.674 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -177.42 164.44 2.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.582 0.706 . . . . 1.0 111.324 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 76.6 mt -139.78 122.81 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 114.909 -1.041 . . . . 1.0 109.813 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 49.88 24.2 1.24 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.892 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.34 -6.12 61.18 Favored Glycine 0 N--CA 1.466 0.681 0 N-CA-C 111.801 -0.52 . . . . 1.0 111.801 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -93.0 107.88 28.17 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 116.887 0.344 . . . . 1.0 111.231 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 136.42 71.03 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 121.905 1.737 . . . . 1.0 111.546 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 32.3 mm -102.84 113.31 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 121.68 0.752 . . . . 1.0 111.886 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.464 ' OD1' ' NE2' ' A' ' 41' ' ' GLN . 51.4 p30 -114.14 -20.65 10.86 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.416 -1.266 . . . . 1.0 111.586 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.43 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 56.4 p -134.6 160.34 38.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.015 0.436 . . . . 1.0 110.859 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.8 p -77.55 -27.61 51.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.052 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -67.8 -30.34 69.74 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.024 -0.535 . . . . 1.0 111.018 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.464 ' NE2' ' OD1' ' A' ' 37' ' ' ASN . 16.0 mt-30 -64.11 -27.45 69.1 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 mm -78.06 -26.55 14.54 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.506 0 CA-C-N 116.522 -0.308 . . . . 1.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.5 t -70.46 -41.79 78.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 123.536 0.522 . . . . 1.0 110.209 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.1 m -70.07 -39.29 75.73 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.307 0.575 . . . . 1.0 109.782 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.408 ' OH ' ' CG1' ' A' ' 55' ' ' VAL . 86.4 t80 -58.89 -55.74 31.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.41 -0.814 . . . . 1.0 110.888 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.4 m -55.45 -36.7 42.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 CA-C-O 120.733 0.301 . . . . 1.0 110.354 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.655 ' NH2' HE22 ' A' ' 81' ' ' GLN . 30.1 mmt180 -65.58 -36.57 84.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.941 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -58.44 -43.41 88.77 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.4 -0.52 . . . . 1.0 110.013 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.2 mmmt -93.29 149.8 20.95 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.309 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.58 ' CD ' ' H ' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -101.24 178.3 4.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.143 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.88 138.58 57.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.646 -0.706 . . . . 1.0 110.125 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.47 -1.87 82.35 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 110.782 -0.927 . . . . 1.0 110.782 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 54' ' ' ARG . 24.4 t70 -71.95 175.93 5.45 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.826 0.345 . . . . 1.0 110.716 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.478 ' H ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -139.39 129.99 25.84 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.481 -0.562 . . . . 1.0 109.481 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.408 ' CG1' ' OH ' ' A' ' 45' ' ' TYR . 5.9 m -136.11 130.89 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.974 0.892 . . . . 1.0 111.395 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -80.85 106.51 12.91 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.286 -1.325 . . . . 1.0 108.968 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 53.6 t -97.07 143.46 12.39 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.791 0 CA-C-N 115.73 -0.668 . . . . 1.0 110.599 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.1 m -109.75 138.88 45.48 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 123.536 0.522 . . . . 1.0 109.685 179.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -150.24 150.91 32.21 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.485 HD13 ' HB2' ' A' ' 29' ' ' ALA . 1.5 mp -107.88 134.06 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-O 121.672 0.749 . . . . 1.0 111.192 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 57.2 ttt85 -138.05 121.9 17.66 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 114.37 -1.287 . . . . 1.0 109.885 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 49.11 43.25 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.851 179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 71.67 3.11 4.54 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.886 -0.143 . . . . 1.0 111.343 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -108.61 105.36 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.72 0.295 . . . . 1.0 110.946 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -78.26 138.68 38.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.057 0.456 . . . . 1.0 111.011 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -148.43 145.24 27.92 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.641 -0.708 . . . . 1.0 110.992 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -89.89 132.88 35.06 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.246 -0.888 . . . . 1.0 110.343 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HA ' ' HE ' ' A' ' 21' ' ' ARG . . . -110.13 121.3 44.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.843 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -78.0 102.3 7.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.01 -0.995 . . . . 1.0 109.394 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.3 tt -115.51 149.68 37.74 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.56 -0.746 . . . . 1.0 111.876 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.8 m -128.25 135.58 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 115.268 -0.878 . . . . 1.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 72' ' ' LEU . 4.0 mm? -61.45 130.83 47.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.548 -0.751 . . . . 1.0 110.443 -178.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -143.59 92.91 6.41 Favored Pre-proline 0 CA--C 1.546 0.797 0 CA-C-N 115.715 -0.675 . . . . 1.0 110.473 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.3 177.45 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.664 0 C-N-CA 122.719 2.279 . . . . 1.0 112.424 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -109.65 148.3 37.86 Favored Pre-proline 0 N--CA 1.474 0.763 0 CA-C-N 115.655 -0.702 . . . . 1.0 110.872 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.06 -30.84 76.23 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.103 1.869 . . . . 1.0 111.845 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.497 ' ND1' ' N ' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -74.05 -33.5 63.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.965 0.412 . . . . 1.0 109.988 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -132.66 72.22 77.84 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 115.711 -0.677 . . . . 1.0 109.888 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -61.14 -20.69 68.95 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.231 1.954 . . . . 1.0 111.878 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -93.63 17.08 12.36 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.956 -0.387 . . . . 1.0 109.956 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.655 HE22 ' NH2' ' A' ' 47' ' ' ARG . 9.3 tp-100 -136.02 124.57 23.61 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.003 0.43 . . . . 1.0 110.094 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.757 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -84.97 -175.59 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.422 -0.808 . . . . 1.0 110.003 -179.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 163.31 172.99 31.48 Favored Glycine 0 CA--C 1.521 0.456 0 N-CA-C 110.925 -0.87 . . . . 1.0 110.925 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 84' ' ' LEU . 3.6 mm? -78.24 -88.67 0.05 Allowed 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.578 -0.449 . . . . 1.0 110.53 -178.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -179.23 -11.12 0.02 OUTLIER Glycine 0 CA--C 1.531 1.054 0 N-CA-C 110.967 -0.853 . . . . 1.0 110.967 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.0 m -109.63 170.87 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 122.469 0.308 . . . . 1.0 110.262 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.218 -0.597 0 CA-C-O 118.029 -0.986 . . . . 1.0 111.051 -179.162 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' ASN . 83.1 mmm . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 108.81 -0.811 . . . . 1.0 108.81 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' MET . 65.9 m-80 57.54 118.72 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.777 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.5 tp10 50.39 64.36 1.83 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.108 0.48 . . . . 1.0 110.694 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -168.74 166.66 11.56 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.747 -0.661 . . . . 1.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -134.7 -112.1 0.21 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' A' ' 8' ' ' TYR . . . 108.73 111.32 3.45 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.575 -0.61 . . . . 1.0 111.575 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.4 t -59.2 96.1 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 6' ' ' GLY . 4.1 m-85 -60.72 114.01 2.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.845 -0.616 . . . . 1.0 111.528 -178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -79.54 131.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.074 -0.512 . . . . 1.0 109.906 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 13.9 ttt -81.27 -72.75 0.41 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 111.692 0.256 . . . . 1.0 111.692 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.2 m -129.71 162.0 29.38 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.17 0.51 . . . . 1.0 111.209 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.8 t -124.64 131.5 72.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 115.307 -0.861 . . . . 1.0 108.915 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 13' ' ' LEU . 4.2 mm? -89.09 115.2 62.99 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.771 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.04 -19.94 12.69 Favored 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 121.976 1.784 . . . . 1.0 112.246 178.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -99.19 22.28 10.69 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.653 -0.248 . . . . 1.0 110.982 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 7.7 mmt -121.04 159.05 50.93 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.683 -0.235 . . . . 1.0 110.905 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.85 -22.05 66.63 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.485 2.123 . . . . 1.0 112.772 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -78.11 -14.23 59.56 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.833 0.349 . . . . 1.0 111.671 -178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.13 132.74 48.44 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.915 0.388 . . . . 1.0 110.407 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.12 -19.98 27.97 Favored Glycine 0 N--CA 1.468 0.829 0 N-CA-C 110.881 -0.888 . . . . 1.0 110.881 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 84.8 mtt85 -104.92 -41.49 5.6 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.15 156.63 31.92 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.068 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -138.34 155.95 48.08 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.542 -0.754 . . . . 1.0 111.101 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.21 134.29 56.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.311 -0.858 . . . . 1.0 109.469 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.37 -26.4 18.59 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -70.07 145.46 51.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 121.075 -0.25 . . . . 1.0 110.381 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -111.0 153.24 25.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.871 0.367 . . . . 1.0 110.657 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.8 mm -95.43 119.62 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 1.0 109.861 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 30' ' ' ALA . . . -93.75 -16.95 23.69 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.99 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.457 ' HB2' ' O ' ' A' ' 29' ' ' ALA . . . 174.41 164.32 0.22 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.31 0.576 . . . . 1.0 110.934 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.408 HG21 ' CE2' ' A' ' 45' ' ' TYR . 92.7 mt -135.93 125.98 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.625 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.419 ' OD2' ' CE1' ' A' ' 45' ' ' TYR . 1.0 OUTLIER 49.97 17.91 0.33 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.15 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.95 -5.84 46.95 Favored Glycine 0 N--CA 1.469 0.872 0 CA-C-N 115.906 -0.588 . . . . 1.0 112.053 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -92.94 108.77 34.76 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.978 0.389 . . . . 1.0 111.318 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.04 133.28 52.32 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.219 1.946 . . . . 1.0 111.551 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.1 mm -102.16 116.7 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 121.649 0.738 . . . . 1.0 111.855 -178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 38' ' ' THR . 48.9 p30 -107.92 -23.52 12.0 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.579 -1.191 . . . . 1.0 111.409 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.467 ' N ' ' OD1' ' A' ' 37' ' ' ASN . 69.2 p -137.21 155.26 49.74 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.034 0.445 . . . . 1.0 111.113 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 78.2 p -68.73 -32.81 72.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.715 -0.675 . . . . 1.0 109.484 178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -61.94 -30.87 71.2 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.264 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -61.99 -30.01 70.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.318 -0.553 . . . . 1.0 109.946 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -71.6 -29.63 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 CA-C-N 116.564 -0.289 . . . . 1.0 110.547 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.3 t -66.65 -43.68 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.268 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 40.7 t -65.17 -42.51 93.63 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.843 -0.429 . . . . 1.0 109.843 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.419 ' CE1' ' OD2' ' A' ' 32' ' ' ASP . 64.8 t80 -57.61 -57.1 14.21 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.765 -0.652 . . . . 1.0 110.325 -179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 50.6 t -53.96 -40.93 47.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -65.97 -20.81 66.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.923 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -61.85 -56.19 21.98 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -90.71 -163.41 1.02 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.961 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -141.46 -171.62 3.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.343 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 134.72 53.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.141 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.52 63.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -79.42 161.79 25.91 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.831 0.348 . . . . 1.0 111.068 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -127.5 122.35 33.16 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 109.268 -0.641 . . . . 1.0 109.268 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.62 132.78 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-O 121.997 0.904 . . . . 1.0 111.535 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 35.1 mmm-85 -83.34 116.34 22.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.401 -1.272 . . . . 1.0 109.033 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.0 t -107.41 131.14 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.95 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.4 m -101.48 133.4 46.19 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.317 -0.401 . . . . 1.0 109.993 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.47 ' C ' HD12 ' A' ' 60' ' ' ILE . 32.4 p90 -147.83 152.19 37.23 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.47 HD12 ' C ' ' A' ' 59' ' ' PHE . 1.6 mp -109.67 139.47 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-O 121.389 0.614 . . . . 1.0 110.651 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -142.84 121.85 12.84 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.192 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 52.39 40.82 30.16 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.862 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 69.1 13.37 8.69 Favored 'General case' 0 C--N 1.332 -0.168 0 O-C-N 123.332 0.395 . . . . 1.0 111.363 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -114.16 109.0 17.73 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -77.27 131.52 38.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.191 0.519 . . . . 1.0 111.278 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -146.07 144.47 30.05 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.949 -0.568 . . . . 1.0 111.037 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.452 ' N ' ' OE1' ' A' ' 67' ' ' GLU . 40.6 mp0 -90.89 137.46 32.34 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.469 -0.787 . . . . 1.0 110.649 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.9 120.21 41.75 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.321 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -80.86 101.44 9.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.251 -0.886 . . . . 1.0 109.93 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.7 tt -110.95 140.99 44.98 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.959 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.85 131.97 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-O 121.456 0.645 . . . . 1.0 110.651 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.587 HD22 ' N ' ' A' ' 72' ' ' LEU . 3.8 mm? -65.71 121.99 16.25 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.6 -0.727 . . . . 1.0 110.641 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -132.23 124.53 19.39 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.873 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.19 -177.0 3.36 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.824 2.349 . . . . 1.0 112.565 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -118.75 144.6 35.88 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.275 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.27 -36.43 16.33 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.997 1.798 . . . . 1.0 111.934 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.4 m-70 -70.42 -39.16 74.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.066 0.46 . . . . 1.0 110.119 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 45.2 m-70 -139.9 74.05 32.48 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-N 115.708 -0.678 . . . . 1.0 110.715 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.07 -23.34 60.34 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.658 2.239 . . . . 1.0 111.703 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -59.34 -17.36 28.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.615 -0.72 . . . . 1.0 110.748 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' C ' HD13 ' A' ' 82' ' ' ILE . 66.5 tp60 -111.97 147.61 35.54 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-O 121.171 0.51 . . . . 1.0 109.877 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.671 ' N ' HD13 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -94.05 179.62 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 115.418 -0.81 . . . . 1.0 110.602 -179.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.71 130.0 36.44 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.402 -0.679 . . . . 1.0 111.402 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.63 -17.94 20.06 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.719 0.295 . . . . 1.0 110.692 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.61 -94.45 0.34 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.74 -0.544 . . . . 1.0 111.74 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.4 m -107.42 172.2 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.489 0.316 . . . . 1.0 110.68 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 118.108 -0.949 . . . . 1.0 110.967 -178.91 . . . . . . . . 0 0 . 1 stop_ save_